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Abstract 
 
Industrial uses of polyethers have expanded to medical applications, ranging from artificial 
tissues (i.e. implants, sutures and prosthetics), to the encapsulation of drugs; however post-
polymerisation functionalisation methods are limited. Olefin cross metathesis (CM) is a 
powerful carbon-carbon bond forming reaction, and therefore could potentially conjugate 
polymers possessing pendent olefin handles. This could be of significant importance as the 
alkenes do not readily interfere with common polymerisation techniques such as anionic 
ring opening polymerisation (ROP), polyesterifications, or polyamidations. 
 
 
 
This project describes the synthesis of novel biocompatible polyethers with diverse pendent 
olefins and their cross metathesis reaction with a range of partners. These various polymers 
are designed to probe the possibility of preventing the occurrence of self metathesis upon 
functionalisation using Hoveyda-Grubbs’ second-generation catalyst. One such polymer, 
poly(methallyl glycidyl ether) has been proven to be immune to the undesired self 
metathesis pathway allowing for retention of the low polymer dispersity ( = 1.15). We have 
shown that the cell signalling peptide RGD can be coupled efficiently to this polymer. 
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Chapter 1 : Introduction 
1.1 History 
The area of polymer functionalisation dates back to 1840 with the discovery of vulcanised 
rubber.[1] Reported independently by both Ludersdorf and Hancock this process of heating 
natural rubber, poly(cis-isoprene) with sulfur, produced a material that was more durable 
and less prone to cracking than its precursor. The ability to modify the chemical and physical 
properties of polymers, to create more pertinent materials, hailed a new era in materials 
science. 
Polymer functionalisation expanded into a variety of industries. In 1865, Schützenberger 
reported the synthesis of cellulose acetate by heating cellulose with acetic anhydride.[2] This 
new material was found to be a good replacement for nitrate film, a material commonly used 
by the film industry (for photographic film) and healthcare industry (as X-ray film). In 1922 
Hermann Staudinger proposed the general structure of polymers that is accepted today.[3] 
He suggested that macromolecules were the product of many small monomers covalently 
bonded together.[4] This was initially met with much speculation especially by colloid 
chemists, since at the time macromolecules were defined as colloids/aggregates of multiple 
small molecules.[3] Examining the chemistry of the monomers allowed for the synthesis of 
polymers with controlled properties such as strength, malleability, conductivity, 
degradability, and optics. This was revolutionary, since the start of the 20th century was 
focused primarily on replicating natural polymers; i.e. Chardonnet’s report in 1883 on the 
synthesis of artificial silk by spinning concentrated nitrocellulose,[5] and Hoffmann’s report 
in 1907 on the synthesis of natural rubber by addition polymerisation. Staudinger was 
ultimately awarded the Nobel Prize for his work in 1953. 
Staudinger polymer model led to an increase in post-polymerisation functionalisation 
techniques. In 1948, Serniuk et al. reported the conjugation of polybutadienes with aliphatic 
thiols via thiol–ene addition.[6] In the 1950’s the chlorination of polystyrene–divinylbenzene 
beads were developed as ion exchange resins.[7] In 1963, Merrifield used a halogenated 
polymer to develop solid-state peptide synthesis by attaching amino acids to the 
electrophilic chlorinated sites.[8] However, until this point the modifications of polymers were 
limited in that the functionalisation methods were not quantitative. This was in large part 
due to the difficulty at the time to produce polymers with a range of functional handles with 
controlled dispersity. However, this changed in the 1990’s with the emergence of new 
functional group-tolerant polymerisation techniques such as atom-transfer radical 
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polymerisation (ATRP),[9] reversible addition-fragmentation chain transfer (RAFT),[10] 
nitroxide-mediated radical polymerisation (NMP),[11] and single-electron transfer living 
radical polymerisation (SET-LRP).[12]  
 
Graph 1 - Timeline of post-polymerisation modifications [13] 
Due to the difficulty often associated with the purifications or polymers, it is desirable to 
develop reactions that require low catalytic loadings, and give low quantities of side 
products. It is for these reasons that click reactions have generated a great deal of interest 
in recent years.[1]  
1.2 Overview of polymerisation process 
The classification of polymers can sometimes be a confusing process, as polymers can fall 
into many different groups depending on the criteria being discussed. For example, the ring-
opening metathesis polymerisation (ROMP) of cyclopentene 1.1 (Scheme 1.1) can be 
considered as a chain-growth polymerisation, but also as an addition reaction, whereas 
radical polymerisation of dioxolane 1.3 is also a chain-growth polymerisation, but releases 
benzophenone as a by-product, and is therefore a condensation polymerisation. Figure 1.1 
shows a non-extensive summary of possible criteria pertaining to polymers. This project will 
focus on the anionic ring-opening polymerisation (ROP) of oxiranes in a chain-growth 
polymerisation (CGP). 
N
u
m
be
r 
o
f p
a
pe
rs
 
illu
st
ra
tin
g 
po
st
po
lym
e
ris
a
tio
n
 
m
o
di
fic
a
tio
n
 
o
f p
e
n
de
n
t f
u
n
ct
io
n
a
l g
ro
u
ps
 
5 
 
 
Scheme 1.1 – Examples of addition chain-growth polymerisation (CGP) and 
condensation CGP. 
 
 
Figure 1.1 – Non-extensive summary of the classifications of polymerisation based on 
specific criteria.[14] 
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1.2.1 Calculating polymer dispersity 
The dispersity of a polymer is a measure of how even in length the polymer strands are. A 
dispersity of 1.00 would indicate a monodisperse material where all strands are equal in 
length. This is calculated by considering the number average molecular weight, Mn, and the 
weight average molecular weight, Mw. 
Mn is simply the total weight of all the polymer strands divided by the number of polymer 
strands present. It does not convey any information about how varied the polymer lengths 
are, however it does indicate what the average molecular weight is (Equation 1). 
 
  ∑   ∑   
Ni = number of strands with mass Mi. 
Equation 1 
On the other hand, Mw factors into account how common a particular chain length is, relative 
to all other polymer chains in the sample. This is done by first calculating the weight fraction, 
Wi, which is the fraction of the total sample that a particular chain length represents 
(Equation 2). 
     ∑    Equation 2 
 
Summation of all the weight fragments ( WiMi) will then give the weight average molecular 
weight of the polymer (Mw), (Equation 3). 
 	  
     ∑   ∑     Equation 3 
Comparison of Mn and Mw as a ratio is referred to the dispersity (). Overall, the ability to 
control the dispersity of a polymerisation is normally desirable, and so generally a value 
close to 1.00 is optimal, although this depends on the application of the polymer. 
   	  Equation 4 
 
1.3 Polyethylene Glycol (PEG) / Polyethylene 
Oxide (PEO) 
The focus of this thesis is on the post-polymerisation functionalisation of various species of 
poly(ethylene glycol) (PEG) and poly(ethylene oxide) (PEO), synthesised by ROP of 
epoxide monomers. This section will focus on the applications of PEG derivatives as well 
as discuss the synthesis of PEG/PEO polymers. Note that the terms PEG and PEO are 
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often used interchangeably, however polymers with Mn < 20,000 g.mol-1 are referred to as 
PEG, whereas polymers with Mn > 20,000 g.mol-1 are referred to as PEO (Figure 1.2).[15]  
 
Figure 1.2 - PEG and PEO 
 
1.3.1 Biomedical Applications of PEG/PEO 
A variety of conjugated proteins are made naturally in the body via post-translational 
modifications such as phosphorylation, acylation, glycosylation, sulfation and 
methylation.[16] These modifications can alter the chemical properties of the protein such as 
cell-signalling, targeting, metabolism, as well as modify the native proteins circulation time 
in the body.  
It is estimated that up to 90% of current drugs and/or drug candidates suffer from poor 
aqueous solubility, which could in turn result in poor bioavailability.[17,18] Bioactive 
compounds including peptides, proteins or other molecules are commonly coupled with 
PEG via a process called PEGylation. This can improve the pharmacokinetics of the 
bioactive compound, often by reducing the half-life of the drug-moiety.[19] PEGylated drugs 
typically experience reduced renal filtration, decreased uptake by the macrophage system, 
and decreased degradation by enzymes.[20,21]  
Medium size drugs are typically conjugated to PEG with molecular weights ranging from 20 
kDa to 50 kDa.[21] This coupling to the high molecular weight PEG helps primarily to 
decrease the kidney filtration of the drug. These high molecular weight PEGs are also less 
prone to biodegradation than low molecular weight PEGs.[15]  
Larger drugs such as antibodies are more commonly bound to lower molecular weight PEG 
ranging from 1 kDa to 5 kDa.[21] This helps to limit targeting by the macrophage system, 
decrease enzymatic degradation, and hide cationic charges. This reduction in kidney 
filtration of a PEGylated drug, due to large hydrodynamic volumes, can also be beneficial 
to drug delivery in anti-cancer therapeutics, as large nanoparticles have shown a propensity 
to accumulate in cancerous tissue. This is referred to as the enhanced permeability and 
retention (EPR) effect, and was first reported by Maeda et al.[22] This ability of nanoparticles 
to apparently target tumours is generally explained by the need for the cancer cells to grow 
rapidly resulting in the stimulated production of blood vessels (hypervascularisation). The 
growth of these connected endothelial cells are unorganised and less tightly packed than 
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normal, allowing nanoscopic particles to enter and remain inside the neoplastic tissue. Lack 
of lymphatic drainage also prevents the clearance of these nanoparticles (Figure 1.3), 
overall resulting in accumulation in the tumour.[23]  
 
Figure 1.3 - Influence of the drug-polymer conjugate on drug delivery due to EPR 
effect.[21] 
In 2004, Kim et al. observed this EPR effect when studying polymeric micelles (PM) of 
methoxy-PEG (mPEG) loaded with paclitaxel (PTX).[24] This polymeric prodrug (Genexol-
PM®) offered increased delivery of PTX to the tumour cells,[25] and Genexol-PM® has now 
been approved by the FDA for use for treating patients with breast cancer.[26] 
Overall, PEG itself is a very suitable candidate for many biological application due to its high 
solubility in a range of aqueous and organic media,[27] low toxicity,[19] resistance to 
biodegradation,[15] and ease of excretion.[28] Additionally, PEG can be synthesised in low 
dispersity, in line with the pharmaceutical standard of   = 1.10.[16,21] This desire for 
monodispersity is driven by the need for reproducible criteria such as body clearance times 
and cell targeting.  Polymer-drug conjugates that are polydisperse can result in a broad half-
life, which is an undesirable uncertainty when administering medication.  
 
Limitations of PEG  
The limitations of PEG can generally be divided into three groups i) adverse side effects 
that arise from either the polymer itself, or the side products that can be formed during the 
synthesis of the polymer, ii) changes in the pharmacokinetics of the drug-PEG conjugate, 
or iii) side effects from the low biodegradability of the PEG.[21] 
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Adverse side effects 
PEG has been shown undergo non-specific interaction in the body, such as potentially 
inducing blood clotting when delivered intravenously.[21] However, PEG has also been 
shown to undergo specific recognition by the immune system. This can ultimately lead to 
hypersensitivity reactions (HSR) and anaphylactic shock.[29] The exact origin of this 
response is not fully understood. One possibility is that the terminal hydroxyl groups of the 
PEG could provide molecular sites for the hydrolysis of C3 protein in the bloodstream.[21] 
This fragmentation of C3 protein can lead to a biochemical cascade, leading to the 
polymeric surface being labelled as a foreign body by the immune system. However, many 
PEG products are based on methoxypolyethylene glycol (mPEG), which should prevent this 
immunological response. Overall, the exact cause of HSR is not fully understood, however 
the possibility of PEG to induce an immunological response should always be kept in mind. 
 
Changes in the pharmacokinetics 
PEG has also been shown to result in accelerated blood clearance (ABC). This is a 
phenomenon whereby a preceding injection of PEGylated-drug can influence the circulation 
time of subsequent PEGylated-drug injections. This was first observed by Dams et al. while 
studying the retention time of 2,000 kDa mPEG liposome in rats.[30] Upon the first injection, 
the concentration of mPEG liposome after 4 hours was found to have reduced to 52 ± 3.7%, 
however upon a second injection the concentration in the blood was significantly reduced 
after 4 hours to 0.6 ± 0.1%. 
It is believed that the mechanism for this process stems from the production of an anti-PEG 
antibody, IgM, which is produced upon the first injection.[31] This leads to binding of the IgM 
to the PEG upon a second injection, resulting in hydrolysis of the C3 protein, leading to an 
immunological response. This results in uptake of PEG by the Kupffer cells, and rapid 
accumulation of the non-biodegradable PEG in the liver. 
 
Low biodegradability 
High molecular weight PEG has been shown to have low biodegradability, which can result 
in problems for excretion. Typically PEG is excreted in the urine and faeces, however high 
molecular weight PEG can accumulate in the liver and may lead to macromolecular 
crowding (also called macromolecular syndrome), a process that can drastically change the 
behaviour of cells.[16] This occurs when high concentration of large molecules effectively 
reduce the volume of solvent, leading to abnormal cell behaviour. 
Typically the Bowman’s capsule of the kidney has a protein clearance limit of ~60 kDa 
(albumin), however due to the hydrophilicity of PEG, the hydrodynamic volume of the 
polymer is typically 2-5 times greater than the a globular protein of the same molecular 
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weight.[16] Overall, the upper limit for urinary excretion of PEG is ~30 kDa, above which 
excretion in the faeces is the more predominant excretion route. 
PEG remains one of the most widely used polymers in biomedical applications due to its 
ability to increase the bioavailability of drugs whilst allowing for limited toxicity.[21] 
Additionally, utilisation of the EPR effect can prove a valuable tool for targeting cancerous 
cells. Unfortunately the possibility of hypersensitivity, accelerated blood clearance and low 
biodegradability, has been shown to be problematic in some PEG applications. 
 
1.3.2 Polyallyl glycidyl ether (PAGE) 
Although PEG has found many uses, the lack of functional handles along the polymer 
backbone limits the possible modification of the material. Use of an allylic functional group 
allows for a range of post-polymerisation modifications to be carried out, whilst being 
innocuous to anionic ROP polymerisation. Poly(allyl glycidyl ether), PAGE 1.7 has been 
previously synthesised as a homopolymer as well as a copolymer 1.11 with various oxirane 
monomers including ethylene oxide (EO) 1.8, glycidol (G) 1.9 and ethoxy ethyl glycidyl ether 
(EEGE) 1.10 (Scheme 1.2).[32–38] Post-polymerisation modification of AGE polymers has 
also been performed by utilising thiol-ene chemistry.[36,39,40] 
 
Scheme 1.2 – Various polymers of allyl glycidyl ether. 
PAGE Synthesis 
In 2000, Sunder et al. achieved the synthesis of hyper-branched polyethers, PG-co-PAGE 
1.13 by the copolymerisation of glycidol 1.9 and allyl glycidyl ether 1.6.[32] This was done by 
using bis(2,3-dihydroxypropyl)octadecylamine 1.12 in a base catalysed random 
copolymerisation to synthesise the hyper-branched copolymers 1.13 in controlled degree 
of polymerisation (DP), with a dispersity of  ~ 1.7, and controlled degree of branching (DB) 
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(Scheme 1.3). A small fraction (<5%) of the alkenes underwent isomerisation to the trans-
1-propenyl isomer 1.15 during the polymerisation process (Scheme 1.4). Interestingly, they 
showed that this pendent allyl group could undergo a number of post-polymerisation 
transformations; (i) cleavage of the allyl groups, resulting in 1,3-glycerol units 1.16 bearing 
primary hydroxy groups; (ii) dihydroxylation of the double bond, leading to polyglycerols 
1.17 with greatly increased polarity, and (iii) hydroformylation to aldehyde 1.18 followed by 
reductive amination and protection to amine 1.19, highlighting the ability to achieve 
orthogonality between the hydroxyl and allyl groups. 
 
Scheme 1.3 – Polymerisation of glycidol and allyl glycidyl ether to yield hyperbranched 
copolymers.[32] 
 
 
Scheme 1.4 – Post-polymerisation modifications of PG-co-PAGE by Sunder et al.[32] 
In 2007, Erberich et al. studied the synthesis of PAGE 1.7 as a protecting group for the 
production of polyglycidols.[33] Use of potassium alkoxide 1.20 as an initiator allowed for the 
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production of PAGE 1.7 with good dispersity ( = 1.27), however only 80% conversion could 
be achieved. The group propose that as the reaction proceeds the decreasing monomer 
concentration allows a side reaction to occur, whereby the propagating alkoxide chain 1.20 
abstracts proton from the allylic position of either a monomer or a polymer’s pendent allyl 
group 1.21. This protonation of alkoxide 1.20 results in chain termination. However this 
process presumably results in the isomerisation of alkene 1.21 to 1-propenyl species 1.23 
(Scheme 1.5),[37] although the group do not mention this. Additionally, the group noted the 
gelation of the PAGE 1.7 after having been left to stand for several days, which they propose 
might have occured by a radical or ionic process, although this is not investigated further. 
 
Scheme 1.5 – Chain termination/Isomerisation of AGE 
Hans et al. have studied the chain transfer (as opposed to chain termination) of EEGE 1.10 
via ROP using both lithium and potassium based alkoxide initiators.[35] Polymerisation 
proceeded with full conversion and good dispersity ( = 1.09 – 1.19), although the observed 
Mn was consistently 10% higher than the calculated Mn. Additionally, the dispersity 
increased with increasing ratios of [monomer]:[initiator]. The group observed that one of the 
methylene protons of 1.10 underwent abstraction by propagating alkoxide chain 1.24, 
resulting in chain transfer (Scheme 1.6) and production of allyl alkoxide 1.10b. This alkoxide 
was then able to reinitiate the polymerisation, however this process did limit the Mn to 30,000 
g.mol-1. The reaction conditions were varied to prevent this proton abstraction process and 
overall found that it could be reduced by use of potassium based initiators as opposed to 
lithium. This is explained by the potassium species exhibiting decreased basicity and 
increased nucleophilicity, thus resulting in decreased chain transfer compared to lithium. 
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Scheme 1.6 – Chain transfer from propagating PEEGE chain to monomer 
In 2010, Obermeier and Frey utilised a caesium alkoxide initiator to produce PEO-co-PAGE 
in very good dispersity ( = 1.02 – 1.05).[36] Caesium initiators exhibit more ionic character 
than potassium based initiators, which increases the reactivity of the propagating chain. 
Additionally, Cs+ ions are less efficient at alkene isomerisation. However, the caesium 
based initiators such as caesium 2-methoxyethoxide were poorly soluble in THF, and so 
addition of DMSO was required. Polymerisation in benzene used PEG (Mn > 1000 g mol-1) 
as a macro-initiator by deprotonating both termini of the PEG with CsOH. Unfortunately, 
polymerisations could only be carried out up to 10,000 g.mol-1.[36] This is most likely the 
result of chain termination, caused by protic impurities such as water that was produced 
during the initiator synthesis.[37] The authors also reported the isomerisation of the terminal 
olefin to the trans-enol ether. This occurred readily when the polymerisation was carried out 
at both 100 °C and 60 °C, although lowering the temperature to 40 °C reduced the degree 
of isomerisation to <10%.  
Up until this point, many of the initiators of AGE 1.6 relied on the use of strong, non-
nucleophilic bases after the removal of the conjugated acid e.g. tert-butanol, in order to 
generate an alkoxide that could function as an initiator when AGE was added.[37] In 2011, 
the Hawker group. proposed that these strategies allowed for the introduction of protic 
impurities e.g. alcohols or water, which can lead to problems during polymerisation such as 
chain termination.[37] Instead, they investigated the use of the radical-anion potassium 
naphthalenide 1.27, titrated with benzyl alcohol 1.28 to yield potassium alkoxide initiator 
1.29, which was then used to polymerise AGE (Scheme 1.7). Notably this method produced 
naphthalene 1.30 and dihydronaphthalene 1.31 by-products, which are inert to the anionic 
ROP polymerisation. This method allowed for PAGE to be synthesised with controlled DP, 
excellent dispersity ( between 1.05 and 1.20) and quantitative conversion; however it was 
observed that higher Mn PAGE (Mn > 90 kg.mol-1) experienced an increased dispersity ( ~ 
1.33). It was proposed that these increases in dispersity occurs due to either radical 
coupling of the pendent allyl groups, or chain coupling occurring after the polymerisation 
14 
 
has achieved full conversion. Unfortunately, no details are discussed regarding the 
mechanistic feasibility of these processes. This is different from the chain termination 
reactions as observed by Erberich et al.[33] as well as being different from chain transfer as 
had been observed by Hans et al.[35]  
Hawker et al. also reported the occurrence of isomerisation of the allylic group of 1.32 to 
the cis-enol ether 1.33,[37] which was in contrast to the trans-isomer 1.15 reported by Sunder 
et al.,[32] as well as Obermeier and Frey (Scheme 1.7).[36] The group proposes that 
deprotonation by the alkoxide chain 1.32 at the allylic position leads to the alkyl potassium 
species 1.22 in a 5 membered cyclic intermediate. Subsequent deprotonation of a dormant 
hydroxylated chain by carbanion 1.22 could then reinitiate the polymer propagation, whilst 
leaving olefin 1.33 in a cis configuration. Although Erberich et al. believed this allylic 
deprotonation resulted in chain termination (Scheme 1.5), Hawker et al. propose that it does 
not constitute chain termination since the reactive nature of the alkyl potassium intermediate 
1.22 means that the isomerisation of the alkene is fast relative to the chain propagation. 
The Hawker group then go on to show that cis-propyl 1.33 could then be cleaved in 
methanol over a polymer-supported sulfonic acid resin (DOWEX) to produce a linear 
random copolymer with pendent allyl and hydroxyl groups.  
 
Scheme 1.7 – Polymerisation of AGE by potassium alkoxide with possible 
isomerisation mechanism 
Finally, in 2015, Groll and Kuhlmann showed that the slow addition of the AGE monomer 
1.6 to a potassium tert-butoxide initiator could be used to synthesise PAGE 1.7 in controlled 
dispersity.[38] While synthesising PEEGE 1.25, Hans et al. had observed the bimodal 
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distribution on the size exclusion chromatography (SEC) elugrams, with one peak being 
exactly twice the molar mass of the other, indicating the coupling of the polymer chains. 
Additionally Hans et al. had reported that an increase in the ratio of [monomer]:[initiator] led 
to an increase in this bimodal distribution, which Groll and Kuhlmann subsequently saw 
during the synthesis of PAGE 1.7. Both groups suggest that this dimerisation, during the 
synthesis of PEEGE 1.25 and PAGE 1.7, was likely due to the formation a ketone 
intermediate such as 1.39 that can undergo nucleophilic attack by a propagating chain 1.35 
(Scheme 1.8).[35,38,41] 
 
Scheme 1.8 – Dimerisation of PAGE, rapid reversal preventing trimer formation.[38] 
Formation of this ketone enolate 1.38b is probably formed by the deprotonation of monomer 
1.6 by a propagating chain 1.35 allowing epoxide 1.43 to irreversibly open to form 
disubstituted enolate 1.38b. This unstable intermediate will then tautomerise to the more 
stable trisubstituted enolate 1.38b, which can then reinitiate the polymerisation reaction to 
yield the ketone capped propagating chain 1.39 (Scheme 1.9). Due to the lack of low 
molecular weight polymer on the SEC elugram, this ketone-alkoxide coupling to form dimer 
1.41 must be reversible, and must only be pushed to completion when the concentration of 
monomer 1.6 decreases to zero i.e. when the reaction has achieved full conversion.[38] 
Neither group mention the possible formation of the kinetically favoured aldehyde enolate 
monomer 1.36, which, considering its high reactivity, should allow for rapid nucleophilic 
attack on epoxide monomer 1.6. However recovery of solely hemiacetal 1.41 indicates that 
the rate of formation of aldehyde 1.37 must be slower than the equilibrium to form the 
thermodynamically favoured ketone enolate 1.38. 
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Scheme 1.9 – Polymerisation of AGE by potassium alkoxide with possible 
isomerisation mechanism. 
Groll and Kuhlmann propose that the equilibrium between the ketone capped chain 1.39 
and dimer 1.41 is rapid in comparison to the propagation of the terminal alkoxide with AGE, 
therefore any dimer that is formed quickly breaks apart before it can form a trimer (Scheme 
1.8). Therefore, slow addition of the AGE 1.6 should limit the monomer deprotonation side 
reaction that allows for formation of ketone enolate 1.38 in the first place, thereby limiting 
the ketone induced coupling responsible for the bimodal distribution.  
In general, the group found that dispersity of PEEGE 1.25 was lower than PAGE 1.7 with 
the latter being more sensitive to the rate of monomer addition. When DP = 50, the 
dispersities of PAGE 1.7 could be reduced from 1.30 to 1.16 by slow addition (Figure 1.4), 
whereas dispersities for PEEGE 1.25 were reduced from 1.16 to 1.11. Additionally, these 
polymerisation were performed at 45 °C since the isomerisation reactions of the pendent 
allyl handles reported by previous groups,[32,35–37] were supressed at this temperature.  
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Figure 1.4 - Molar-mass distribution of PAGE. Decreasing the monomer feed rate from 
5000 to 50 µL.h-1 reduces the dispersity from 1.30 to 1.16. 
Overall, a range of techniques have been investigated to produce PAGE 1.7 in low 
dispersity, controlled DP, and high molecular weight, however side reaction of chain 
termination, chain transfer or isomerisation are often observed. These findings are 
summarised in Table 1.1. 
 
 Polymer Initiator Chain 
termination 
Chain 
transfer 
Isomerisation Dispersity 
Sunder PG-co-
PAGE 
K+ None reported None reported trans 1.7 
Erberich PAGE 
 
K+ Deprotonation 
at allylic 
position 
None reported None 
reported* 
1.27 
Hans PEEGE K+ and 
Li+ 
None reported Deprotonation 
of CH2 
adjacent to 
oxirane 
N/A 1.09 – 1.19 
Obermeier 
and Frey 
PEO-co-
PAGE 
Cs+ None reported limited trans 1.02 – 1.05 
Hawker pEO-co-
PAGE 
K+ None 
observed by 
SEC 
None 
observed by 
SEC 
cis 1.05 – 1.33 
Groll and 
Kuhlmann 
PAGE K+ None reported Ketone 
induced 
coupling 
None 
reported** 
1.16 – 1.30 
* Although no isomerisation was reported, deprotonation at the allylic position should lead to isomerisation to 
the enol ether. 
** Isomerisation supressed by low reaction temperature (45 °C). 
Table 1.1 - Summary of PAGE synthesis by various groups. 
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Overall, PAGE has been investigated for a range of uses such as pH sensitive drug delivery, 
however many of these modifications are limited to thiol-ene click chemistry. Olefin 
metathesis could prove to be a useful method to install further functionality. 
1.4 Olefin Cross Metathesis 
Developed over 40 years ago, olefin metathesis is used to exchange the substituents of a 
double bonds between two alkene species. This results in the formation of new carbon-
carbon bonds, with the aid of a transition metal catalysts. It was in 2005 that Yves Chauvin, 
Robert Grubbs and Richard Schrock received the Nobel Prize for their work in this field. 
 
Scheme 1.10 – Simplified example of cross metathesis. 
This exchange, represented in Scheme 1.10, can occur either intramolecularly or 
intermolecularly. If this occurs intramolecularly it is referred to as ring closing metathesis 
(RCM), as the reaction results in the formation of a cyclic structure such as 1.1. This has 
the entropic driving force of producing two molecules from one, where one of these 
molecules is often gaseous ethylene (Scheme 1.11). Intermolecular olefin metathesis is 
referred to as cross metathesis (CM). If the CM reaction is occurring between two terminal 
alkenes 1.51 & 1.52 then the reaction will be pushed to completion by the evolution of 
ethylene, however in the cases of non-terminal alkenes, this driving force is lost. As a result 
CM is often more challenging than RCM. 
 
Scheme 1.11 - General scheme of olefin cross metathesis including CM, RCM, ROMP 
and ADMET. 
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Olefin metathesis has been used to develop new polymerisation reactions, namely ring-
opening metathesis polymerisation (ROMP), acyclic diene metathesis polymerisation 
(ADMET), and ring-opening cross-metathesis (ROCM). ROMP, derived from RCM, occurs 
whereby a strained cyclic unsaturated monomer 1.1 undergoes metathesis with another 
monomer to yield a polymer chain. The driving force for ROMP is the release of the ring 
strain of the alkene monomer. This is a chain-growth polymerisation process due to the 
addition of a single monomer at a time. ADMET, derived from CM, occurs whereby a diene 
monomer 1.50 undergoes CM with another monomer in a step-growth polymerisation 
process.  
Olefin metathesis was first observed by Ziegler whilst studying the use of organometallic 
complexes as catalysts in the synthesis of polyolefins.[42] It was observed that, as well as 
catalysing the polymerisation of ethylene, some alkyl aluminium catalysts also produced 
but-1-ene as a side product. Further studies by the Philips Petroleum Co. showed that 
propene, with cobalt molybdate, yielded ethylene and but-2-ene, indicating a cross 
metathesis reaction of the olefin.[43] 
The accepted mechanism for this process was first proposed by Yves Chauvin in the 1970’s 
(Scheme 1.12) by studying RCM of 1,7-octadiene as a substrate.[44] The first stage is a [2+2] 
cycloaddition of a diene 1.54 with metal-methylene complex 1.59, to yield cyclobutane 
intermediate 1.55. Although a [2+2] cycloaddition is normally symmetry forbidden under 
thermal conditions, this process is able to proceed at room temperature as interaction 
between the p-orbitals of the alkene and d-orbitals of the metal lower the activation energy 
sufficiently by breaking the symmetry of the system.[45] After this, the four-membered ring 
1.55 undergoes cycloreversion to form a new carbene complex 1.57, as well as affording 
the release of ethylene - an entropically favoured process which acts as a strong driving 
force. This is followed by a consecutive [2+2] cycloaddition between carbene of 1.57 with a 
second alkene. This four-membered 1.58 ring again collapses to yield the final cross-
metathesis product 1.60, and the regenerated metal carbene catalyst 1.59.  
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Scheme 1.12 - Ring-Closing Metathesis catalytic cycle 
In 1990, Richard Schrock published the synthesis of a molybdenum complex Mo1 that was 
capable of efficiently carrying out this reaction (Figure 1.5).[46] This reactive species offered 
a high turnover frequency (TOF) and would readily facilitate olefin metathesis. It was 
however limited in its tolerance of functional groups, especially protonated heteroatoms, as 
the electron deficient molybdenum will complex with the heteroatom, therefore disabling it 
as a catalyst.[47] As a result, use of this catalyst must also be carried out in an inert 
atmosphere.  
In 1992, Robert Grubbs developed a ruthenium type complex, G1, which was less moisture 
sensitive (Figure 1.5). Although less reactive than Schrock’s molybdenum complex, this 
catalyst offers a greater degree of selectivity in the reaction, as well as being able to tolerate 
a broader range of functional groups. The Ru(II) of G1 is a 16-electron d6 coordinated centre 
complexed with two chlorine atoms, two electron-rich tricyclohexyl phosphine ligands, and 
a benzylidene ligand.  
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Figure 1.5 - Metathesis catalysts 
The first stage in the catalytic cycle is the activation of the pre-catalyst, which can occur by 
three possible mechanisms; associative, dissociative and interchange (Scheme 1.13). With 
respect to G1, the activation of the catalyst from a 16 electron species 1.61 to a 14 electron 
species 1.64 occurs by dissociation of a PCy3 group. This more reactive intermediate can 
then coordinate to a coupling partner 1.66 and continue with the catalytic cycle previously 
discussed. 
In the case of G2, the ruthenium is also in the Ru(II) oxidation state, however one of the 
phosphine ligands has been replaced by a N-Heterocyclic carbene (NHC) ligand. This NHC 
ligand acts as a strong -donator and weak -acceptor, allowing it to stabilise the 14-
electron intermediate 1.64, which means that the catalyst is less reactive towards air and 
moisture. Activation of the G2 catalyst occurs by a combination of the dissociative and 
interchange mechanism.[48] In general, G2 is a more active catalyst than G1 because the 
rate of PCy3 rebinding is slower in the case of G2, allowing for the catalyst to exist in the 
more CM active 14 electron species 1.64. 
In 2000, Hoveyda et al.[49] and Blechert et al.[50] reported almost simultaneously the 
development isopropoxystyrene-coordinated catalyst referred to as Hoveyda-Grubbs’ 
second generation catalyst, HG2. Compared to the phosphine containing G2, the HG2 
catalyst shows increased thermal stability, and tolerance to both oxygen and moisture.[45] In 
addition, HG2 showed increased reactivity towards electron poor alkenes acrylonitriles, 
fluorinated alkenes, vinyl phosphine oxides, and sulfones.[51] 
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Scheme 1.13 – The pssible mechanisms of pre-catalyst activation.[48] 
It is commonly believed that G2 and HG2 yield identical active catalyst 1.71 after the first 
catalytic cycle, however the well documented differences in reactivity (especially towards 
electron deficient alkenes) indicate that the mode of propagation must be different (Scheme 
1.14).[51] This difference is believed to be due to the “boomerang-effect” of the 
isopropoxystyrene, whereby HG2 is in equilibrium with the 14 electron species 1.71. This 
boomerang effect is not observed with the styrene of G2. 
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Scheme 1.14 – Comparison of G2 and HG2 catalytic cycles[51] 
During the CM catalytic cycle, the ruthenium centre goes through sequential cycloadditions 
and cycloreversions to yield various alkylidene complexes, and methylidene complex 1.71 
(Scheme 1.15). This methylidene species is fragile and prone to degradation. In the case 
of G2 this can occur by the phosphine abstracting the methylidene of 1.71 to produce a 
phosphonium salt 1.73, leaving the ruthenium in a 12 electron state.[52] This highly unstable 
complex can co-ordinate to a neighbouring methylidene complex 1.71 to form a bimetallic 
hydride 1.72 (Scheme 1.16). 
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Scheme 1.15 – Catalytic cycle of the ruthenium catalyst.[48] 
 
 
Scheme 1.16 – Decomposition of methylidene complex.[48] 
 
Alkene Selectivity 
For the cross metathesis between two terminal alkenes, the products are dependent upon 
the chemical nature of the two alkenes. For example, the products of the intended 
metathesis could be either the E or Z isomer; however homodimerisation of each individual 
coupling partner could also occur, leading to a range of possible products (Scheme 1.17).  
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Scheme 1.17 - Potential products of olefin metathesis 
 
The degree to which the desired cross metathesis takes place can be controlled by varying 
the equivalents of the starting material, but more importantly it is dictated by the chemical 
properties of each coupling partner. In general, olefins can be categorised into one of four 
types (Table 1.2).[53] 
 
Type 
of 
olefin 
Product Example 
1 Rapid homodimerisation, and 
homodimers are consumable 
Terminal olefins, allyl halides, allyl 
phosphonates, allyl silanes, allyl sulphides, 
styrenes with no large ortho substituent. 
2 Slow homodimerisation, and the 
homodimers are slightly 
consumable 
Acrylates, vinyl ketones, secondary allylic 
alcohols, styrenes with large ortho 
substituent. 
3 No homodimerisation 1,1-disubstituated olefins, non-bulky 
trisubstituted olefins, vinyl phosphates, 
phenyl vinyl sulfone, tertiary allylic alcohols 
(protected) 
4 Olefins do not partake in CM, 
however they do not hinder it by 
catalyst deactivation 
Vinyl nitro olefins, trisubstituted allyl 
alcohols (protected). 
Table 1.2 - Types of olefin for Grubbs’ second-generation catalyst. 
Type 1 olefins all possess reactive electron-rich double bonds, and are prone to rapid 
homodimerisation, and so reacting a type 1 olefin with another type 1 olefin will yield a 
statistical mixture of products that is only influenced by the equivalents of starting materials 
used. The homodimer that is formed is however capable of subsequent metathesis 
reactions, so reacting a type 1 olefin with a type 2 or 3 alkene will eventually lead to the 
coupling of the two different partners (the thermodynamic product). Type 2 olefins are 
electron deficient or hindered and are less reactive to olefin metathesis than type 1 alkenes, 
and will slowly dimerise. The resulting dimers are typically type 4 in character, which do not 
normally participate in subsequent metathesis. Type 3 molecules do not homodimerise and 
so will only react with type 1 and type 2 olefins. Type 4 olefins do not undergo olefin 
metathesis, although they do not deactivate the catalyst.  Coupling partners may fall into 
26 
 
different classifications depending on the catalyst used, although in all cases the deciding 
factors come down to steric bulk and electron deficiency of the olefin. 
The cis/trans stereochemistry of the alkene product is reliant on the reaction being 
reversible. This means that the reaction will reach its thermodynamic product, which is 
almost always the E-alkene. The exception to this is the case of small-ring forming RCM, 
which will be unable to give an E-alkene due to ring strain. 
 
 
Scheme 1.18 – RO/RCM/CM of dicyclopentene. 
An example that nicely showcases many of these olefin metathesis reactions in action was 
reported by Grubbs et al. whilst development of a new type of polymerisation; tandem ring-
opening metathesis/ring-closing metathesis (ROM/RCM) polymerisation of monomers 
containing two cyclopentene moieties 1.80 followed by modification via insertion 
polymerisation (Scheme 1.18).[54] Firstly, ROM/RCM was used to yield well defined 
polymers 1.81 with no evidence of cross linking or depolymerisation. Coupling of polymer 
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1.81 with diacrylate 1.85 yielded an A,B-alternating copolymer 1.86. Furthermore, they 
showed that these two sequential processes could actually be done in a one-shot process; 
multiple olefin metathesis polymerisation (MOMP), a combination of ROM/RCM/CM. 
Initial focus on the ROM/RCM of dicyclopentene 1.80 found that dilute concentration of 0.1M 
led to successful polymerisation to yield poly(2,5-disubstituted-2,5-dihydrofuran) 1.81 as a 
soluble polymer, however increasing the concentration to 1.0 M led to an insoluble gel after 
10 mins. This is likely due to the high concentrations allowing for the ROMP to dominate, 
resulting in a cross linked network. The critical monomer concentration, [M]c of a ROMP is 
the concentration below which the cyclic monomer predominates, and above which linear 
chains emerge.[55] Cyclopentene 1.80 has an [M]c of 0.8 M at 25 °C, therefore it is expected 
that above this concentration, the ROMP to form 1.81 will dominate, and below which either 
no polymerisation will occur, or ROM/RCM will take over. Indeed Grubbs et al. showed that 
at 0.5 M the ROM/RCM of dicyclopentene 1.80 resulted in full conversion to soluble polymer 
with a dispersity of 1.79. Interestingly, ROMP of dicyclopentene 1.80 at 1.0 M to yield the 
cross linked gel followed by dilution to 0.5 M, resulted in the dissolution of the polymer after 
6 h. This was possible as the dilution led to the decross-linking via the intra-molecular 
ROM/RCM to yield soluble polymer. 
Synthesis of the A,B-alternating copolymer 1.86 was then investigated. It was found that 
coupling of poly(2,5-disubstituted-2,5-dihydrofuran) 1.81 with diacrylate 1.85  could be 
achieved with the use of HG2 without disturbing the cyclic olefin of the polymer backbone, 
to produce copolymer with dispersity of 2.09. Furthermore, a one-shot polymerisation was 
achieved by the ROM/RCM/CM of dicyclopentene 1.80 and diacrylate 1.85  to yield 
copolymer 1.86   with dispersity 2.11. This was the first reported synthesis by multiple olefin 
metathesis polymerisation (MOMP). 
1.5 Post-polymerisation Modification 
Reactions 
Polymers with appropriate functionalisation are vital to the application of the polymer, 
however the synthesis of pertinent and useful polymers frequently require post-
polymerisation modification via a grafting-onto approach in order to incorporate functionality 
that is not compatible with the polymerisation process.[56] Pre-functionalised monomers 
could potentially be protected prior to polymerisation, however due to the added step of 
deprotection and, most importantly, purification, this is often an undesirable option. As a 
result, many chemists opt for a post-polymerisation method. Additionally, some architecture 
can only be installed as a post-polymerisation modification, such as cross-linking.[57]  
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With respect to side-chain functionalisation with small molecules, this is commonly achieved 
by employing azide-alkyne cycloaddition,[58] terminal functional group modification,[59] thiol-
ene addition,[60] Michael-type addition,[61] and amidation.[62] Recently, there has been a focus 
on using olefin cross metathesis to functionalise polymers.[63–65] 
1.5.1 Olefin Cross Metathesis on polymers 
Initial use of olefin metathesis to modify polymers was first investigated in 1998 by Grubbs 
et al. with the synthesis of covalently linked peptide helices using RCM.[66] Acyclic dienes 
were incorporated into the linear peptide sequence of heptapeptide (Scheme 1.19). These 
allylic ethers were installed at the i and i + 4 positions, as it was believed that these positions 
would be close to each other in space in the final helical structure. Treatment of 20 mol% of 
G1 resulted in the RCM of pendent olefins in 90% yield (n = 1), and E:Z selectivity of 5:1. 
 
Scheme 1.19 - Diene analogues of 
heptapeptides[66] 
Figure 1.6 - Stabilizing -helices by CM of 
unnatural amino acids[67] 
In 2000, Verdine et al. built upon this work by incorporating various S and R configured -
allyl amino acids within the peptide sequence prior to CM.[67] The match/mismatch use of 
these S and R unnatural amino acids at the i and i + 4 positions allowed for the successful 
stabilisation of the helical structure as determined by circular dichroism spectroscopy 
(Figure 1.6). In particular optimal stabilisation was achieved using Ri,i+7S(11), which 
corresponded to a peptide with an R and an S configured amino acid at positions “i”, and 
“i+7” respectively, and 11 carbons in the metathesised cross-link.  
In 2007, Coates et al. reported the synthesis of nanoparticles by crosslinking linear 
polymers using CM.[68] Polycarbonate possessing pendent vinyl groups were synthesised 
by living polymerisation to yield polymers in narrow dispersity ( = 1.20) with Mn = 54,100 
g.mol-1. Treatment with G2 at high concentrations led to crosslinking and large increase in 
dispersity indicating that intermolecular cross linking was prevalent. However, under dilute 
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conditions (1 mg/mL), CM occurred with the retention of a narrow dispersity, indicating the 
absence of intermolecular CM, to yield nanoparticles that were observable by atomic force 
microscopy (AFM). 
The use of olefin cross metathesis to couple small molecules to polymers is a relatively new 
field, with only a handful of articles tackling this area. In 2004, Coates used CM to couple 
type 1 and type 2 alkenes with various polyolefins possessing pendent vinyl groups 1.87 
(Scheme 1.20).[69] This was accomplished without considerable increases in dispersity 
indicating that self-metathesis was subdued. Conversion rates varied between 45% and 
91% even when 10 equivalents of coupling partner were used.  
 
Scheme 1.20 - CM on polyolefins using G2 catalyst by Coates et al.[69] 
In 2010, Mecking et al. reported the coupling of 4-phenylbutene 1.97 to poly(ethylene-co-
AAEM-co-APEG) 1.96 (AAEM = 2-(methacryloyloxy)ethyl acetoacetate, APEG = oligoglycol 
monoacrylate).[70] Catalytic insertion polymerisation was accomplished using dimeric 
compound [({(P^O)Pd(Me)Cl}µ-Na)2] 1.99, which is selective for the unhindered acrylate 
region of AAEM 1.93, leaving the methylacrylate moiety intact and available for post-
polymerisation modification (Scheme 1.21). Subsequent CM with 4-phenylbutene 1.97 
using G2 allowed for successful conjugation. Unfortunately, this was not accomplished in 
quantitative yield, likely due to the pendent olefin of polymer 1.96 being an electron poor 
gem-disubstituted alkene, and therefore relatively unreactive to CM. 
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Scheme 1.21 - CM of 4-phenylbutene with poly(ethylene-co-AAEM-co-APEG). 
In 2012, Hoogenboom and Meier et al. showed that a range of acrylate moieties could 
successfully be coupled to 10-undecenoic acid derived poly(2-oxazoline) 1.100 (Scheme 
1.22).[63] Previous work by Hoogenboom et al. had achieved the synthesis of poly(2-(dec-9-
enyl)-2-oxazoline) (PDecEnOx) 1.100 by cationic ROP of the unsaturated fatty acid based 
monomer.[71] The pendent terminal alkenes were then subjected to CM with various 
acrylates (Table 1.3). This was done with good success however the occurrence of self 
metathesis (SM) was observed, which is the process by which the pendent olefins of the 
polymer undergoes CM with another pendent olefin either intramolecularly (to yield cyclic 
structures), or intermolecularly (resulting in cross linking). This homodimerisation occurs 
due to the unhindered nature of the pendent olefin, allowing for the ruthenium catalyst to 
easily access the alkene.  
Investigation into the reaction conditions was carried out focussing on reaction 
concentration, temperature and the number of equivalents of the acrylate coupling partner. 
It was hypothesised that a decrease in concentration would keep the pendent alkenes far 
away from each other thereby lowering the occurrence of intermolecular SM, however this 
may also reduce the catalytic activity resulting in lower successful conjugation with the 
acrylate. Interestingly, a concentration of 0.6 M was suggested to be optimal to achieve low 
SM and high conversion. No discussion was made to why this relatively high concentration 
is necessary, however we speculate that this increase in concentration helps to drive 
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successful conjugation in the early stages of the reaction, which then acts as steric 
hindrance to subsequent SM. Overall, this undesired homodimerisation process was limited 
by using a high number of equivalents of the type 2 acrylate coupling partner with HG2 in 
dichloromethane at 40 °C.[53] 
Investigation of coupling partner found that an increase in the size of the acrylates led to a 
decrease in intermolecular SM. The group propose the reason for this may be that once the 
acrylate is attached, the large steric bulk results in significant hindrance around the polymer 
backbone, thereby preventing adjacent pendent olefins from undergoing CM with other 
polymer strands. 
 
 
Scheme 1.22 - CM of poly(2-oxazoline) with acrylate 
 
R Yield (%) Mn (kDa) a  a 
 
92 15.7 1.33 
 
89 16.4 1.32 
 
84 17.3 1.27 
 
72 18.1 1.15 
 
80 16.6 1.21 
 
87 23.6 1.19 
 
60 20.7 1.14 
 
87 18.3 1.23 
Table 1.3 - CM of PDecEnOx with various acrylates  a analysed by 
GPC 
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In 2014, Edgar et al. studied the modification of polysaccharides by CM to synthesise 
cellulose 7-carboxyalkanoates 1.107.[72] The olefin handle was first grafted onto the primary 
alcohol of polysaccharides 1.103 with 10-undecenoyl chloride 1.104  (Scheme 1.23). These 
terminal alkenes were then conjugated with acrylic acid using HG2 catalyst. Use of acrylic 
acid as a solvent yielded 100% conversion, however when solvents of DCM or THF were 
used, the product attained only 90% conversion and appeared to undergo gelation, which 
is thought to be the product of cross-linking. Edgar et al. then built upon this work by using 
CM to synthesise hydroxypropyl cellulose.[73] 
 
 
Scheme 1.23 - Modification of polysaccharides using CM. 
The substrate scope for polymer functionalisation by CM has recently been extended 
beyond acrylate coupling partners. In 2014, Balcar et al. reported the ROMP of 
vinylnorbornene (VNBE) 1.109 followed by successful conjugation with a variety of type 1 
coupling partners. ROMP of VNBE was performed with catalysts of i) Hoveyda-Grubbs type 
complex (Zhan 1B), and (ii) molybdenum (VI) complex Mo2 with a bidentate 
aminophenolate ligand (Scheme 1.24). The synthesised polymer 1.110 possessed Mn in 
the range of 10,000 to 13,000 g.mol-1. In the case of Mo2 , the dispersity of the polymer was 
3.2. Pendent vinyl groups were found to remain intact, which is due to the Mo2 catalyst 
being specific for ROMP over CM.[74] However, use of Zhan-1B resulted in dispersity values 
ranging from 4.6 to 8.5. This increase in dispersity is likely due to the less selective Ru 
based catalyst being able to react with the pendent vinyl groups, resulting in 
branching/cross linking.[75] Post-polymerisation modification of 1.110 via CM reactions of 
pendent vinyl groups was carried out with the Zhan-1B catalyst. Functionalised soluble 
polymers of Mn from 6,000 to 23,000 g.mol-1 were prepared. A decrease in Mn may be due 
to the depolymerisation of the unsaturated polymer backbone. Functionalisation of PVNBE 
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via CM of pendent vinyl groups was accomplished with partners 1.112-1.117, with the best 
results observed with cis-1,4-diacetoxybut-2-ene 1.112 (59% conversion). Diacetoxybut-2-
ene is essentially the homodimer of allyl acetate, and it has been reported by Grubbs et al. 
that use of the preformed homodimer in a CM coupling often affords better results than the 
non-homodimerised coupling partner.[76] This difference in yield is likely due to the rapid 
homodimerisation of the type 1 allyl acetate dominating the catalytic cycle, resulting in the 
increased formation of a less stable ruthenium methylidene species.[77] By extension, this 
may be the reason that lower conversions were obtained for the nondimerised coupling 
partners: 5-hexenyl acetate 1.113, allyl acetoacetate 1.114, and allyltrimethylsilane 1.115 
(30%, 11% and 6% respectively). Dispersity remained relatively constant with all coupling 
partners, except in the case of allyltrimethylsilane 1.115, where a dispersity value of 32 was 
reported. Functionalisation of PVNBE was also performed via ene-yne cross-metathesis of 
pendent vinyl groups with (4-fluorophenyl) acetylene 1.116 and (2,4-
difluorophenyl)acetylene 1.117, achieving 23% and 35% conversion respectively. Overall, 
Balcar et al. expanded the scope of post-polymerisation modification by CM, however in the 
case of PVNBE, extensive polymer degradation was observed in many cases. 
 
Scheme 1.24 – ROMP of VNBE and subsequent functionalisation. 
Work by Prunet and Thomas et al. in 2016 studied the functionalisation of pendent allyl 
groups of aliphatic polyesters by CM (Scheme 1.25).[64] Synthesis of copolymers were 
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achieved by the tandem catalysis of camphoric anhydride (CA) with various epoxides using 
salen aluminum chloride complex and [PPN]Cl ([PPN] = 
bis(triphenylphosphoranylidene)iminium) as a co-catalyst.[78] This resulted in polyesters of 
Mn 8 10,000 g.mol-1 and  8 1.3. Both PCA-co-PEH and PCA-co-PAGE are type 1 in nature, 
and so may result in rapid self-metathesis. The more hindered olefin of PCA-co-PIO means 
that this type 2 alkene may be less prone to homodimerisation. Gem-disubstituted PCA-co-
PLO is a type 3 olefin, which may result in an inability to undergo successful CM, although 
there should be no possibility of self-metathesis. 
Investigation with the coupling of type 1 polymers, PCA-co-PEH and PCA-co-PAGE with 
methyl acrylate allowed for good conversion (93 and 98% respectively). There was no 
evident self metathesis as observed by NMR, and dispersity values remained constant. 
Interestingly, this coupling with methyl acrylate only resulted in a marginal increase in Mn 
compared to their parent polymers as observed by GPC, which the authors propose is due 
to a small change in hydrodynamic volume of the functionalised polymers. Type 2 and 3 
polymers, PCA-co-PIO and PCA-co-PLO, only led to trace amounts of coupling. PCA-co-
PAGE was then subjected to CM with allyl trimethylsilane, styrene and allyl acetate, and in 
each case conversion >90% was achieved, with little change in dispersity.  
In general it was found that PCA-co-PAGE was the best candidate for post-polymerisation 
modification by CM. Methyl acrylate was an optimal coupling partner when  HG2 was used 
at 15 mol% loading.[64] Notably PCA-co-PAGE showed no evidence of self metathesis, even 
when the polymer was stirred with HG2 in the absence of a coupling partner, which is 
surprising considering the type 1 nature of the terminal olefin. However, self metathesis is 
possibly subdued due to the cyclopentene containing backbone of PCA-co-PAGE being 
more rigid in nature than the linear polymers e.g. poly(2-oxazoline) synthesised by 
Hoogenboom/Meier. This rigidity would especially prevent intramolecular cyclisation by 
RCM. 
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Scheme 1.25 - Structures of various polyesters synthesised with aluminium complex 
catalyst. 
Recently Shaver et al. have use olefin metathesis to synthesise various functionalised 
biodegradable poly(hydroxyalkanoate)s (Scheme 1.26).[65] This was achieved by both pre 
and post-polymerisation functionalisation of -heptenolactone (HL) 1.120. The lactone 
monomer 1.120 was first synthesised by carbonylation of 1,2-epoxy-5-hexene 1.119 using 
[salph(Cr(THF)2][Co(CO)4] catalyst. In the pre-polymerisation modification, lactone 1.120 
was subjected to CM with methyl acrylate to yield the monomer 1.121 that was then 
subjected to ROP using aluminium salen catalyst. This resulted in polymerisation with 93% 
conversion, however molecular weight of 1.122 was low (Mn = 4,200 g.mol-1), below the 
target of Mn = 18,400 g.mol-1. Additionally the dispersity was relatively high,  = 1.65, and 
it was proposed that the acrylate species coordinates to the Lewis acid aluminium centre, 
resulting in supressed control of the polymerisation. 
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Scheme 1.26 – Polymerisation and modification of polyesters by Shaver et al.[65] 
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In the post-polymerisation method, the lactone monomer 1.120 underwent ROP with 
Al(salen) catalyst to yield polyester 1.123 possessing pendent terminal olefins (Mn = 12,100 
g.mol-1,  = 1.09) Coupling with methyl acrylate allowed for 99% conversion, however only 
a marginal increase in Mn was recorded by GPC (Mn = 13,400 g.mol-1,  = 1.84). This 
marginal change in Mn after CM was a similar effect to that observed by Prunet and Thomas 
et al.[64] The increase in dispersity indicates the occurrence of self metathesis, which is 
unsurprising considering the type 1 nature of the pendent olefins. Additionally, when 
polyester 1.123 was subjected to CM in the absence of coupling partner, extensive cross-
linking occurred to yield an insoluble gel. 
Copolymerisation of lactone 1.120 with renewable and inexpensive lactide was then 
performed to produce copolymer 1.133. Due to the high rate of polymerisation of lactide 
compared to lactone 1.120, a gradient copolymer was produced (Mn = 12,000 g.mol-1,  = 
1.02). An extensive substrate scope for CM was then investigated including a range of type 
1-3 olefins.  In general, type 2 and 3 coupling partners yielded full conversion with good 
retention of dispersity. Other type 1 species yielded lower conversion, likely due to the rapid 
homodimerisation pathway dominating catalytic cycle. The group did isolate the polymers 
that did not go to full completion, and resubmit them to CM, however only 1.124 (n=2) and 
1.119 resulted in full conversion after the second round of CM. The remaining polymers 
retained between 10-40% of the parent alkene. Shaver et al. propose that the rate of 
successful CM between the polymer and the coupling partner is in competition with the rate 
of homodimersation of the coupling partner.[79] However we propose that, in addition to this, 
the rapid homodimersation of the type 1 coupling partner may be leading to less stable 
ruthenium methylidene species that leads to degradation of HG2 as reported by Grubbs et 
al.[77] It would be interesting to repeat these coupling reactions with the preformed dimers 
of the type 1 coupling partners. 
The group also performed double CM, where the conjugated polymer from the first CM 
coupling was subjected to a second CM reaction with a different partner. (Scheme 1.27). 
The general approach to this was to start with the CM of 1.133 with a type 2 or 3 species 
and, as the coupling approaches completion, add a more reactive type 1 partner (Table 
1.4). It was observed that the order of the CM is crucial to obtaining a dual functionalised 
polymer 1.135. Addition of methacrylate first followed by secondary CM with epoxide 1.119 
allowed for incorporation of both coupling partners in roughly equal proportions. However 
reversing the order of addition resulted in solely conjugation of the polymer to methyl 
acrylate. Shaver et al. propose that rate of secondary metathesis of the functionalised 
polymer bearing methyl acrylate is slower than the rate of homodimerization of epoxide 
1.119.[79] Coupling of type 3 olefin 1.132 followed by secondary CM with epoxide 1.119 
yielded no incorporation of the epoxide into the polymer. This indicates that the alkene that 
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results from the coupling of the type 3 species is unreactive to CM, and therefore type 4 in 
nature as it is unable to undergo secondary metathesis with the epoxide 1.119. 
 
 
Scheme 1.27 – Double CM of copolymer[65] 
 
B Eq % of 1.133 
remaining 
C Eq A:B:C 
 
1 13 
 
8 0:1:0.78 
 
12 13 
 
5 0:0:1 
 
1 18 
 
5 0:0.36:1 
 
8 0 
 
0.3 0:1:0.25 
 
8 6 
 
0.3 0.26:0.9:1 
 
8 0 
 
0.3 0:1:0 
Table 1.4 - Double CM of copolymer 
 
In conclusion, CM is a relatively unexplored method of functionalising polymers, even 
though it has the added benefit over many click-reactions of retaining the olefin moiety that 
could be utilised to achieve further functionalisation. Unfortunately, a common problem for 
some polymers undergoing CM is the propensity to yield a self-metathesis product. This 
can lead to an increase in polymer dispersity, which can be detrimental for drug delivery 
39 
 
applications. Additionally, no research has yet been published on the use of CM on 
polyethers; a family of polymers widely used in medical applications. 
1.5.2 Thiol-Ene Addition on polymers 
As discussed previously, the use of the thio-ene addition reaction to achieve polymer 
modification was first described in the vulcanisation of poly(cis-isoprene). This radical-
mediated addition is what is commonly referred to as thio-ene addition, however the process 
can also occur by nucleophilic attack of an olefin by anionic sulfur in a Michael-type addition.  
The radical mediated pathway can be initiated either thermally or photochemically. Hawker 
et al. have shown that both of these pathways are possible in order to achieve full 
conversion of pendent olefins of 1.136 with various thiols 1.138-1.142, however 
photochemical induction offered the advantage of milder reaction conditions and shorter 
reactions times (Scheme 1.28).[80]  
 
Scheme 1.28 - Thiol-ene addition - Hawker et al.[80] 
Schlaad et al. have reported that use of thiol-ene addition to pendent olefins of 1,2-
polybutadiene 1.143 can be problematic due to the formation of the anti-Markovnikov radical 
1.144, formed upon conjugation with radical sulphur 1.148, to undergo cyclisation with an 
adjacent alkene to yield 1.146 (Scheme 1.29).[81] However this process can be limited by 
increasing the concentration of thiol and decreasing the temperature.[82] Additionally 
increasing the distance of the pendent olefins from the polymer backbone has been proven 
to be a good way to limit this radical cyclisation.[83]  
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Scheme 1.29 - Potential radical reaction pathways of the addition of mercaptans onto 
the vinyl double bonds of 1,2-polybutadiene by Schlaad et al.[81] 
Lowe et al. have used a combination of thiol-ene addition in both a radical and Michael 
fashion to synthesise novel polymers via acyclic diene metathesis (ADMET) 
polymersation.[84] Starting with the synthesis of the ,7-diene,2-(undec-10- en-1-yl)tridec-
12-en-1-yl 1.149, followed by the chemoselective Michael-type addition of thiol 1.150 with 
the electron poor acrylate, to furnish a range of monomers. (Scheme 1.30).  
 
 
Scheme 1.30 - Monomer synthesis by Michael type thiol-ene addition by Lowe et al.[84] 
Subsequent ROMP of the electron rich alkenes using G1 was not possible due to the strong 
coordination strength of sulphur for ruthenium, however after oxidation of the thio-ether 
1.151 to the sulfoxide-sulfone 1.157 using triazotriphosphorine tetrachloride (TAPC), the 
polymerisation was achieved in high conversion. The thiol-ene reaction was then employed 
in a radical fashion to further functionalise backbone of polymer 1.157 at the unsaturated 
positions (Scheme 1.31). This example nicely highlights the possible incompatibilities 
between two functionalisation methods, and so attention must be paid to the order in which 
functionalisations are conducted. 
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Scheme 1.31 - Radical thiol-ene addition to alkene groups on the polymer backbone by 
Lowe et al. 
 
PAGE Functionalisation by thiol-ene click 
Hu et al. functionalised PAGE-b-PLA 1.162 with glucose species 1.163 using thiol-ene click 
chemistry.[85] The group polymerised AGE 1.6 using sodium ethoxide initiator to yield PAGE 
1.160 with controlled, yet low Mw (2000 – 4000 g.mol-1) and good dispersity ( = 1.04 – 
1.08) (Scheme 1.32). This monohydroxyl polymer 1.160 was then used as a macroinitiator 
in the ROP of lactide 1.161. This block copolymer 1.162 was functionalised using 2-
mercaptoethyl--glucoside 1.163 via radical thiol-ene addition, which was achieved with full 
conversion. These amphiphilic glycopolymers 1.164 were then able to undergo self-
assembly into core-shell micelles with a glucose outer coating, which could potentially be 
used in polymeric micelles for drug delivery. 
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Scheme 1.32 – Synthesis of P(AGE-glucose)-b-PLA. 
Hrubý et al.[86,87] studied the development of a micellar pH-sensitive system for the drug 
delivery of the antibiotic doxorubicin (DOX). This polymer micelle created from 
poly(ethylene oxide)-block-poly(allyl glycidyl ether) PEO-b-PAGE, which had undergone 
radical thiol-ene with methyl sulfanylacetate. The pendent ester was then converted to the 
hydrazide 1.165 using hydrazine hydrate. This was then coupled with the DOX to yield the 
pH sensitive hydrazone 1.166 (Scheme 1.33). This drug-polymer conjugate was then 
treated with either aqueous buffers at pH 5.0 (simulating the pH in endosomes) or pH 7.4 
(pH of blood plasma). The group were able to show that doxorubicin was released much 
faster at pH 5.0 compared to pH 7.4. 
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Scheme 1.33 – Synthesis of DOX hydrazone 
 
An interesting use of thiol-ene chemistry has been demonstrated by Geest et al. when 
synthesising a prodrug of paclitaxel-polymer by grafting the polymer from the drug itself.[25] 
This is especially interesting because it concerns paclitaxel (PTX); a widely used anticancer 
drug that has been conjugated to a variety of macromolecules with the aim of improving the 
drugs pharmacokinetic properties, namely solubility. This synthesis began with 
esterification of (2-(butylthiocarbonothioylthio)propanoic acid (PABTC) 1.167 with PTX at 
the C2’ position to yield the paclitaxel-chain transfer agent (PTX-CTA) 1.168. RAFT 
polymerisation of this CTA with N,N-dimethylacrylamide 1.169 led to polymer 1.170 in low 
dispersity, possessing a terminal trithiocarbonate, which could undergo aminolysis to the 
thiol (Scheme 1.34). Thiol-ene addition to tetramethylrhodamine (Rho) maleimide was then 
conducted to yield a fluorescently tagged paclitaxel-polymer conjugate 1.171. Although this 
is an example of an end-group modification as opposed to side-chain modification, it nicely 
exemplifies one of the possible uses of the CTA trithiocarbonate after RAFT polymerisation 
has been complete.  
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Scheme 1.34 - Synthesis of paclitaxel-polymer conjugate by RAFT of drug-CTA 
precursor, followed by thiol-ene addition to fluorescent maleimide by Geest et al.[25] 
 
1.5.1 Diels-Alder reaction on polymers 
Diels-Alder reaction is an attractive method to functionalise polymers as it can often be 
achieved quantitatively with no side products, whilst being compatible with a wide range of 
functional groups.[88] The most widely used precursors to polymer functionalisation by the 
Diels-alder reaction are furan (diene) and maleimide (dieneophile) to yield an oxabicycle.[89] 
Upon heating, this Diels-Alder adduct can revert back to the diene and dienophile. This is a 
property that has been utilised to develop thermoresponsive materials in the form of gels, 
dendrimers and smart copolymers.[90,91]  
Work by Wei et al. has focused on the use of the Diels-Alder reaction to create thermos-
responsive hydrogels.[90] These were synthesised in aqueous conditions by a Diels-Alder 
reaction of poly(N,N-dimethylacrylamide-co-furfuryl methacrylate) (PDMAFM) 1.172 and N-
[4-(formyl polyethylene glycol ester)] bismaleimide 1.173, resulting in cross linked 
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architecture 1.174. It was found that aqueous media could accelerate the Diels-Alder 
reaction, whereas DMF could accelerate the retro-Diels–Alder reaction, thereby controlling 
disassembly of the hydrogel (Scheme 1.35). Interestingly these hydrogels were stable in 
hot water,[91] with an increase in temperature leading to a decrease in gelation time. The 
group have also increased the biocompatibility of these hydrogels by using a dienophile 
terminated PEG in place of bismaleimide 1.173.[90] 
 
 
Scheme 1.35 - Hydrogels formed by the Diels-Alder reaction – Wei et al.[90] 
A similar process has been employed by Marref et al. to develop self-healing polymers that 
would decross-link upon heating and cross-link upon cooling (Scheme 1.36).[89] Furan–
maleimide 1.175 were grafted onto copolymers of polyethylene 1.176. Heating of material 
1.177 allowed for the Diels-Alder reaction to take place and create a cross linked structure 
1.178. This material can be used as a thermally reworkable film.[88] 
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Scheme 1.36 - Thermoresponsive Diels Alder – picture from Hall et al.[88] 
 
1.5.2 Azide-Alkyne reaction on polymers 
Copper-catalysed azide alkyne cycloaddition (CuAAC) is used extensively in polymer 
functionalisation as well as macromolecule synthesis, as it can often be done in both organic 
and aqueous media, and is compatible with a wide range of functional groups.[1] Additionally, 
both the azide and alkyne functionalities are innocuous to a variety of polymerisation 
techniques, often preventing the need for deprotection prior to post-polymerisation 
modification. This was nicely exemplified by Benicewicz et al. with their work on the 
synthesis of a “clickable” polymer 1.180 by the RAFT of 2-azidoethyl methacrylate 1.179 
(Scheme 1.37). Subsequent CuAAC with phenyl acetylene 1.182  was achieved in full 
conversion.[92] Additionally, in a pre-functionalised approach, methacrylate 1.179 was 
coupled to phenyl acetylene 1.182  to yield monomer 1.183, which was also subjected to 
RAFT.  The post polymerisation functionalised polymer 1.181 possessed identical 1H-NMR 
to that of the pre-functionalised approach, indicating that the azide side chains of 1.180 
remain intact during the RAFT polymerisation. Unfortunately, even though azides should 
not have interfered with the RAFT polymerisation, their thermal instability did require that 
the polymerisation take place below 50 °C. It was speculated that at elevated temperatures 
the azide was undergoing decomposition into a nitrene, which was then reacting with AzMA 
monomers 1.179 via cycloaddition, allowing for the cross linking of polymer strands. This 
was reflected in an increase in dispersity. 
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Scheme 1.37 - CuACC functionalisation of poly(AzMA) with phenyl acetylene by 
Benicewicz et al.[92] 
One of the drawbacks to CuAAC is the troublesome removal of residual copper from the 
product, which complexes with the triazole ring. This can cause problems with solubility as 
well as biological applications which are sensitive to Cu(I).[1,93] In the previous example, 
Benicewicz et al. had managed to reduce the Cu(I) content down to 32 ppm after 
purification,[92] however this is above the limit for many pharmaceutical applications of 15 
ppm.[94] For this reason, this click process can be achieved using copper free strain-
promoted azide alkyne cycloaddition (SPAAC). This was demonstrated by Zou et al. when 
tagging biotin-conjugated cyclooctyne derivatives to azide-substituted substrate bound to a 
peptidyl carrier protein (PCP).[95] As in many SPAAC reactions, the cyclooctyne moieties 
1.185 used in this case was difluorinated. Introduction of these electron withdrawing groups 
are used to decrease the energy of the lowest unoccupied molecular orbital (LUMO) of the 
alkyne, allowing for the cycloaddition to proceed under mild conditions, which is necessary 
to prevent decomposition of azide 1.185. (Scheme 1.38).[96] 
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Scheme 1.38 - Use of difluorinated cyclooctyne (DIFO) derivatives in a SPAAC 
reaction.[96] 
 
1.6 Drug Polymer – Conjugates 
As discussed previously, the conjugation of a drug to a polymer can improve the 
pharmacokinetics of a compound. A notable example of this is the anticancer drug, 
paclitaxel (marketed as Taxol®), which experiences poor water solubility. For this reason 
paclitaxel is commonly administered in a surfactant formulation of Cremophor EL (CrEL); a 
polyoxyethylated castor oil with anhydrous ethanol, which results in severe side effects in 
patients such as hypersensitivity reactions and neurotoxicity.[97,98] Strategies to avoid the 
use of CrEL and improve drug delivery have been investigated, which include polymer-drug 
conjugates and polymer-drug micelles (Scheme 1.39). 
 
Scheme 1.39 - Schematic representation of polymer-paclitaxel conjugates (I) and 
polymeric- paclitaxel micelles (II).[99] 
Polymer-paclitaxel conjugates include OpaxioTM, a poly(glutamic acid)-paclitaxel PGA-PTX 
conjugate currently in phase III clinical trials for the treatment of brain cancer (Scheme 
1.40). OpaxioTM offers greater water solubility and antitumor activity as compared to free 
PTX.[97] However, conjugation of the hydroxyl at the C2’ position of paclitaxel with pendent 
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carboxylic acids of PGA proceeds without control over the placement of the drug along the 
polymer backbone, resulting in poorly defined polymer aggregates.[100] This statistic 
distribution along the polymer chain results in moderate loading of paclitaxel (37 wt%), as 
loading above this value resulted in poor dispersion of the conjugate in solution.[99,100]  
Studies have also been investigated using poly(hydroxypropylmethacrylamide) (HPMA) 
coupled to both PTX and the bone targeting agent alendronate (ALN) (HPMA-PTX-ALN) 
(Scheme 1.40).[101] This polymer-drug conjugate offers improved delivery of PTX to the 
bones due to the targeting action of ALN. Both ALN and PTX are conjugated to HPMA via 
peptide linkers that are cleaved by Cathepsin B, a lysosomal enzyme that is overexpressed 
in tumour endothelial and epithelial cells.[102] Unfortunately, loading of PTX is relatively low. 
(approximately 5 wt%).[99,101] 
 
 
Scheme 1.40 – Paclitaxel-polymer conjugates; OpaxioTM and HPMA-PTX-ALN.  
Polymeric micelles (PM) have been proven to be effective drug delivery agents due to their 
size in the nanorange, which can exploit the enhanced permeability and retention effect 
(EPR), as well as offering high stability in plasma and longevity in vivo.[103] Genexol-PM®; a 
PEG and poly(D,L-lactic acid) (PDLLA) copolymer-based PM has shown to be an effective 
way to delivery PTX (Scheme 1.41).[26] Genexol-PM demonstrated a 3-fold increase in the 
maximum dose tolerance (MTD) due to its decrease in side effects compared to free PTX. 
It also showed a significantly increase anti-tumour efficacy. Genexol-PM has been approved 
by the FDA for the treatment of patients with breast cancer.[26] Other notable examples are 
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paclitaxel-based Abraxane®, an albumin-bound conjugate and EndoTAG®, a liposome 
based system.[97] 
 
Scheme 1.41 – Schematic representation of micelle; Genexol-PM®.[99]  
Cell recognition by drugs/polymers can be achieved by interaction with inegrins, which are 
transmembrane receptors that act as bridges between cell-cell and for cell-extracellular 
matrix.[104] When triggered, integrins can generate a biochemical cascade responsible for a 
range of behaviours such as cell adhesion, cell signalling, apoptosis, tumour angiogenesis 
and metastasis. Integrins are composed of an - and 9-subunit, of which there are 18 
possible -subunits and 8 possible 9-subunits. The combination of these pairs influence the 
integrin’s ligand binding specificity and signalling properties. Most integrins recognise their 
respective integrin by an exposed tripeptide sequence (arginine-glycine-aspartate, 
RGD).[104] This allows drugs that possess this RGD sequence to act as complementary 
ligands to integrins, such as v93, which has been shown selectively expressed on 
endothelial cells that are undergoing tumour angiogenesis.[105] 
 
1.7 Previous Work in the Prunet Group 
Work by Amaia Altuna focused on the functionalisation of synthetic macromolecules by 
olefin metathesis.[106] This project first involved the synthesis of poly(divinylbenzene) 1.190 
by precipitation polymerisation to yield insoluble porous beads. CM of residual pendent vinyl 
groups allowed for the functionalisation of these polymer beads. This functionalisation could 
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perhaps allow the polymer beads to take part in ion exchange, and overall be used for 
example as a purification system for drinking water. It was shown that it was possible to 
perform cross metathesis of poly(divinylbenzene) 1.190 with various coupling partners 
using G2. These coupling partners include methyl acrylate, homoallylamine, allyl glycine 
and allyl bromide (Scheme 1.42). 
 
Scheme 1.42 - Synthesis of insoluble poly(divinylbenzene), and subsequent 
functionalisation using CM. 
Work in the Prunet group has also investigated the cross metathesis between PCA-co-
PAGE and methyl acrylate, which has previously been discussed in Section 1.5.1.[64] 
1.8 Project Aim 
PEG species are used extensively in biomedical applications, with common functionalising 
methods including thiol-ene, Diels-Alder, azide alkyne, amongst others, however the use of 
olefin cross metathesis to functionalise PEG is an unexplored area. To date, the studies of 
the CM on polymers have focused on polyoxazolines, polyesters and polyolefins, and so 
expanding this scope to PEG based material may allow for the development of new 
biocompatible polymers. Additionally, olefin metathesis has the added benefit of retaining 
the alkene moiety, which would allow for further functionalisation to be carried out, such as 
fine tuning the hydrophilicity by dihydroxylation. 
 
The main aims are as follows: 
1. Investigate the CM on PEO-PAGE with discrete molecules such methyl acrylate, 
and optimise the reaction conditions to achieve maximal conversion and minimal 
self metathesis. 
2. Synthesise new copolymers that allow for the production of a dual functionalised 
biocompatible polymers, which possesses both a warhead such as PTX and a 
targeting species such as RGD (Scheme 1.43).  
3. Couple bioactive compounds PTX and RGD onto the polymer backbone using CM 
to yield a dual functionalised polymer with retention of monodispersity. 
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Scheme 1.43 – PTX and RGD 
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Chapter 2 : Cross Metathesis with small 
molecules 
2.1 Synthesis of PAGE  
Initial work investigating the CM on polyethers was conducted using the copolymer 
poly(ethylene oxide)-co-(allyl glycidyl ether), PEO-co-PAGE, shown in Figure 2.1, which 
was supplied to us by the Hawker group.[37] This polymer was synthesised by 
copolymerisation of ethylene oxide with allyl glycidyl ether using benzyl alkoxide initiator, 
yielding a polyether with molecular weight of 25,000 g.mol-1.  
 
Figure 2.1 - PEO-co-PAGE synthesised by the Hawker group. 
Initial experiments found that the bulk of the supplied PEO-co-PAGE material did not fully 
dissolve in CH2Cl2 or other solvents including methanol, chloroform, THF or toluene. This is 
in contrast to the polymer described by Hawker et al., however it is believed that the PEO-
co-PAGE had undergone a similar gelation process described by Erberich et al.[33] For this 
reason we decided to freshly synthesise PAGE ourselves using the methodology developed 
by Hawker et al. for anionic ROP.[37] 
Synthesis of the initiator starts by the reduction of naphthalene 1.26 using potassium in THF 
to yield a green solution of potassium napthalenide 1.27 (Scheme 2.1). This was followed 
by titration with benzyl alcohol 1.28 to yield colourless benzyloxide initiator 1.29 as well as 
by products naphthalene 1.30 and dihydronaphthalene 1.31, which are innocuous to the 
ROP reaction. Addition of ally glycidyl ether monomer 1.6 to initiator 1.29 allowed for the 
ROP to occur with a target Mn of 10,000 g.mol-1. This is a very air/moisture sensitive process 
and so maintenance of an inert atmosphere was vital, however without a glove box this was 
exceptionally difficult.  
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Scheme 2.1 – Polymerisation of allyl glycidyl ether using potassium benzoyloxide. 
Polymerisation of AGE monomer 1.6 with initiator 1.29 in THF was initially achieved with 
little success, with recovery of only starting material (Table 2.1). In an attempt to promote 
the initiation of the polymerisation, the concentration of 1.29 was increased (entry 2 and 3) 
as well as increasing the ratio of initiator 1.29 to monomer 1.6 (entry 4), however no 
polymerisation was observed in each case. We believe that this was perhaps due to THF 
solvent diluting the monomer, thereby limiting the initiation of the ROP of 1.6, however it 
may also be possible that small amounts of moisture in the THF was terminating the ROP 
reaction. 
 
Entry 
[Initiator] 
mol.L-1 
Initiator : 
monomer 
DP a 
Observed 
Mn (g.mol-1) b 
Theoretical 
Mn (g.mol-1) c 
Yield d 
(%) 
1 0.1 1:88 0 - 10,044 0 
2 0.4 1:88 0 - 10,044 0 
3 0.7 1:88 0 - 10,044 0 
4 0.7 1:44 0 - 5,022 0 
Table 2.1 - Attempted polymerisation of allyl glycidyl ether with potassium benzyloxide in 
THF. a DP = degree of polymerisation, b Measured by 1H-NMR, c defined by initiator to 
monomer ratio, d b.r.s.m. 
Removal of THF solvent prior to the addition of the monomer allowed for the polymerisation 
of AGE to proceed, however the observed Mn was significantly lower than the theoretical 
Mn  (Table 2.2). This is potentially due to protic impurities i.e. a slight excess of benzyl 
alcohol 1.28 that was added during the titration with naphthalenide 1.27, resulting in 
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protonation of the propagating chain (chain termination). We attempted to prevent this by 
using a slight excess of napthalenide 1.27 prior to addition of monomer 1.6, however this 
resulted in gelation of the polymer. This is possibly due to deprotonation at the allylic 
position of either the unreacted monomers, or the polymer chain to yield carbanion 1.22. 
This carbanion could then act as a site for propagation, resulting in a branched or network 
structure (Scheme 2.2). Additionally, other research groups had reported the isomerisation 
of the ally group to the 1-propenyl isomer that occurred at elevated temperature.[32,36,37]  In 
order to prevent this isomerisation, polymerisations were carried out at 30 °C, allowing for 
suppression of isomerisation. 
 
Entry 
Initiator : 
monomer 
DP 
Observed 
Mn (g.mol-1) a 
Theoretical 
Mn (g.mol-1) b 
 Yield c 
(%) 
1 1:20 27 3,082 2,283 1.13 45 
2 1:40 28 3,196 4,566 1.10 44 
3 1:50 22 2,512 5,707 1.06 95 
4 1:100 72 7,990 11,414 1.08 22 
Table 2.2 - Polymerisation of allyl glycidyl ether with potassium benzyloxide neat.  
a
 Measured by 1H-NMR, b defined by initiator to monomer ratio, c b.r.s.m. 
 
Scheme 2.2 – Mechanism of gelation by use of excess potassium naphthalenide.  
 
2.2 Purification of CM polymer product 
Although the Mn of the obtained polymers were below the target of 10,000 g.mol-1, we 
decided to move on to investigating the coupling with methyl acrylate (MA) by CM, as the 
Mn of the polymer should not influence the reactivity of the pendent olefin handles (Scheme 
2.3).  
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Scheme 2.3 - CM of PAGE with MA 
Unfortunately the purification of the conjugated product PAGE-graft-MA proved difficult and 
initially prevented us from carrying out 1H-NMR analysis. Purification relied on the 
precipitation of the polymer in hexane. After precipitation it was observed that the polymer 
would not re-dissolve in CH2Cl2 (Figure 2.2), indicating a change in structure during the 
precipitation process. It is believed that upon precipitation, the polymer and HG2 catalyst 
are brought into immediate proximity of each other allowing for intermolecular cross linking 
to occur via CM, resulting in a network structure that is insoluble in CH2Cl2. It was found that 
the addition of DMSO to the crude mixture prior to precipitation in hexane could limit this 
process. Coordination of the DMSO to the ruthenium centre of HG2 occurs through either 
the oxygen or sulfur,[107] thereby displacing the N-heterocyclic carbene (NHC) and removing 
the catalytic activity to CM (Scheme 2.4). 
This use of DMSO worked well for short term storage of the polymer (i.e. to carry out an 
NMR analysis), however storing the precipitated polymer for longer than 24 hours resulted 
in the formation of an insoluble cross linked gel. This highlighted that impact that self-
metathesis could have on the polymer. For this reason, we investigated the use of a stronger 
quenching agent. 
The use of the isocyanide species, SnatchCat (Scheme 2.4) proved effective at disabling 
the self-metathesis process upon storage for prolonged periods of time (measured up to 4 
weeks). In order to completely remove the possibility for SM, the PAGE-graft-MA was 
hydrogenated, however this removes the functionality of the polymer, removing the 
possibility to use the olefin to fine-tune the hydrophilicity by dihydroxylation.  
After successful suppression of the cross linking during purification, we then moved onto 
examining the reaction conditions necessary to attain maximum amounted of grafting of 
MA. 
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Scheme 2.4 - Methods for quenching ruthenium 
catalyst.[107] 
Figure 2.2 - Cross linked PAGE-
graft-MA. 
 
2.3 Possible products of CM using PAGE 
We propose that, in any polymer subjected to a CM reaction, there are three potential 
outcomes for each pendent olefin; successful coupling, no reaction, and self-metathesis 
(Scheme 2.5). By comparing the 1H-NMR integration of each olefin signal it is possible to 
determine the ratios of x:y:z.  
Unfortunately, the production of three different products on the same polymer chain, each 
with a different molar masses, complicates the calculation of the yield, since the average 
molar mass of a repeating unit () will depend on the ratios of x:y:z. For this reason, the 
theoretical yield is calculated after 1H-NMR of the product has been used to calculate  
using Equation 5. 
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Scheme 2.5 - Potential outcomes of olefin handle (x = conversion into desired product, 
y = unreacted olefin, z = self metathesis) 
 
        
     
    = molar mass of polymer  = molar mass of region x,  = percentage of species x,  = molar mass of region y,  = percentage of species y,  = molar mass of region z,  = percentage of species z. 
Equation 5 
 
An example of these three distinct products can be seen in the 1H-NMR spectrum of PAGE-
graft-MA, which clearly shows the electron deficient protons (X1 and X2) of the grafted MA 
region, as well as the two terminal olefinic protons (Y2 and Y3) (Figure 2.3). The occurrence 
of self-metathesis can also be seen at 5.78 ppm. We have assertained that this signal is 
due to SM as it is identical to the one seen when PAGE was subject to CM in the absence 
of a coupling partner.  
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Figure 2.3 - PAGE-graft-MA. 
The degree of successful coupling (conversion) is inversely proportional to the degree of 
SM. The reversibility of the olefin metathesis reaction means that the SM olefin should 
eventually equilibrate towards PAGE-graft-MA i.e. the thermodynamic product, however 
this is not the case as we observe SM even when the reaction has been left for prolonged 
periods of time. This may be due to conformation of the polymer, which could prevent either 
the HG2 catalyst or MA from accessing the site of self-metathesis and allowing for 
sequential coupling with MA. This theory is also supported by the presence of unreacted 
terminal olefins as seen in Figure 2.3. These alkenes are type 1 in nature and should rapidly 
homodimerise, however their presence in PAGE-graft-MA indicate that they are shielded 
from the reaction media. It should be noted however that when the levels of SM are high, 
the observered NMR spectrum is broad, resulting in a greater degree of error when 
calculating the ratios of x:y:z. Additionally, this broadening prevents us from distinguishing 
between E and Z olefins. 
After developing our understanding of how to analyse these polymers, we then moved onto 
optimising the CM reaction conditions. 
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2.4 Optimisation of CM reaction with MA. 
Previous work in the group by Alice Gonzalez had indicated HG2 to be an optimal catalyst 
for CM with polyesters, however we wanted to confirm this was true for PAGE.[64] G1 is 
more commonly used for RCM, and so it was not surprising that this catalyst gave a low 
conversion (x = 65%). Use of the G2 catalyst (a more common catalyst for CM) afforded a 
good conversion of 81%. Most notably, the use of the more stable HG2 catalyst allowed for 
the highest conversion of 90% (Table 2.3). 
Catalyst Conversion 
(%) 
G1 65 
G2 81 
HG2 90 
Table 2.3 – Various catalyst effect on conversion of PAGE with methyl acrylate (4 eq.) 
reflux in CH2Cl2 for 18 h at a concentration of 0.2 M relative to PAGE. 
Previous work by Alice Gonzalez with methyl acrylate (MA) had shown that reflux of 4 
equivalents of MA at a 0.2 M concentration of polymer had resulted in successful CM with 
PAGE, however there was still evidence of self metathesis (Scheme 2.6) (Table 2.4, entry 
1). Various conditions were examined in an attempt to limit SM, however it was first 
important to confirm that homodimerisation of the pendent alkenes was indeed the cause 
of this signal at 5.78 ppm. We had already confirmed that this signal was the predominant 
product when PAGE was reacted with HG2 in the absence of MA, however it was also 
possible that isomerisation of the terminal olefin to the enol ether was the cause for this 
apparent change in structure.[108] If this was to be true, the most likely source would be a 
ruthenium-hydride species such as 1.72, which would be produced by the decomposition 
of HG2. Work by Grubbs et al. has shown p-benzoquinone to be effective in preventing this 
isomerisation by acting as a hydride scavenger. However use of p-benzoquinone additive 
resulted in a decreased conversion of polymer (Table 1, entry 2 and 3). Lowering the 
temperature may have lowered the rate of homodimerisation of PAGE, however this also 
reduced the ability of the polymer to conjugate with MA resulting in a decrease in conversion 
(entry 4). 
Changes in concentration resulted in the most effective change in conversion. Decreasing 
the concentration from 0.2 M to 0.1 M (entry 5) resulted in a decrease in conversion from 
75% to 60%, which was expected as the decrease in concentration reduces the likelihood 
of the PAGE coupling with the MA. Even when the number of equivalents of MA was 
doubled at this lower concentration, there was little change in conversion of the polymer 
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(entry 6). Reaction of PAGE in MA as a solvent offered a moderate conversion of 78% (entry 
7). This indicates that, at a concentration of 0.1 M, the number of equivalents of MA is not 
the limiting factor in preventing SM of PAGE. 
 
 
Scheme 2.6 – CM of PAGE with MA using HG2 catalyst 
 
Entry Equivalents 
of MA 
Molarity 
w.r.t  
PAGE 
Temperature 
(°C) 
Additive x:y:za Yieldb 
(%) 
1  4 0.2 45 - 75:1:24 73 
2 4 0.2 45 p-Benzoquinone 
(0.2 eq) 
47:7:46 93 
3 4 0.2 45 p-Benzoquinone 
(0.4 eq) 
54:2:44 93 
4  4 0.2 0 - 30:9:61 85 
5 4 0.1 45 - 60:2:38 80 
6 8 0.1 45 - 63:0:37 85 
7 neat 0.2 45 - 78:0:23 87 
8 4 0.4 45 - 98:0:2 95 
9 8 0.4 45 - 95:0:5 92 
10 c 4 0.4 45 - 85:0:15 91 
62 
 
Table 2.4 - CM of PAGE with MA using HG2 (5 mol%). a x = PAGE-graft-MA, y = 
unreacted PAGE, z = self metathesis. b calculated using adjusted molar mass (Equation 
5). c Slowly added 0.4 M of PAGE in CH2Cl2 to reaction mixture of MA and HG2 in CH2Cl2. 
The best results came when the concentration was increased to 0.4 M as this led to 98% 
conversion (entry 8). Theoretically, an increase in concentration should result in an increase 
in intermolecular SM, however the apparently decrease in SM could be due to two factors. 
Firstly, homodimerisation may be occurring preferentially in an intramolecular fashion. This 
should lead to a folded conformation, such as the ones reported by Coates et al. while 
investigating the CM of polycarbonates.[68] Production of a folded conformation would also 
explain the presence of unreacted terminal alkenes that are seen in many polymers where 
SM is prevalent, as these unreacted pendent alkenes could be internalised within the 
macromolecule, and therefore hidden from the reaction media. When high levels of self 
metathesis are observed, the 1H-NMR olefin signal corresponding to the homodimerised 
alkene is very broad and thus little information can be gained about the chemical structure 
of the alkene; however the low degree of SM seen in entry 8 resulted in clear resolution of 
the signal at 5.78 ppm in the 1H-NMR spectrum (Figure 2.4). J-coupling of 11.4 Hz indicated 
the presence of cis olefin, which corresponds to a relatively low strained 12-membered ring 
resulting from the RCM between two adjacent pendent alkenes (Scheme 2.7). If this SM 
was intermolecular, it would likely yield the thermodynamic trans olefin that would have a J-
value closer to 17.0 Hz. 
 
 
Figure 2.4 - NMR doublet of triplets from 
intramolecular SM. 
 
Scheme 2.7 – Intramolecular SM to yield 
12-membered cycloalkene. 
Secondly, an increase in concentration should facilitate the coupling of PAGE with MA in 
the early stages of the reaction, which could then sterically hinder the SM of the polymer 
strand. However in light of the result of the reaction of PAGE in a neat solution of MA (entry 
7), we propose that the number of equivalents of MA plays a lesser role in preventing SM 
than the concentration of PAGE does. This was confirmed when the equivalents of MA were 
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increased whilst maintaining a high concentration (entry 9), which resulted in a slight 
decrease in concentration, likely due to dilution of the concentration of HG2.  
Finally we proposed that slow addition of PAGE to a solution of MA and HG2 may allow to 
artificially increase the number of equivalence of MA relative to PAGE, whilst preventing 
dilution of the HG2 catalyst. NMR analysis of the CM reaction was carried out at 1 hour time 
intervals in order to gain insight into how fast this successful coupling to the polymer was 
occurring, and overall it was found that PAGE achieved ~85% conversion within the first 
hour (Graph 2). As a result of this finding we decided to conduct the slow addition of PAGE 
to a reaction mixture over 1 hour, as this time should be sufficient to prevent the 
accumulation of unreacted PAGE (entry 10). Under these conditions we found that the 
conversion decreased to 85%. This could be further evidence that when the number of 
equivalents of MA is greatly increased, the CM of PAGE with MA is limited. We also 
considered that homodimerisation of the abundant MA could be occurring, which would 
decrease the ability for HG2 to facilitate the CM of PAGE with MA. However, we do not 
believe homodimerisation of MA is occurring as we did not recover any dimethyl fumarate 
upon column chromatography (Scheme 2.8). 
 
 
Scheme 2.8 – Homodimerisation of MA (not observed) 
Overall we found that a higher concentration of PAGE yielded the optimal conditions for 
conjugation with MA. Using these conditions we reacted MA with PAGE of various Mn 
reported in Table 2.2, and we found almost identical ratios of x:y:z across the polymer 
range. With regards to the structure of the SM product of the polymer we believe that a 
combination of both intramolecular and intermolecular CM is resulting in the polymer 
conformation that to a certain degree can shield the pendent allyl handles from subsequent 
conjugation with MA. 
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Graph 2 - CM of 0.4 M PAGE with MA (4 equiv) in CDCl3 at 30 °C. 
 
2.5 Optimisation of CM reaction with allyl 
acetate 
While optimising the reaction conditions using MA (type 2 olefin), we also investigated how 
efficiently a type 1 coupling partner could undergo cross metathesis with PAGE. Type 1 
olefins have continued to be difficult coupling partners for CM, due to their tendency to 
homodimerise and cause a high turn over number (TON) of catalyst, which in turn can lead 
to undesired side products. In order to study this, allyl acetate was initially chosen as a 
coupling partner for two reasons; a) it is small in size, and so any low conversion results 
would most likely not be due to steric hindrance along the polymer backbone, and b) the 
characteristic CH3 signal would be easily observed by 1H-NMR.  
When this CM reaction was first conducted (Scheme 2.9) a low conversion of 32% was 
achieved. This was expected due to allyl acetate’s ability to homodimerise, exemplified by 
the recovery of dimer 2.3 as a E:Z ratio of 10:1 in a 50% yield. It was proposed that the 
conversion could be improved by the addition of another four equivalents of allyl acetate 
after a 12 hour period; however, surprisingly this resulted in a decrease in conversion to 
24% (entry 2). This decrease in conversion is potentially due to the increase in the ratio of 
AA:PAGE, allowing for the active HG2 catalyst to promote the homodimerisation of AA, 
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therefore limiting the successful coupling of AA with PAGE. In general, HG2 is a less 
reactive catalyst towards CM than G2 (due to the boomerang effect of the isopropenyl-
styrene moiety), which may be limiting the coupling of a self-metathesis olefin with AA, 
resulting in the retention of a self-metathesis product once it has been formed. However, 
when HG2 was replaced with G2, we observed a slight decrease in conversion from 32% 
to 28% (entry 3). This is possibly due to the highly reactive G2 facilitating rapid 
homodimerisation of AA.  
In cases of a type 1 coupling partner, use of the preformed homodimer is commonly used 
in order to a) prevent the dimerisation of the type 1 species from dominating the catalytic 
cycle, and b) limit the formation of the less stable ruthenium methylidene species, which 
can result in undesirable side products.[52] Reaction of trans-2-butene-1,4-diol diacetate 2.3 
with PAGE resulted in an increase in conversion to 60% and 54% when HG2 and G2 were 
used, respectively (entry 4 and 5). Use of cis-2-butene-1,4-diol diacetate 2.4 led to an 
improved conversion of 85%, which is likely due to the alkylidene species of PAGE-Ru 
preferentially coupling with thermodynamically unstable Z-alkene coupling partner as 
opposed to undergoing self-metathesis (entry 7). Unfortunately, under CM conditions the Z-
alkene 2.4 isomerises to the E-alkene 2.3 over time, which diminishes the observable 
benefit of the Z-alkene coupling partner as the reaction proceeds. Potentially lowering the 
number of equivalents of Z-alkene coupling partner could prevent the HG2 catalyst from 
spending the majority of the time facilitating the conversion of the coupling partner from the 
Z isomer to the E alkene, and instead allow the catalyst to react with PAGE. Unfortunately, 
this decrease in equivalence of Z-alkene coupling partner led to a decrease in conversion 
to 65% (entry 8). Decomposition of the catalyst may have been limiting the degree of 
conversion, and so we investigated using two loadings of HG2 catalyst separated by a 4 
hour interval. This led to an increased conversion of 95% (entry 9).  
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Scheme 2.9 - CM of PAGE with allyl acetate (1:4 equiv, conc = 0.2 M) 
 
Entry Coupling 
partner 
Equivalents 
of AA 
Molarity 
w.r.t  
PAGE 
Catalyst x:y:za E:Z 
selectivity 
Yieldb 
(%) 
1  AA 4 0.2 HG2 32:46:22 6:1 75 
2  AA 4 + 4 0.2 HG2 24:49:27 6:1 91 
3  AA 4 0.2 G2 28:51:21 6:1 68 
4  E-2.3 4 0.2 HG2 60:12:28 7:1 80 
5  E-2.3 4 0.2 G2 54:8:38 7:1 64 
7  Z-2.3 4 0.2 HG2 85:2:13 8:1 87 
8 Z-2.3 2 0.2 HG2 65:7:28 7:1 89 
9  Z-2.3 4 0.2 HG2 
(2x2.5%) 
95:0:5 9:1 72 
10  Z-2.3 4 0.4 HG2 90:5:5 9:1 79 
11 Z-2.3 4 0.4 HG2 
(2x2.5%) 
98:0:2 9:1 92 
12  Z-2.3 20 neat HG2 94:3:3 9:1 80 
Table 2.5 - CM of PAGE with allyl acetate derivatives. a x = PAGE-graft-AA, y = unreacted 
PAGE, z = self metathesis. b calculated using adjusted molar mass (Equation 5). 
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It was at this time, while studying the CM of PAGE with MA that we discovered the 
importance of concentration in achieving high conversion. Indeed when we increased the 
concentration from 0.2 to 0.4 M using Z-alkene coupling partner we observed an 
improvement in conversion from 65% to 90% (entry 8 vs 10). As stated previously, this is 
likely due to the high concentration allowing for an increased rate of coupling of PAGE with 
allyl acetate in the early stages of the reaction, leading to retardation of self-metathesis. By 
using a combination of increased concentration and sequential dosing of HG2 we observed 
our highest conversion of 98% (entry 11). We also investigated using Z-alkene coupling 
partner as the solvent, whilst mainlining the concentration relative to PAGE, however we 
saw a slight decrease in conversion to 94% (entry 12). Overall, we found that use of high 
concentration in conjunction with multiple loadings of HG2 catalyst allowed for the highest 
degree of conversion. 
Additionally there was a clear relationship between the degree of conversion and the E:Z 
diastereomeric ratio of the conjugated polymer. We believe primarily that an increase in 
conversion leads to steric crowding around the polymer backbone, resulting in a strong drive 
for the grafted sites to achieve the most thermodynamically favoured position (E-alkene), 
as this will allow for the least steric interaction of the pendent arms.  
2.6 Optimisation of CM reaction with amino 
acids 
Following on from our work with MA and AA, we were eager to investigate the coupling of 
amino acids and peptides to the polymer, with the ultimate goal of synthesising an RGD 
conjugated polymer. However firstly we investigated the synthesis of protected amino acids, 
with an interest in finding the optimal position to install the olefin group in order to achieve 
high conversion of cross-metathesis reactions. There are three possible positions that have 
been investigated (Scheme 2.10). 
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Scheme 2.10 - Positions of olefin on amino acids . 
 
2.6.1 CM with amino acids bearing side chain 
alkenes 
We first investigated various allyl glycine derivatives with an olefin installed at the -position 
(Scheme 2.11). Allyl glycine derivatives are interesting coupling partners as they can be 
integrated into cyclic peptides, and therefore allow the coupling such cyclic structures onto 
the polymer backbone.  
Protection of the amino and carboxylic acid groups of allyl glycine 2.11 was necessary 
before the cross-metathesis reactions as there is potential for these groups to deactivate 
the Grubbs catalyst by complexation with the ruthenium centre. This is especially true for 
the amine group as it possesses a lone pair of electrons that would have a strong affinity 
for the 14-electron metal complex that is formed during the catalytic cycle.  
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Scheme 2.11 – CM of PAGE with allyl glycine derivatives 
 
Entry Coupling 
partner 
x:y:za Yieldb (%) 
1  2.11 5:90:5 - 
2  2.12 30:5:65 - 
3 2.13 35:5:60 - 
4 2.14 22:7:71 - 
5  2.15 26:3:71 - 
6 2.16 Cross-linking - 
Table 2.6 - CM of PAGE with allyl glycine derivatives a x = PAGE-graft-X, y = unreacted 
PAGE, z = self metathesis. b calculated using adjusted molar mass (Equation 5). 
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Cross metathesis of unprotected 2.11 with PAGE resulted in the expected low conversion 
and  low degree of self metathesis, due to deactivation of the HG2 catalyst by the free amine 
and carboxylic acid groups of 2.11 (Table 2.6, entry 1). Protection of the N-terminus with a 
Boc group allowed for 2.12 to couple to PAGE with 30% conversion, however a large degree 
of self metathesis was observed (entry 2). Use of the methyl ester species 2.13 allowed for 
a slight improvement to 35% conversion, however this was a long way off the desired full 
conversion (entry 3). Use of Fmoc protected allyl glycines with a free carboxylic acid 2.14 
and methyl ester 2.15 yielded 22% and 26% conversion respectively (entry 4 and 5). This 
decrease in conversion when using Fmoc as opposed to Boc is possibly due to the increase 
in steric hindrance around the polymer backbone due to the large size of the fluorenyl 
moiety. 
We hypothesised that the rapid homodimerisation of the type 1 of allyl glycine analogues 
were limiting the successful CM pathway. The use of a preformed dimer had proved 
successful when investigating the CM of PAGE with allyl acetate, however when we tried 
to form the homodimer of allyl glycine 2.13 by CM using HG2 we retrieved a mixture of 
compounds that were inseparable by column chromatography. This lack of propensity to 
homodimerise indicates that allyl glycine species may not be favourable to CM conditions, 
which is a finding expressed in the literature.[109] However in a final effort we looked at an 
alternative less reactive trisubsituted allyl glycine 2.16. This species would be unlikely to 
undergo homodimerisation, and may therefore allow for a more efficient coupling of the allyl 
glycine species with PAGE. Alkene 2.16 was synthesised by reacting 2.13 in a neat solution 
of 2-methylbut-2-ene (Scheme 2.12). Unfortunately, upon reacting 2.16 with PAGE we 
observed rapid cross linking (entry 6) since the coupling partner was type 3 in nature and 
unable to readily take part in the CM pathway. 
Overall, we did not achieve high conversion of allyl glycine species with PAGE, which is 
potentially due to ally glycine undergoing unidentifiable side reactions under CM conditions. 
Note that the yields have not been reported here as the 1H-NMR of these allyl glycine 
functionalised polymers were not clean, and contained unexpected signals that we could 
not assign. 
 
Scheme 2.12 - Conversion of allyl group from type 1 to type 3. 
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2.6.2 CM using amino acids bearing N-terminus 
alkenes 
Next we moved onto investigating how an alkene installed at the N-terminus of allyl glycine 
would behave under CM conditions with PAGE. With the results of methyl acrylate in hand 
it was decided to emulate the alkene reactivity by installing an acrylamide on the N-terminus. 
Leucine was chosen as an amino acid, as the terminal CH3 protons gave a characteristic 
signal that is easily identifiable on the 1H-NMR spectrum (Scheme 2.13).  
CM of acrylamide 2.19 with PAGE allowed for 64% conversion, however we noticed a 
significant retention of the pendent allyl group of PAGE, indicating that the catalyst was 
perhaps being deactivated and preventing CM of self metathesis to occur (Table 2.7, entry 
1). Use of a slightly less bulky acrylamide coupling partner 2.20 also yielded low conversion 
(entry 2). We believe that the close proximity of the nitrogen to alkene may be allowing for 
coordination with the ruthenium centre of HG2, thereby disabling it. We postulated that 
increasing the distance of the nitrogen from the alkene may allow for more efficient CM. 
Unfortunately upon reacting acrylamide 2.21 we observed a further decrease in conversion 
to 24%. Homodimerisation of 2.21 was potentially preventing efficient conversion, and 
therefore we attempted to pre-form the homodimer. Unfortunately upon subjecting 2.21 to 
CM conditions we observed only trace amounts of the corresponding dimer, firmly indicating 
that these N-terminus alkenes were not favourable to CM conditions. Overall, we found that 
an N-terminus functionalised alkene resulted in very poor conversion, which we attribute to 
the amide functionality interacting unfavourably with the ruthenium catalyst. 
 
Scheme 2.13 – CM of PAGE with acrylamide derivatives 
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Entry Coupling 
partner 
x:y:za Yieldb (%) 
1  2.19 64:15:21 83 
2  2.20 30:52:18 81 
3 2.21 24:40:36 68 
Table 2.7 - CM of PAGE with acrylamide derivatives. a x = PAGE-graft-X, y = unreacted 
PAGE, z = self metathesis. b calculated using adjusted molar mass (Equation 5). 
2.6.3 CM using amino acids bearing C-terminus 
alkenes 
It has been shown that allyl acetate dimer 2.4 was a good coupling partner for PAGE and 
so the same functional group was employed to place the olefin on the C-terminus of the 
amino acid. This was done by the esterification of Boc-Glycine-OH 2.22 with diol 2.23 using 
EDCI to furnish diester 2.24 in quantitative yield (Scheme 2.14). When 2.24 was subjected 
to CM with PAGE the conversion was 30%, compared to 95% when allyl acetate dimer 2.4 
was used (Table 2.8, entry 1). Although this was a relatively low conversion, the 1H-NMR 
of the coupled polymer was clean and possessed few of the unidentifiable signals that were 
common when acrylamides and allyl glycine derivatives were used. Additionally it was at 
this point that we acquired a GPC system, which allowed us to conduct dispersity analysis. 
The GPC elutogram indicated an increase in dispersity from 1.08 to 1.77, which was 
reflected in the 1H-NMR indicating 70% rate of self metathesis. Additionally, we noticed that 
the reaction mixture was more viscous than previous CM reactions, which is likely due to 
the large molecular weight of 2.24. We sought to reduce this viscosity by diluting the reaction 
from 0.4 M to 0.2 M, however this resulted in a decrease in conversion to 13% (entry 2). 
Whilst studying the coupling of PAGE with AA we had found that two sequential additions 
of HG2 catalyst had resulted in high conversion, however when we implemented this 
method for coupling PAGE and 2.24 we noticed a slight decrease in conversion to 25%. 
Overall, we believe these low conversion may be due to the coupling partner being too large 
in size as to allow for efficient coupling to every pendent olefin of PAGE, yet too small in 
size as to act as effective steric hindrance to self metathesis of nearby PAGE chains. We 
decided to continue investigating other C-terminus allylic functionalised coupling partners, 
namely a bulky peptide that could potentially prevent intermolecular self metathesis. 
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Scheme 2.14 – CM of PAGE with Boc-Gly-O-allyl  
 
Entry [2.24] 
mol/L 
HG2 
(mol%) 
x:y:za  Yieldb (%) 
1  0.4 5 30:0:70 1.77 87 
2  0.2 5 18:15:67 1.85 85 
3 0.4a 2 × 2.5 25:0:75 1.90 80 
Table 2.8 - CM of PAGE with Boc-Gly-O-allyl. a x = PAGE-graft-X, y = unreacted PAGE, z 
= self metathesis. b calculated using adjusted molar mass (Equation 5). 
As well as potentially preventing self metathesis, coupling peptides to PAGE was also part 
of our overall goal. This was first done using a dipeptide of alanine 2.26 and glycine 2.27, 
which were coupled together using BOP to produce the methyl ester Boc-Ala-Gly-OMe 2.28 
that was then hydrolysed using NaOH in methanol to yield the free acid 2.29 (Scheme 2.16). 
Upon esterification with diol 2.23, the diester 2.30 was achieved in 99% yield. CM with 
PAGE resulted in a conversion of 40%, although interestingly the remaining repeating units 
had not all undergone self metathesis, rather 22% of repeating units were left unchanged 
as the allyl group and 38% had shown self metathesis. This indicated that the increased 
size of a peptide, as compared to amino acid residues, was possibly sterically hindering the 
unreacted allyl handles from self metathesis, a theory that is supported by Meier et al, 
whose work showed that increasing size of acrylate esters lead to lower occurrences of self 
metathesis.[63] GPC analysis also indicated self metathesis with an increase in dispersity 
from 1.08 to 1.68, a slight improvement than when PAGE was coupled to amino acid 2.24. 
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Scheme 2.15 - Synthesis of dipeptide Boc-Ala-Gly-O-allyl dimer and subsequent CM 
with PAGE 
 
We were also interested to see how placing the alanine closer to the alkene may affect the 
conversion with PAGE (Scheme 2.16). The hypothesis was that with alanine being closer 
in space to the olefin, there may be a decrease in the conversion of coupling onto the 
polymer backbone. After CM a conversion of 36% was observed (compared to 40% for 
2.30), indicating that the methyl group may play a role in shielding the polymer from 
successive CM. However, this may well be within experimental error as the CM was only 
attempted once. Dispersity showed in increase from 1.08 to 1.44 indicating that self 
metathesis was not as prevalent as when PAGE was coupled with 2.30. 
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Overall, we found that C-terminus functionalised peptides did not allow for the high levels 
of conversion that we obtained with smaller simpler molecules such as MA and AA. 
However it should be noted that the C-terminus alkenes yielded a much cleaner polymer 
with less unidentifiable side reactions that were prevalent when allyl glycine and 
acrylamides were used. At this point, we were interested to investigate how the size of the 
coupling partner influences the successful conversion when coupled to PAGE.  
2.7 Influence of the size of the coupling 
partner on CM 
Results to this point were implying that the size of the coupling partner played a vital role in 
determining the conversion of the CM reaction, and additionally influencing the degree of 
self metathesis observed. This was an issue that would certainly become important when 
the project moved towards the goal of coupling the PAGE with large biomolecules such as 
Taxol or RGD. In order to study the effect of coupling size, some simple biomolecules were 
studied. 
 
 
Scheme 2.16 - Synthesis of dipeptide Boc-Gly-Ala-O-allyl dimer and subsequent CM 
with PAGE 
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Scheme 2.17 - CM of PAGE with allyl glucose 
The first sterically encumbered molecule chosen as a model substrate was allyl glucose 
derivative 2.36, as it was inexpensive and possessed no functional groups that would 
interfere with the CM reaction. This coupling partner was produced by allylation of glucose 
at the anomeric position to yield 2.35 followed by acetylation of the remaining hydroxyl 
groups using acetic anhydride. This peracetylation was necessary in order for the glucose 
derivative to be soluble in dichloromethane for the CM with PAGE (Scheme 2.17). As 
expected the conversion was low at 15%, but the residual allyl repeating units was 30%. 
High degrees of self metathesis (55%) were expected due to the type 1 nature of the 
coupling partner, which have previously been explained to be troublesome in CM reactions. 
CM of 2.36 with HG2 yielded dimer 2.38, which was then and subjected to CM with PAGE. 
Unfortunately no conversion was achieved and only cross linked polymer was recovered. 
This is most likely due to large steric hindrance around the disubstituted olefin of the glucose 
dimer 2.38. The larger benzylated glucose compounds 2.39 and 2.40 were also synthesised 
and subjected to CM with PAGE, however these species also showed no evidence of 
successful coupling, with mostly self metathesis being observed (Scheme 2.18). 
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Scheme 2.18 - CM with glucose derivatives. Reaction conditions HG2 (5 mol%, CH2Cl2, 
45 °C, 18 h) 
Overall the only successful conversion we observed was with the homodimer of acetylated 
glucose 2.36, which coupled to PAGE with the retention of 30% of polymer allyl handles. 
This retention of the allyl groups could be due to deactivation of the ruthenium catalyst, 
which we had suggested when we observed poor coupling of the acrylamides to PAGE, 
however due to the lack of functional groups in this case we propose two alternative 
explanations.  
Scenario A. the large size the coupling partner sterically hinders other polymer chains from 
coming into contact with a polymer strand, thereby limiting self metathesis and retaining the 
allyl handle intact. 
Scenario B. unsuccessful coupling of PAGE with 2.36 allows for self-metathesis to occur in 
a predominantly intramolecular fashion to yield a globular particle. These structures could 
possess a folded conformation with residual pendent allyl handles located internally, 
allowing them to be shielded from the reaction media, and thus left intact.  
Scenario A would be justifiable had we achieved moderate conversion, however 15% 
conversion seems too low to have any real effect on preventing polymer strands from 
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coming into proximity with one another. Scenario B seemed like the most likely since 
production of Z-alkenes (indicative of intramolecular self metathesis) was something that 
we had previously observed when optimising reaction conditions for coupling PAGE with 
MA. Unfortunately due to the high levels of self metathesis of PAGE-graft-3.26, the 1H-NMR 
showed a broad singlet, preventing us from using coupling constants to conclude weather 
the self metathesis was intramolecular or intermolecular. However GPC analysis indicated 
a large increase in dispersity from 1.08 to 2.10 indicating significant intermolecular cross 
linking.  
Overall, it is likely that the self metathesis we saw was a combination of both intramolecular 
and intermolecular homodimerisation, and so we were not able to conclude at this point 
whether the size of coupling partner played a vital role in preventing self metathesis. 
 
2.8 Conclusion 
Synthesis of PAGE was achieved using potassium metal, naphthalene and benzyl alcohol, 
to produce polymer in Mn = 7,990 g.mol-1 and  = 1.08. Optimal conditions for the coupling 
of MA (type 2) to PAGE were sought, and we found that relatively high concentration (0.4 
M) was required to achieve conversion of 98%. Allyl acetate was also investigated as a 
model coupling partner for type 1 analogues. Unfortunately low conversions were observed 
for AA, however upon use of the preformed Z-2.3, we were able to obtain the desired graft 
polymer in 98% conversion.  
Coupling of amino acids to PAGE were also investigated. Use of allyl glycine derivatives as 
well as various acrylamides resulted in poor conversion and unidentifiable side reactions. 
Although C-terminus ally esters only offered a moderate conversion of ~30%, it should be 
noted that the grafted polymers were significantly cleaner. Ultimately, we achieved coupling 
of dipeptides 2.30 and 2.32, which is a positive step towards coupling tripeptide RGD. 
Investigation into the use of a bulky coupling partner was disappointing as it did not appear 
to supress self metathesis as we had intended. Due to broadening of the 1H-NMR spectrum 
is unclear whether self metathesis is predominantly occurring inter or intramolecularly. 
Retention of pendent olefin handles indicate the possible formation of a folded 
conformation, formed by intramolecular self metathesis, however significant increases in 
dispersity suggest intermolecular homodimerisation is present. Therefore, we suspect the 
self metathesis that is present in many couplings with PAGE it is a combination of both 
intramolecular and intermolecular processes.  
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Chapter 3 : Synthesis of polymer range 
PAGE, PCGE, PPGE, PMAGE 
 
This chapter will discuss the synthesis of a new range of polymers that are intended to 
reduce the degree of self metathesis, and thus improve the dispersity of the conjugated 
polymers. Cross metathesis will then be carried out on these polymers with the ultimate 
goal of attaching cell targeting tripeptide RGD. Focus will then be shifted to the synthesis of 
various copolymers, which would enable to bifunctionalisation of the PEG chain. This would 
be of particular interest when synthesising a polymer conjugate that contains both a drug 
and a cell targeting moiety such as RGD.  
3.1 New approach to prevent self metathesis 
of the polymer during CM 
It was decided at this point in time that the self metathesis of the polymer was a problem 
that could not be solved by only adjusting reaction conditions or using specific coupling 
partners. Therefore, we decided to synthesise a range of new polymers that were naturally 
less likely to undergo self metathesis.  
As described by Grubbs et al., olefins can be categorised into one of four types according 
to their rate of homodimerisation in the presence of a specific catalyst.[53] We proposed that 
by changing the type of alkene present on the polymer, we could control the degree of self 
metathesis, allowing for a more monodisperse product to be formed. The polymers 
proposed are shown in Figure 3.1. 
 
 
Figure 3.1 - New polymer range with varying olefin reactivity. 
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As previously stated, poly(allyl glycidyl ether), PAGE is a type 1 olefin and although it is 
capable of coupling with less reactive coupling partners such as MA, it has been shown to 
readily homodimerise to yield a cross linked polymer. When a type 2 coupling partner such 
as MA is used, the ruthenium catalyst should react primarily with allyl handle of PAGE to 
form the metal-polymer alkylidene complex 3.1, which would then react readily with another 
pendent type 1 group, yielding a SM product 3.4 (Scheme 3.1). Homodimerisation can be 
prevented to some degree by using high equivalents of coupling partner, however, as our 
work with MA and AA proved, this cannot entirely prevent this undesirable 
homodimerisation. 
Poly(crotyl glycidyl ether), PCGE is also type 1 olefin that should show good reactivity 
towards metathesis; however it should be less likely to undergo self metathesis than PAGE. 
Under CM conditions, the ruthenium catalyst will first undergo a [2+2] cycloaddition with the 
crotyl handle PCGE to form the metal-polymer alkylidene complex 3.1, as it did with PAGE, 
however this alkylidene complex should have a decreased propensity for subsequent 
homodimerisation than when PAGE was used. This is due the methyl group of the crotyl 
handle creating an increase in steric hindrance around the four-membered transition state 
3.6, which is not present in the homodimerisation of PAGE (Scheme 3.1). Overall, PCGE 
should offer a decrease in the rate of homodimerisation, whilst maintaining sufficient 
reactivity to coupling partners such as MA.  
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Scheme 3.1 – Reaction pathway for the conjugation of PAGE and PCGE using CM. 
 
Poly(prenyl glycidyl ether), PPGE is type 2 in nature, and therefore the pathway towards 
successful conjugation should be highly dependent on the type of coupling partner used. In 
the case of coupling with a type 1 coupling partner, self metathesis of PPGE should occur 
to a much lesser degree than in the case of PCGE or PAGE, as the trisubstituted olefin 
should be less likely to form the metal-polymer alkylidene intermediate 3.1 that is necessary 
for self metathesis (Scheme 3.2). Instead, the ruthenium catalyst should react principally 
with the type 1 coupling partner 3.7 before reacting with the PPGE. This final coupling of 
3.8 with PPGE would be slow due to the trisubstituted nature of the prenyl olefin, however 
a low conversion with no self metathesis that allows for retention in monodispersity may 
potentially be favourable over a polymer that results in high self metathesis. A possible pitfall 
of PPGE may be subsequent secondary self metathesis of conjugated polymer 3.2 to form 
3.4. Time may prove to be an important factor in preventing this secondary metathesis from 
producing high degree of self metathesis. 
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Scheme 3.2 - Reaction pathway for the conjugation of PPGE with type 1 coupling 
partner. 
 
In the case of coupling a type 2 species with PPGE, we believe that, due to the unreactive 
coupling partner 3.9 being unlikely to form an alkylidene intermediate 3.10, the ruthenium 
catalyst would react principally with the prenyl olefin of PPGE (Scheme 3.3). This may occur 
relatively slowly due to the trisubtituted nature of the alkene, however should eventually 
occur, leading to form polymer-ruthenium carbene 3.1. Self metathesis could occur at this 
point, however due to the high energy of the dimethyl substituted 4-membered ring 
intermediate 3.12, it is more likely that 3.1 would undergo CM with coupling partner 3.9 to 
yield the desired functionalised polymer 3.11. Interestingly, when coupling partner 3.9 is 
electron deficient, the final product 3.11 should be stable and unlikely to undergo secondary 
CM that could lead to self metathesis product 3.4. 
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Scheme 3.3 - Reaction pathway for the conjugation of PPGE with type 2 coupling 
partner. 
 
Poly(methallyl glycidyl ether), PMAGE is a type 3 gem-disubtituted olefin like PCGE 
however its capability to undergo self metathesis should be minimal as homodimerisation 
would result in a tetrasubstituted (type 4) olefin 3.15, which is not possible under typical CM 
conditions (Scheme 3.4). The reaction pathway should start with the ruthenium catalyst 
reacting with the coupling partner 3.7 (type 1) to yield alkylidene intermediate 3.8, which 
would then undergo CM with PMAGE to produce 3.14 (Scheme 3.4). When a type 2 olefin 
is reacted with PMAGE there should be no observable coupling, as both the formation of 
carbene 3.10, and the subsequent coupling to PMAGE would be very slow, leading to 
minimal successful coupling to PMAGE. 
Overall, even though PMAGE possesses a type 3 olefin, which may make full conversion 
difficult, the absence of any pathway leading to the self metathesis 3.15, makes PMAGE a 
very interesting candidate for functionalisation. 
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Scheme 3.4 - Reaction pathway for the conjugation of PMAGE using CM. 
 
3.2 Synthesis of PAGE, PCGE, PPGE, PMAGE 
Synthesis of the monomers CGE, PGE, and MAGE ethers was achieved by the SN2/SN2’ 
reaction of racemic epichlorohydrin with the crotyl, prenyl, and methylallyl alcohols 
respectively. The reaction could also occur by nucleophilic attack of the epoxide followed 
by intramolecular displacement of the chlorine which would also furnish the same product 
(Scheme 3.5).  Obtaining a pure monomer product was of paramount importance, as 
anionic ROP is extremely sensitive to protic species such as alcohol 3.16, 3.19, and 3.22, 
as well as electrophiles such as epichlorohydrin 3.17. Due to both epichlorohydrin and 
alcohols 3.16, 3.19, and 3.22 possessing similar boiling point to the monomer products 3.18, 
3.20, and 3.23, it was difficult to obtain a pure product using only distillation. For this reason, 
excess alcohol was used in the coupling, as this polar starting material was more easily 
removed during column chromatography. Additionally, the relatively volatile monomers 
required careful handling to prevent loss by evaporation.  
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Scheme 3.5 – Synthesis of monomers CGE, PGE, MAGE. 
 
Polymerisation of the monomers 3.18, 3.20, and 3.23 was then attempted using potassium 
benzoxide 1.29 under conditions previously used to achieve the synthesis of PAGE. 
Unfortunately, only MAGE monomer 3.23 successfully underwent polymerisation (yield = 
53%, DP = 40,  = 1.09), with CGE and PGE returning only starting material (Scheme 3.6). 
Initially, we believed that this was due to residual epichlorohydrin left over from the monomer 
synthesis. Therefore, we moved from distilling the monomer from CaH2, to distilling it from 
isopropyl magnesium chloride as the increased nucleophilicity of i-PrMgCl should aid the 
removal of the electrophilic impurity. In the case of CGE, this change in purification allowed 
for sufficiently pure monomer that could undergo polymerisation in 10% yield, however the 
DP was very low (DP = 5). Due to the low molecular weight of the obtained polymer, it was 
not possible to measure the dispersity using GPC as it was out with the range of the column 
(1,000 – 40,000 Da). Additionally, without the use of a glove box to handle potassium we 
were concerned that the preparation of initiator 1.29 was allowing for the incorporation of 
moisture to the reaction.  
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Scheme 3.6 – Polymerisaiton of CGE, PGE and MAGE monomers using potassium 
benzoxide. 
 
Fortunately, at this point we read of a recent development by Groll et al. allowing for the 
facile synthesis of PAGE in controlled dispersity by the slow addition of the AGE monomer 
to potassium tert-butoxide initiator 3.24, as discussed in Section 1.3.2.[38] Slow addition of 
the monomer at 2 mL.h-1 over 4 hours to t-BuOK 3.24 in THF allowed for the successfully 
production of a quasi-monodisperse polymers (Scheme 3.7). Unlike the previous synthesis 
developed of PAGE using benzyl alkoxide 1.29 by C. Hawker, which required the removal 
of THF solvent prior to the addition of monomer, this new method worked well with the THF 
still present. This is likely due to the commercially supplied t-BuOK 3.24 in THF possessing 
less protic impurities than the manual synthesis of benzyl alkoxide 1.29. 
Polymers were synthesised with a target Mn > 10,000 g.mol-1, which was achieved for all 
four polymers. Hawker et al. had reported instances of olefin isomerisation during the 
synthesis of PAGE, however fortunately we did not observe any occurrence of this during 
the synthesis of PAGE, PCGE, PPGE, or PMAGE.[37] 
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Acceptable dispersity was also obtained for all polymers, however PPGE possessed a 
dispersity of 1.38. We repeated this polymerisation but the second batch of PPGE showed 
similarly higher dispersity. Due to the lack of isomerisation that would occur by chain 
termination (Scheme 1.5), we suggest that this occurrence of high dispersity must be due 
to residual protic impurities left over from the synthesis of PGE. Although this relatively high 
dispersity was not ideal, we were interested principally in the change in dispersity upon 
coupling by CM, therefore decided to proceed with the coupling of the new polymer range 
with various small molecules. 
 
 
Scheme 3.7 - New polymer range using slow addition method by Groll et al.[38] 
 
Entry Monomer a
 
Yield 
(%) 
Mn b 
(g/mol) 
Mn c 
(g/mol) 
Mw c 
(g/mol) 
Mn 
(theoretical)  c 
1 AGE 99 10773 10009 11620 11400 1.16 
2 CGE 85 14970 9166 11443 12800 1.25 
3 PGE 90 13380 9980 13778 14200 1.38 
4 MAGE 98 13250 15849 18239 12800 1.15 
Table 3.1 - Synthesised polymer range. a Monomer added at 2 mL.h-1 and reactions 
performed at 50 °C, 24 h. b Determined by 1H-NMR. c Determined by GPC analysis. 
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3.3 Cross Metathesis with PAGE, PCGE, 
PPGE, and PMAGE 
Coupling of PAGE to various small molecule olefins as described in chapter 2 included MA, 
AA, and amino acids. We then applied the same reaction conditions to the new polymer 
range of PAGE, PCGE, PPGE, and PMAGE.  
3.3.1 CM with MA 
Using the optimised conditions from Chapter 2, we repeated the CM of PAGE with MA 
(Scheme 3.8)  
 
Scheme 3.8 - CM of PAGE, PCGE, PPGE and PMAGE with MA. 
 
We were surprised that the new polymer of (t-BuO)-PAGE (synthesised with t-BuOK initiator 
3.24) only achieved 85% conversion compared to 98% with the previous polymer (BnO)-
PAGE (synthesised by benzyl alkoxide initiator 1.29) (Entry 1, Table 3.2). The differences 
between polymers (BnO)-PAGE and (t-BuO)-PAGE are in Mn (~8 kDa and ~11 kDa 
respectively) and dispersity (1.08 and 1.16 respectively) (Figure 3.2). Considering the 
identical nature of the pendent allyl olefins in both polymers, the difference in conversion 
must due to the macromolecular structure of these polymers. (t-BuO)-PAGE possesses a 
higher Mn, which means that the number of (t-BuO)-PAGE molecules, per mol of allyl 
groups, is lower than in (BnO)-PAGE. A diagrammatic example of this is shown in Figure 
3.2, whereby each polymer could have an equal number of allyl groups, but difference 
number of molecules. This increases the chances of (t-BuO)-PAGE undergoing 
intramolecular self metathesis, leading to a folded polymer than shields the internal 
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macrostructure from the reaction media, thereby limiting access of MA to the residual allyl 
handles of the polymer.  
Note that from now on (chapter 3 and 4), unless otherwise stated, any mention to PAGE is 
referring to (t-BuO)-PAGE (Mn ~11 kDa,  = 1.16). 
 
Figure 3.2 – Comparison of both PAGE polymers. 
Coupling of PCGE with methyl acrylate saw a slight decrease in conversion in comparison 
to PAGE (80% and 85% respectively), with an overall increase in self metathesis, indicating 
that the added methyl group in the four membered transition state was not inhibiting the 
formation of the SM product (entry 2).  
The reaction of PPGE with MA saw a significant increase in conversion to 95% with a 
significant drop in self metathesis to 3% (entry 3),  which is likely due to the increased strain 
around the 4-membered intermediate 3.12 limiting the homodimerisation of the pendent 
prenyl handle. Additionally, although the self metathesis decreased significantly, the 
dispersity increased to 2.00, which supports the idea that even a small amount of self 
metathesis can result in a polydisperse product. Unsurprisingly, use of PMAGE saw no 
conversion with MA due to the low reactivity of the pendent type 3 olefin. 
  
Conversion 
(x) a 
Unreacted 
(y) a 
Self 
Metathesis 
(z) a 
 
before b 
 
after b 
Yield 
(%) 
Entry 1 PAGE 85 5 10 1.16 2.11 92 
Entry 2 PCGE 80 0 20 1.25 2.21 95 
Entry 3 PPGE 95 2 3 1.38 2.00 84 
Entry 4 PMAGE 0 100 0 1.15 - - 
Table 3.2 - CM of polymer range with MA. a Determined by 1H-NMR integration. x,y,z relate 
to Scheme 3.8. b Measured by GPC. 
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3.3.2 CM with AA 
Previous work using (BnO)-PAGE had shown the Z-alkene dimer Z-2.3 to be the optimal 
coupling partner for grafting allyl acetate onto the polymer backbone, and so Z-2.3 was 
investigated as a model type 1 coupling partner for the new polymer range. 
 
Scheme 3.9 - CM of PAGE, PCGE, PPGE, and PMAGE with AA. 
 
Coupling of Z-2.3 with (t-BuO)-PAGE resulted in a decrease in conversion in comparison to 
the previous polymer (BnO)-PAGE (Table 3.3). As discussed in Section 3.3.1 we believe 
that the increase in Mn leads to a greater propensity to undergo self metathesis. This was 
accompanied by an increase in dispersity from 1.16 to 1.46. Unfortunately neither PCGE, 
PPGE or PMAGE offered greater conversion, however interestingly, PMAGE underwent 
23% conversion with no evidence of SM. This absence of self metathesis was reflected in 
the dispersity which decreased slightly from 1.15 to 1.09 (entry 4). 
 
  
Conversion 
(x) a 
Unreacted 
(y) a 
Self 
Metathesis 
(z) a 
 
before 
b
 
 
after 
b
 
Yield 
(%) 
Entry 1 PAGE 87 4 9 1.16 1.46 90 
Entry 2 PCGE 73 12 15 1.25 1.98 83 
Entry 3 PPGE 60 30 10 1.38 1.76 95 
Entry 4 PMAGE 23 77 0 1.15 1.09 95 
Table 3.3 - CM of polymer range with AA. a Determined by 1H-NMR integration. x,y,z relate 
to Scheme 3.9. b Measured by GPC. 
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Up to this point we had found PMAGE to be the best candidate for CM, as it offered no self 
metathesis pathway, however there is a limitation in the obtainable conversion, due to the 
unreactivity of the olefin of the polymer. As a result, we then focused on finding the optimal 
conditions to achieve high conversion with PMAGE by varying the reaction conditions for 
CM. This was done by varying solvent and temperature (Table 3.4). 
Changing the solvent from CH2Cl2 to 1,2-dichloroethane (entry 2) yielded an identical 
polymer, however use of toluene at the same temperature increased the conversion from 
23% to 41% (entry 3). It has been documented in the literature that the initiation of HG2 
catalyst, whereby the isopropoxystyrene dissociates from the ruthenium complex, occurs 
much faster in toluene than in CH2Cl2.[110] Due to the unreactive nature of PMAGE, this 
increase in the initiation of HG2 must play a crucial role in allowing for high conversion of 
the polymer with Z-2.3. 
Surprisingly, increasing the temperature to 85 °C while using 1,2-dichloroethane did not 
result in an increase in conversion (entry 4), however switching to toluene at this elevated 
temperature resulted in a further increase in conversion to 50% (entry 5). Pushing the 
reaction conditions to employ refluxing toluene did not result in further conversion (entry 6). 
It is possible that when 50% conversion is reached, the steric hindrance around the polymer 
backbone is the limiting factor, as opposed to unreactivity of the gem-disubstituted olefin. 
This plateauing of the conversion is exemplified when the time is increased to 48 h, which 
sees the conversion remain steady at 48% (entry 7).  
 
Entry Solvent Temperature 
(°C) 
Conversion 
b
 
Yield 
1 CH2Cl2 45 23 98 
2 C2H4Cl2 45 23 96 
3 Toluene 45 41 98 
4 C2H4Cl2 85 23 98 
5 Toluene 85 50 97 
6 Toluene 110 47 99 
7a Toluene 110 48 99 
Table 3.4 - CM of PMAGE with Z-2.3 with various temperature and solvents a All reactions 
performed over 18 h, except entry 7, which was performed over 48 h. b Determined by 1H 
NMR integration. 
Results of the coupling of PMAGE with Z-2.3 had indicated that conversion was limited to 
~50%, which may be caused by steric hindrance around the polymer backbone. In order to 
investigate this, we envisaged the synthesis of poly(methylbutenyl glycidyl ether), PMBGE, 
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which possesses a gem-disubstituted alkene, and would therefore not undergo self 
metathesis, however with a pendent olefin that is slightly further away from the polymer 
backbone (Scheme 3.10). Synthesis of PMBGE started with the coupling of 3-methyl-3-
butene-1-ol 3.30 with epichlorihydrin  3.17 to yield monomer MBGE, which was then slowly 
added to t-BuOK to furnish PMBGE with a dispersity of 1.76.  
 
Scheme 3.10 – Synthesis of PMBGE 
 
Monomer a 
Yield 
(%) 
Mn b 
(g/mol) 
Mn c 
(g/mol) 
Mw c 
(g/mol) 
Mn 
(theoretical)  
c
 
MBGE 91 5688 4867 8570 14200 1.76 
Table 3.5 – Synthesis of PMBGE. a Monomer added at 2 mL.h-1 and reactions performed 
at 50 °C, 24 h. b Determined by 1H-NMR. c Determined by GPC analysis. 
PMBGE was then reacted with Z-2.3 in toluene at 85 °C as these conditions had been found 
optimal for coupling Z-2.3 with PMAGE (as shown in Table 3.4). The conversion of PMBGE 
with Z-2.3 was found to be 35%, which was marginally lower than when Z-2.3 was coupled 
with PMAGE (Table 3.6). An explanation for PMAGE offering higher conversion than 
PMBGE may come from the macromolecular structure of PMBGE being more branched in 
nature due to intermolecular ketone coupling as described in Section 1.3.2. The branching 
arms of PMBGE may act to limit access to the polymer and result in a decreased 
conversion, however this has yet to be confirmed. Overall we decided to move on with our 
studies focusing on PMAGE as opposed to try to improve the dispersity of PMBGE. 
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Scheme 3.11 - CM of PMBGE with AA. 
 
  
Conversion 
(x) a 
Unreacted 
(y) a 
Self 
Metathesis  
(z) a 
 
before 
b
 
 
after 
b
 
Yield 
(%) 
Entry 1 PMAGE 50 50 0 1.15 1.09 97 
Entry 2 PMBGE 35 65 0 1.76 1.54 95 
Table 3.6 - CM of PMAGE and PMBGE with Z-2.3. a Determined by 1H-NMR integration. b 
Measured by GPC. 
3.3.3 CM with amino acids 
We moved out attention to coupling amino acids such as 2.24 to the newly synthesised 
polymers. Amino acid species 2.24 was chosen as the model coupling partner since we had 
already shown that an allyl ester at the C-terminus was the optimal way to couple glycine 
to the polymers (Scheme 3.12). 
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Scheme 3.12 - CM of PAGE, PCGE, PPGE and PMAGE with 2.24. 
 
Coupling this glycine species 2.24 with the new polymer (t-BuO)-PAGE resulted in 30% 
conversion, which is identical to when 2.24 was coupled to polymer (BnO)-PAGE (entry 1, 
Table 3.7). This similarity in conversion was surprising, considering that in the case of both 
MA and Z-2.3 there was a decrease in conversion when (t-BuO)-PAGE was used compared 
to (BnO)-PAGE. However, coupling of 2.24 with (t-BuO)-PAGE also resulted in retention of 
7% of allyl handles, compared to 0% when (BnO)-PAGE was used. This further indication 
that the higher molecular weight (t-BuO)-PAGE has an increased tendency to form hyper 
cross linked polymers which shield the unreacted olefins in their core. 
Coupling of 2.24 with PCGE resulted in an increase in conversion to 40% (entry 2), however 
significant self metathesis was still prevalent. Coupling to PPGE yielded similar conversion 
of 38% with 27% unreacted prenyl handles remaining (entry 3). Retention of 27% of prenyl 
groups may also be evidence of hyper cross linked structures with the unreacted prenyl 
handles being held within. CM with PMAGE resulted in conversion of 30%, with no evidence 
of self metathesis. Once again, switching to PMBGE resulted in a surprising decrease in 
conversion to 24%, which may be due to branched nature of the polymer preventing 
adequate access for amino acid 2.24. 
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Conversion 
(x) a 
Unreacted 
(y) a 
Self 
Metathesis 
(z) a 
 
before b 
 
after b 
Yield 
(%) 
Entry 1 PAGE 30 7 63 1.16 1.81 94 
Entry 2 PCGE 40 7 53 1.25 1.72 82 
Entry 3 PPGE 38 27 35 1.38 1.84 95 
Entry 4 PMAGE 30 70 0 1.15 1.09 97 
Entry 5 PMBGE 24 76 0 1.76 1.50 90 
Table 3.7 - CM of polymer range with amino acid 2.24. a Determined by 1H-NMR integration. 
x,y,z relate to Scheme 3.12. b Measured by GPC. 
Since PMAGE offered the most promising results in terms of conversion vs self metathesis, 
we were eager to investigate how solvent choice and temperature may influence the 
conversion with amino acid 2.24 (Table 3.8).  
Substituting CH2Cl2 for 1,2-dichloroethane resulted in a decrease in conversion from 30% 
to 25% (entry 1 and 2). Crucially, use of toluene (which had proved optimal in the coupling 
PMAGE with Z-2.3) prevented full dissolution of amino acid 2.24 but surprisingly we still 
observed 24% conversion (entry 3).  Little improvement was observed upon increasing the 
temperature to 85 °C (entry 4-5), however upon increasing the temperature to 110 °C in 
toluene a conversion of 33% was obtained. Overall, little improvement in the conversion 
has been achieved from the initial reaction conditions, which means that the polymer may 
be limited by steric hindrance around the backbone. Importantly though, no self metathesis 
was observed in any of the reactions involving PMAGE. 
 
Entry Solvent 
Temperature 
(°C) Conversion 
b
 Yield 
1 CH2Cl2 45 30 98 
2 C2H4Cl2 45 25 94 
3 Toluene 45 24 95 
4 C2H4Cl2 85 22 96 
5 Toluene 85 29 96 
6 Toluene 110 33 98 
Table 3.8 - CM of PMAGE with 2.24 with various temperature and solvents a All reactions 
performed over 24 h. b Determined by 1H-NMR integration.  
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Overall, polymers PAGE, PCGE and PPGE are able to successfully couple with glycine 
coupling partner 2.24 with between 30-40% conversion. This moderate conversion may be 
due to steric hindrance around the polymer backbone. Additionally characterisation of these 
products was difficult due to the high degrees of self metathesis, as this resulted in 
broadening of the 1H-NMR. Use of PMAGE and PMBGE result in slightly lower conversion 
of 20-30% conversion, which is likely the result of the unreactive nature of the gem 
disubstituted olefins. Due to the total absence of self metathesis of PMAGE we decided to 
move focus our effort on this polymer. 
 
3.3.4 CM with RGD-O-allyl 
After coupling the polymer range with a simple amino acid of glycine, we decided to attempt 
the coupling of PMAGE with tripeptide RGD. As described in Section 1.6, RGD is a peptide 
used in cell recognition, and could potentially be used to target cancerous cells by 
interacting with the integrin v93 that is over expressed on endothelial cells that are 
undergoing tumour angiogenesis.[105] We wanted to perform this coupling with PMAGE as 
it has been proven to prevent any self metathesis from occurring whilst offering similar 
conversion to the other polymers when reacted with amino acid 2.24. 
Our preliminary work on coupling peptides to polymers had found that using a pre-dimerised 
coupling partner with the alkene functionality installed at the C-terminus generally offered 
optimal conversion. For these reasons, we decided to synthesis RGD dimer 3.34, which 
has an allyl ester that is analogous to Z-2.3 and 2.24 (Scheme 3.13).  
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Scheme 3.13 – RGD dimer 
 
We decided to construct RGD dimer 3.34 in a convergent synthesis by subjecting tripeptide 
3.35 to cross metathesis. Tripeptide 3.5 would be synthesised by peptide coupling of 
dipeptide 3.36 and allyl aspartate 3.37, which can each be made from commercially 
available amino acids. 
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Scheme 3.14 – Retrosynthesis of RGD dimer 
 
Synthesis of 3.37 began with the coupling of protected aspartic acid 3.38 with allyl alcohol 
3.39 to form allyl ester 3.40 in 66% yield (Scheme 3.15). Subsequent removal of the Fmoc 
protecting group allowed the formation of the desired free amine 3.37 in 90% yield.   
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Scheme 3.15 – Synthesis of Asp fragment. 
 
Synthesis of the Arg-Gly 3.36 fragment was done by coupling protected arginine 3.43 with 
methyl glycine 3.44 to furnish dipeptide 3.45 (Scheme 3.16). Hydrolysis of methyl ester 3.45 
yielded the free acid 3.36 in 99% yield.  
 
 
Scheme 3.16 – Synthesis of Arg-Gly dipeptide 
 
 
 
Coupling of Arg-Gly 3.36 with aspartic acid species 3.37 using BOP allowed for the 
formation of RGD 3.35 in 79% yield (Scheme 3.17). Submission of 3.35 to cross metathesis 
conditions produced RGD dimer 3.34 in 68%, with the recovery of 10% of starting material. 
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Importantly, recovery of any quantity of the allyl ester 3.35 indicated that the 
homodimerisation was relatively slow, and therefore both RGD 3.34 and 3.35 could be 
classified as a type 2 olefins.[53] 
 
 
Scheme 3.17 – RGD-O-allyl coupling 
Because of the surprisingly low reactivity of the RGD-O-allyl 3.35, it was decided to 
investigate the coupling of PMAGE with both RGD 3.35 and its dimer 3.34 (Scheme 3.18). 
Coupling of PAGE with 3.35 in CH2Cl2 resulted in only 5% conversion (entry 1, Table 3.9), 
which was expected due to the slow rate of homodimerisation of this peptide. Increasing 
the reaction time to 48 hours did not result in an increase in conversion, potentially indicating 
that the hindrance around the polymer backbone has reached its limit (entry 2). Changing 
the solvent to 1,2-dichloroethane did not allow for an increase in conversion (entry 3). Use 
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of toluene was expected to allow for a more efficient cross metathesis reaction as previously 
explained in section 3.3.2, however unfortunately peptide 3.35 did not dissolve in toluene. 
As a result, we attempted to couple RGD 3.35 in a dual solvent system of toluene/CH2Cl2, 
however this did not result in any conversion (entry 4). Use of 1,2-dichloroethane at reflux 
was attempted in a final effort to increase the conversion, however this resulted in only 4% 
conversion (entry 5). Coupling of dimer 3.34 to PMAGE did not show evidence of any 
conversion, which we believe is due to the hindered nature of the RGD alkene. Overall use 
of RGD species 3.34 and 3.35 did not prove to be efficient coupling partners with PMAGE, 
which we attribute to the surprisingly low reactivity of the RGD alkene. 
 
Scheme 3.18 - CM PMAGE with RGD 3.34 and 3.35 
 
Entry RGD Solvent 
Temperature 
(°C) Conversion 
b
 Yield 
1 3.35 CH2Cl2 45 5 95 
2a 3.35 CH2Cl2 45 4 86 
3 3.35 C2H4Cl2 45 5 94 
4 3.35 Toluene/CH2Cl2 (1:1) 45 0 NA 
5 3.35 C2H4Cl2 85 4 87 
6 3.34 CH2Cl2 45 0 NA 
Table 3.9 - CM of PMAGE with RGD allyl esters 3.34 and 3.35 with various temperature 
and solvents a performed over 48 h. b Determined by 1H NMR integration. 
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3.3.5 CM with RGD-O-hexenyl 
We believe that RGD species 3.34 and 3.35 are unreactive to CM due to the close proximity 
of the alkene to the bulky peptide region. As a result we envisioned the use of a longer linker 
in order to reduce the steric hindrance around the alkene, allowing the HG2 catalyst to 
access the double bond. In addition to increasing reactivity of the alkene, this linker would 
help prevent crowding from occurring around the polymer backbone. In order to achieve 
this we synthesised hexenyl ester 3.44. 
 
Scheme 3.19 – RGD-O-hexenyl 3.44 
Synthesis started by coupling aspartic acid 3.38 with hex-5-ene-1-ol 3.45 to furnish ester 
3.46 in 92% yield (Scheme 3.20). Deprotection of the Fmoc group formed free amine 3.47 
in 91% yield. 
 
 
Scheme 3.20 – Synthesis of aspartate ester. 
We used this repeat synthesis of RGD as an opportunity to replace the arginine’s tosyl 
protecting group with a Pbf group, as the latter should be more easily cleaved once 
successfully coupled to the polymer (Scheme 3.21). Coupling of Pbf protected arginine 3.48 
103 
 
with methyl glycine 3.44 yielded dipeptide 3.49 in 66% yield. In hindsight, EDCI could have 
been used for this coupling, which would have had the added benefit of not producing 
HMPA. Hydrolysis of the methyl ester then furnished fragment 3.50 in 75% yield. 
 
 
Scheme 3.21 – Synthesis of Arg(Pbf)-Gly dipeptide 
 
Coupling of dipeptide 3.50 with hexenyl ester 3.47 resulted in the formation of RGD-O-
hexenyl 3.44 in 75% yield. Homodimerisation of 3.44 was carried out, achieving 89% yield 
of 3.51. Importantly no starting material was recovered, indicating that hexenyl species 3.44 
is more adept to cross metathesis than allyl ester 3.35. 
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Scheme 3.22 – Synthesis of RGD-O-hexenyl 
RGD-O-hexenyl 3.44 and 3.51 were then subjected to CM with PMAGE. Conjugation of 
3.44 resulted in a significant increase in conversion to 31% (entry 1) compared to the CM 
of RGD-O-allyl 3.35, which achieved a conversion of ~5%. Increasing the temperature to 
85 °C did not result in a significant change in conversion (entry 2). Use of dimer 3.51 
resulted in slightly lower conversion of 26% (entry 3). This substantial improvement in 
conversion is most likely due to a combination of i) increased reactivity of hexene species 
3.44 and 3.51 compared to allyl esters 3.34 and 3.35, and ii) decreased steric crowding 
around the polymer backbone by the large RGD molecule.  
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Scheme 3.23 - CM PMAGE with RGD-O-hexenyl 
 
Entry RGD Solvent 
Temperature 
°C 
Conversion a 
Yield 
(%) 
1 3.44 CH2Cl2 45 31 85 
2 3.44 C2H4Cl2 85 30 90 
3 3.51 CH2Cl2 45 26 75 
Table 3.10 - CM of PMAGE with RGD allyl esters 3.44 and 3.51 a Determined by 1H-NMR 
integration. 
Deprotection of the RGD conjugated polymer was then carried out using TFA. 1H-NMR 
analysis of the product was not clear, however it indicated successful cleavage of the Boc 
and Pbf from PMAGE-graft-RGD, while the tert-butyl ester of aspartic acid appeared to 
remain in place. The reaction was left for 2 hours as we were concerned that cleavage of 
the allyl ester may occur if left for prolonged periods of time. In the future use of ZnBr2 as a 
deprotection method may be worth investigating, as it has been shown to deprotect tert-
butyl esters in the presence of allyl esters.[111]  
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Scheme 3.24 – Deprotection of PMAGE-graft-RGD 
 
3.4 Bifunctionalisation of copolymers PAGE-
co-PMAGE and PPGE-co-PMAGE 
Studies on the CM of PAGE to undergo successful conjugation with methyl acrylate were 
promising, however GPC studies had shown evidence of self-metathesis. Therefore, it was 
proposed that a co-polymer of AGE and MAGE could limit the ability of self-metathesis 
whilst maintaining the reactivity towards CM via the remaining AGE handles. This obviously 
limits the ability to undergo full conversion, however it opens up the possibility to achieve 
bifunctionalisation if conditions can be found to utilise the difference in reactivity of AGE and 
MAGE. Additionally, by controlling the ratio of the two monomers during the polymerisation 
stage, it may be possible to dictate the ratio of polymer’s bifunctionalisation. This may be 
extremely useful in the case of coupling both a drug and a cell targeting species to the co-
polymer. 
3.4.1 Co-polymer synthesis 
Firstly we wanted to confirm that we could achieve bifunctionalisation by carrying out two 
successive CM reactions, whereby the coupling of the second partner would not result in 
cleavage of the first (Scheme 3.25). It was found that MA coupled polymer 3.26 was 
unreactive to secondary CM with type 1 coupling partner Z-2.3, which is due to 3.26 
possessing an electron deficient, disubstituted olefin. Reversing the order of the coupling 
reactions so that PMAGE was conjugated with Z-2.3 first led to polymer 3.27, and 
subsequent CM with MA allowed for the displacement of allyl acetate, and formation of MA 
conjugated polymer 3.26. These results indicate that, for bifunctionalisation to be achieved, 
it is necessary to couple the less reactive coupling partner in the first CM reaction, as this 
prevents displacement during the second coupling stage. 
107 
 
 
 
Scheme 3.25 – Secondary coupling of PAGE with MA and Z-2.3 
 
In order to achieve a bifunctionable polymer we synthesised copolymers 3.52 and 3.53 
(Scheme 3.26). This was achieved using the slow addition method described in section 3.2, 
with various ratios of x:y (Table 3.11). Successful polymerisation of AGE and MAGE 
monomers yielded polymer 3.52 with desired ratios of x:y (entries 1-3). Polymerisation of 
AGE:MAGE in a ratio of 24:76 yielded a low molecular weight co-polymer in a moderate 
yield (entry 3). We initially believed that this may be due to MAGE undergoing ROP at a 
slower rate than PGE, however this is unlikely since a reaction time of 24 hours proved to 
be sufficient when synthesising PMAGE in section 3.2. Therefore, we suspect that this low 
yield and low Mn may be due to premature termination of the polymerisation by moisture 
entering the reaction flask overnight.  
Synthesis of PPGE-co-PMAGE 3.53 was achieved with controlled ratios of x:y (entries 4-
6), however at 50:50 PGE:PMAGE we observed an Mn ~ 20 kDa with a dispersity of 1.44, 
indicating that some degree of dimerisation had occurred during propagation stage (this is 
described in section 1.3.2). 
 
108 
 
 
Scheme 3.26 – Co-polymerisation of PAGE-co-PMAGE and PPGE-co-PMAGE 
 
Entry Monomer a m:n 
Mn b 
(g/mol) 
Mn 
(theoretical)  
c
 
Yield 
(%) 
1 AGE:MAGE 78:22 10010 13950 1.15 99 
2 AGE:MAGE 54:46 12505 13200 1.33 99 
3 AGE:MAGE 24:76 7600 15670 1.38 65 
4 PGE:MAGE 76:24 12480 13870 1.18 95 
5 PGE:MAGE 50:50 20280 13520 1.44 91 
6 PGE:MAGE 24:76 10011 13440 1.21 90 
Table 3.11 - Synthesised polymer range. a Monomer added at 2 mL.h-1 and reactions 
performed at 50 °C, 24 h. b Determined by 1H-NMR. c Determined by GPC analysis. 
3.4.2 CM of co-polymers 
Co-polymers of PAGE-co-MAGE were then subjected to CM with MA, followed by Z-2.3 
(Scheme 3.27). 1H-NMR and dispersity values were analysed after each CM reaction.  
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Scheme 3.27 – CM of copolymers with MA and Z-2.3.  
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Copolymer 
ratio 
Starting polymer CM with MA Secondary CM 
with Z-2.3 
AGE:MAGE 
78:22 1.15 2.01 1.72 
54:46 1.33 1.75 1.53 
24:76 1.38 2.26 1.82 
PGE:MAGE 
76:24 1.18 1.91 1.65 
50:50 1.44 1.88 1.70 
24:76 1.21 1.79 1.52 
Table 3.12 – Dispersity of copolymers before CM with MA, after CM with MA, after 
secondary CM with Z-2.3 
 
 CM with MA Secondary CM with Z-2.3 
 
 
Polym
er-MA 
(x) 
Unreacted 
AGE or 
PGE 
(y) 
Self 
metathesis 
(z) 
MAGE 
(a) 
Polyer
-MA 
(x) 
Unreacted 
AGE or PGE 
(y) 
Self 
metathesis 
(z) 
MAGE 
(a) 
polymer-
AA 
(b + c) 
AG
E:
 
M
AG
E 
78:22 30 8 38 24 35 0 2 26 37 
54:46 18 12 18 52 19 4 10 51 15 
24:76 8 4 7 81 17 0 3 76 3 
PG
E:
 
M
A
G
E 
76:24 41 6 28 25 40 0 2 22 36 
50:50 25 9 15 51 24 3 3 44 26 
24:76 13 18 4 65 13 7 2 70 10 
Table 3.13 – Conversion ratios of copolymers i) after CM with MA, and ii) after secondary 
CM with Z-2.3.  
In terms of dispersity, each polymer shows an increase in dispersity after the first CM where 
MA is coupled to the polymer (Table 3.12, blue column). This is due to self metathesis of 
the polymer. Interestingly, after these polymers are subjected to the second CM reaction 
where Z-2.3 is conjugated with the polymer, the dispersity values decrease in every case 
(Table 3.12, red column), which indicates that some of the areas of self metathesis have 
been converted into sites of conjugation with Z-2.3. This is supported by the 1H-NMR e.g. 
PAGE-co-PMAGE (78:22) shows 38% self metathesis when MA is coupled, followed by 2% 
self metathesis when the polymer was reacted with Z-2.3 (Table 3.13, entry 1). This ability 
for the homodimerised polymer to undergo coupling with Z-2.3 is beneficial, in that it 
decreases the level of self metathesis (thus improving the dispersity), however this results 
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in 3.34/3.35 possessing both ‘b’ (PAGE-graft-Z-2.3) and ‘c’ (PMAGE-graft-Z-2.3) pendent 
chains (Table 3.13). This results in a complex 1H-NMR spectrum where ‘b’ and ‘c’ are 
indistinguishable, and therefore the loading of Z-2.3 onto the polymer has been categorised 
together as ‘b+c’ (Table 3.13) 
In terms of successful conversion with MA, we were expecting to for ~85% of AGE handles 
to undergo successful conversion with MA, as this is the conversion we observed when 
homopolymer PAGE was coupled to MA. Surprisingly though, in all cases we observed only 
moderate conversion accompanied with high degrees of self metathesis. Subsequent 
coupling with Z-2.3 was intended to functionalise the PMAGE areas of the copolymer, 
however we observed little change the percentage of PMAGE handles indicating that they 
had remained largely untouched. Therefore coupling partner Z-2.3 was coupling 
preferentially with areas of self metathesis ‘z’ and areas of unreacted PAGE ‘y’, as indicated 
by the decrease in ‘z’ and ‘y’ after the second CM stage. This inability to couple Z-2.3 with 
PMAGE handles may be due to the type 3 olefin being too unreactive, as well as Z-2.3 
preferentially reacting with regions ‘z’ and ‘y’. 
The bifunctionalisation of PPGE-co-PMAGE yielded similar results, however due to PGE 
undergoing homodimerisation slower than AGE, the degrees of self metathesis (Table 3.13) 
were also slightly lower than PAGE-co-PMAGE. This was also resulted in the conjugated 
PPGE-co-PMAGE polymers possessing a slightly lower dispersity (Table 3.12). Secondary 
CM with Z-2.3 allowed for moderate conversion (Table 3.13, red column). Some of this 
conjugation with Z-2.3 is due to coupling of Z-2.3 with residual PGE and self metathesis 
regions, however an overall decrease in the presence of MAGE signals indicate that Z-2.3 
is, to some degree also coupling with MAGE regions. 
Overall, bifunctionalisation of copolymer PAGE-co-PMAGE and PPGE-co-PMAGE has to 
some degree been achieved, however this conjugation with a second coupling partner has 
been largely due to reversible self metathesis, whereby Z-2.3 has been coupled to the AGE 
or PGE region of the polymer, as opposed to the intended PMAGE handle. Future work 
should focus on decreasing the levels of self metathesis after the first round of CM, in order 
to allow the second coupling partner to couple with the MAGE handle as intended. 
3.5  Conclusion 
In conclusion, five new homopolymers with varying reactivities towards CM have 
successfully synthesised in dispersity ranging from 1.15-1.38. These polymers were then 
conjugated with a range of coupling partners using olefin CM. Coupling of type 2 coupling 
partner (MA) to the polyether was best achieved using PPGE which resulted in 95% 
conversion and 3% self metathesis. Unfortunately even this low degree of self metathesis 
resulted in an increase in dispersity from 1.38 to 2.00. With regards to type 1 coupling 
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partner (Z-2.3), PAGE resulted in the highest conversion of 87% and self metathesis of 9%, 
however again this was accompanied by an increase in dispersity from 1.16 to 1.46. 
Coupling of PMAGE with Z-2.3 resulted in a moderate conversion of 50% using toluene at 
85 °C, however most importantly this was achieved with no self metathesis and total 
retention of dispersity ( = 1.15). Steric hindrance around the polymer backbone was 
potentially limiting the conversion of PMAGE, and so PMBGE was synthesised. 
Unfortunately this proved ineffective at allowing for increased conversion with coupling 
partners Z-2.3.  
Coupling of amino acid 2.24 proved challenging, with all polymers limited to conversions 
between 24-40%. Interestingly, the in the cases of PAGE, PCGE and PPGE the absence of 
an extensive cross linked polymer indicated that a significant degree of self metathesis had 
occurred intramolecularly, potentially nanoparticle-like structures, however we have not 
attempted to visualize these using scanning electron microscopy (SEM). Use of PMAGE 
and PMBGE allow for moderate conversion with zero self metathesis, which could prove 
crucial in producing a monodisperse polymer-drug conjugate. 
Synthesis of tripeptide RGD has been achieved with various alkene linkers being installed 
at the C-terminus. Coupling of these RGD species to PMAGE showed that we were able to 
achieve a surprisingly high conversion of 30%. 
Two novel co polymers have also been synthesised; PAGE-co-PMAGE and PPGE-co-
PMAGE, which allow for the bifunctionalisation of the co-polymer. Unfortunately this did not 
occur by the intended mechanism, e.g. whereby AGE and MAGE handles are fucntionalised 
exclusively with different coupling partners. Instead we found that the second phase of the 
CM resulted in the majority of the coupling partner Z-2.3 reacting with residual AGE/PAGE 
handles as well as regions of self metathesis. 
Finally, it should be noted that PEG species are commonly functionalized by end group 
modification, and therefore normally achieved very low loading. Our newly synthesised 
polymers offer a way to greatly increase the loading of drugs, with RGD coupling to PMAGE 
with 30% conversion. 
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Chapter 4 : Non-CM postpolymerisation 
modifications  
 
Many of these polymers have never been synthesised before, and so we were interested 
to investigate how they could be functionalised using non-CM means, such as allyl ether 
deprotection, thiol-ene click reaction, hydroboration and dihydroxylation. 
4.1.1 Allyl cleavage of copolymer 
Although the use of copolymers PAGE-co-PMAGE and PPGE-co-PMAGE were restricted 
in terms of coupling efficiently to two different coupling partners, we were interested in using 
them as a possible way to improve the loading of PMAGE, which was limited to ~30-50%. 
We believed that this low conversion was due to steric hindrance around the polymer 
backbone, and so we envisaged to synthesise poly(glycidol)-co-(methallyl glycidyl ether), 
PG-co-PMAGE 4.1, which has fewer MAGE handles along the polymer chain than PAGE-
co-PMAGE or PPGE-co-PMAGE (Scheme 4.1). As well as inducing lower steric hindrance 
around the polymer backbone, the newly formed hydroxyl groups should increase the 
hydrophilicity of the polymer, which would be beneficial for biological systems. 
 
 
Scheme 4.1 – PG-co-PMAGE 
PG-co-PMAGE was made from PAGE-co-PMAGE via Pd(0)-catalyzed deprotection of the 
allyl ether using barbituric acid 4.2 in methanol (Scheme 4.2).[112] Most importantly, by 
controlling the reaction temperature it is possible to selectively cleave allyl, methyl allyl or 
prenyl ether. Using this methodology we were able to selectively cleave the allyl group of 
PAGE-co-PMAGE 3.52 to yield PG-co-PMAGE 4.1 in excellent yield and almost total 
conversion. Additionally the dispersity was found to decrease from 1.33 to 1.26. This 
apparent change in dispersity is likely due to a change in the coiling behaviour of PG-co-
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PMAGE that arises from internal hydrogen bonding of the newly installed hydroxyl 
groups.[38] 
This deprotection proceeds by a typical Tsuji-Trost type mechanism, however the Brønsted 
acid character of 4.4 is necessary in order to activate the oxygen of ether 4.5 for oxidative 
addition to Pd(0) 4.14 to form 3-allyl complex 4.7. Methanol is used in preference to THF 
for two reasons; i) the more polar solvent results in a decrease in the pKa of barbituric acid 
4.2, which is necessary for protonation of allyl ether 4.5, and ii) it accelerates the 
counteranion-exchange stage.  
 
Scheme 4.2 – Tsuji-Trost cleavage of allyl cleavage by Pd(0) as described by Kondo et 
al.[112] 
PG-co-PMAGE 5.1 was then subjected to CM with Z-2.3 (Scheme 4.3). Due to the 
increased hydrophilicty of the copolymer it was not possible to use toluene as a solvent, 
and instead 1,2-dichloroethane was chosen. As expected, the polymer showed no evidence 
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of self metathesis, with a conversion of 35% of pendent methallyl handles (x = 16%), which 
is an improvement on 23% when PMAGE was subjected to CM with Z-2.3 under similar 
conditions (Section 3.3.2, Table 3.4).  
 
Scheme 4.3 – CM of PG-co-PMAGE with Z-2.3 
 
4.1.2 Thiol-ene functionalisation of polyethers 
Achieving orthogonality to functionalise co-polymers can extend beyond utilising the steric 
factors affecting cross-metathesis, and could be accomplished by harnessing the various 
olefin electronics of these novel polymers. Therefore, we wanted to investigate how thiol-
ene click chemistry could be used in conjunction with cross-metathesis to achieve bi-
functionalisation of the co-polymers (Scheme 4.4). 
Due to the sensitivity of the CM reaction to compounds containing sulfur, it was postulated 
that the CM method of functionalisation should occur before the more robust thiol-ene click 
reaction. If done in the reverse order, the thiol ether on the polymer would coordinate 
strongly to the ruthenium centre of the HG2 catalyst, thereby subduing the CM pathway. 
  
 
Scheme 4.4 – CM on polymers followed by thiol-ene click 
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First we carried out the thiol-ene click reaction using AIBN initiator on non-functionalised 
polymers PAGE, PCGE, PPGE and PMAGE. Butyl 3-mercaptopropionate (BMP) was 
chosen as a coupling partner as its non-bulky structure should prevent steric hindrance 
around the polymer backbone (Scheme 4.5).  
1H-NMR analysis of PAGE and PMAGE coupled products indicated full conversion in good 
yield (Table 4.1, entry 1 and 4). However, coupling of BMP with PCGE or PPGE resulted in 
rapid gelation (entry 2-3).  
 
 
Scheme 4.5 – Thiol-ene click of BMP on PAGE, PCGE, PPGE and PMAGE 
 
  
Conversion 
(n) a 
Unreacted 
(y) a 
 
before 
 
after 
Yield 
(%) 
Entry 1 PAGE 100 0 1.16 1.15 97 
Entry 2 PCGE Cross linking - 1.25 - - 
Entry 3 PPGE Cross linking - 1.38 - - 
Entry 4 PMAGE 100 0 1.15 1.13 95 
Table 4.1 - Thiol-ene of BMP on PAGE, PCGE, PPGE and PMAGE 
The proposed mechanism for this cross linking is as follows: thio radical 4.17 couples with 
the prenyl olefin of PPGE, to yield radical 4.18 (Scheme 4.6). This alkyl radical can then 
propagate the reaction with thiol 4.19 to yield the desired product 4.20; however it is possible 
for the stabilised radical to react with another prenyl handles of a polymer chain to yield 
tertiary radical 4.21 (in the case of PCGE this radical would be secondary). Due to tertiary 
and secondary radicals being stabilised by the electron donating methyl groups, this would 
explain the tendency for PPGE and PCGE radical cross linking. 1H-NMR analysis of these 
polymers was not possible due to their apparent network structure, therefore IR analysis 
employed, which indicated the presence of the thiol-ether. Such IR analysis indicates that 
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some degree of coupling between PPGE and BMP has taken place, however it is 
unquantifiable.  
 
 
Scheme 4.6 – Cross linking mechanism of PPGE 
 
However this reasoning does not explain why PMAGE do not undergo such cross linking, 
especially as PMAGE could also form a stabilised tertiary radical. We believe the reason 
for this is that PMAGE radical 4.22 would be located in the centre of the pendent arm 
(Scheme 4.7), and is therefore more sterically hindered than PPGE radical 4.18, thats 
radical is positioned at the end of the pendent arm. This lack of accessibility means that the 
interstrand coupling to form 4.24 may be less likely to occur than radical propagation with 
thiol 4.19. 
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Scheme 4.7 – Coupling of thiol with PMAGE 
 
We then moved onto investigate the thiol-ene click reaction on a polymer that has been 
functionalised by CM. PAGE-graft-MA, that had been synthesised in section 3.3.1, was 
reacted with BMP using AIBN initiator, and we observed the rapid gelation of the reaction 
mixture (Scheme 4.8, Figure 4.1). We believe this cross linking that occurs in a similar 
manner to that described in Scheme 4.6, whereby PAGE-graft-MA is prone to radical 
addition by nearby polymer radicals.  
 
 
Scheme 4.8 – Thiol-ene click of BMP on PMAGE-graft-MA 
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Figure 4.1 – Radically induced scoss linked PAGE-graft-MA 
 
Overall, we found that PCGE and PPGE were not tolerant to thiol-ene click chemistry as 
they tended to form insoluble cross linked structures.  PMAGE-graft-MA also resulted in a 
network structure, which we attribute to the electron deficient olefin acting as an efficient 
electrophile for polymer radicals. PAGE and PMAGE showed excellent reactivity with BMP 
as they achieved almost full conversion with no evidence of radical mediated cross linking.  
 
4.1.3 Dihydroxylation & Hydroboration of 
polyethers 
As discussed in Section 1.3.1 it is estimated that up to 90% of current drugs and/or drug 
candidates suffer from poor aqueous solubility.[17,18] Therefore we were interested in using 
the olefin of the polymer to fine tune the hydrophobicity/hydrophilicity by way of 
hydroboration and dihydroxylation. 
Hydroboration of was investigated using two sources of boron; BH3.DMS and 9-BBN.[113] 
Unhindered BH3.DMS should allow for rapid hydroboration, whereas use of 9-BBN may 
allow for the slower reaction, allowing for accurate tuning of the hydrophilicity by varying the 
reaction time.[114] This was first conducted on PMAGE as this polymer had proved the most 
promising in terms of dispersity control. (Scheme 4.9).   
As expected the use of sterically unhindered BH3.DMS resulted in full conversion (Table 
4.2, entry 1), and the regioselective synthesis of ‘x’ with no evidence of ‘y’ (Scheme 4.9). 
Sterically encumbered 9-BBN resulted in slower addition, with 55% conversion being 
obtained after 4 hours (entry 3). Leaving the reaction for 18 hours allowed for 80% 
conversion.  
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Scheme 4.9 – Hydroboration of PMAGE 
 
 
Entry 
X 
(Boron 
source) 
Time 
(h) 
Conversion 
(x) a 
Conversion 
(y) a 
Residual 
MAGE  (z) a yield  
1 b BH3. DMS 2 100 0 0 67 - 
2 9-BBN 2 33 0 67 72 1.21 
3 9-BBN 4 55 0 45 78 1.24 
4 b 9-BBN 18 80 0 20 82 - 
Table 4.2 – Hydroboration of PMAGE. a Determined by 1H-NMR integration. x,y,z relate to 
Scheme 4.9. b Dispersity not measured due to polymer being insoluble in the THF (GPC 
continuous phase). 
Hydroboration was also conducted on PMAGE-graft-AA, with the specific aim of proving 
that we can fine tune the degree of hydroboration of a polymer that has been functionalised 
by olefin CM (Scheme 4.10). Reacting 9-BBN with the polymer for 4 hours allowed 50% 
hydroboration to occur overall, which was composed of w = 15% and y = 35%. This degree 
of hydroboration is similar to that shown in Table 4.2, reinforcing the correlation between 
reaction time and degree of hydroboration. 
 
As a side note, the ratio of hydroborated w:y of 7.2 is the same as the ratio of a:b in starting 
material PMAGE-graft-AA, indicating that 9-BBN does not show chemoselectivity for the 
functionalised handle (a) over the unreacted MAGE handle (b) (Scheme 4.10).  
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Scheme 4.10 – Hydroboration of PMAGE-graft-AA 
 
 
Dihydroxylation was then carried out on PMAGE using AD-mix-9 (Scheme 4.11). AD-mix 
was chosen in preference to OsO4 as the former utilises fewer mol% of osmium, which 
would be important for pharmaceutical applications. Dihydroxylation followed by quenching 
with methanesulfonamide resulted in full conversion with an overall yield of 70%. 
Unfortunately, due to the polar nature of the resulting polymer, we were unable to analyse 
the polymer by GPC which uses THF as a continuous phase. Dihydroxylation was also 
carried out on allyl acetate functionalised polymer PMAGE-graft-2.3, which resulted in 
complete dihydroxylation of all alkenes present. 
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Scheme 4.11 – Dihydroxylation of PMAGE 
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4.1.4 Solubility testing of polyethers 
With the hydroborated and dihydroxylated polymers in hand, we investigated the solubility 
of each polymer. Homopolymers such as PMAGE, as well as copolymer PAGE-co-PMAGE 
were soluble in most organic solvents however did not dissolve in more polar systems (entry 
1 & 2, Scheme 4.12). PMAGE that had undergone 55% hydroboration was limited to organic 
solvents (entry 3), however as we moved to full conversion, the resulting polymer became 
soluble in only methanol and water (entry 4). As expected the full dihydroxylation of PMAGE 
resulted in the polymer only being soluble in polar solvents (entry 5). Copolymers of PG-co-
PMAGE showed that as the ratios of m:n increased from 50:50 to 75:25, the polymer 
became soluble only methanol and water (entry 6-8), which demonstrates how the removal 
of ally group of PAGE-co-MAGE allows us to control the hydrophilicty of the polymer. 
Entry Polymer Water Ethanol THF CH2Cl2 CHCl3 Toluene 
1 PMAGE  
      
2 PAGE-co-MAGE 
      
3 PMAGE -  
hydroborated 
(55%) 
      
4 PMAGE – 
hydroborated 
(100%) 
      
5 PMAGE  - 
Dihydroxylated 
(100%) 
      
6 PG-co-PMAGE 
(25:75) 
      
7 PG-co-PMAGE 
(50:50) 
      
8 PG-co-PMAGE 
(75:25) 
     
Table 4.3 - Solubility testing of various polymers. (50 mg of polymer in 1 mL of 
solvent.).  = soluble,  = insoluble 
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Scheme 4.12 – Range of polymers that were analysed for solubility 
 
4.1.5 Removal of ruthenium after CM 
Removal of the active ruthenium species was investigated for two main reasons; 1) to 
prevent self-metathesis from occurring once the reaction is over, and 2) reduce ruthenium 
content below the limit of 10 ppm for pharmaceutical applications.[115,116]  
We investigated three methods; size exclusion chromatography, dialysis and CupriSorb™ 
as possible ways of reducing the ruthenium content below our target of 10 ppm (Table 4.4). 
Note that column chromatography has been reported to be effective at removing 
ruthenium,[117] however due to our polymers not eluting on a silica column, we were reliant 
on size exclusion chromatography (LH-20). Additionally due to dialysis relying on an 
aqueous environment, we used PG-co-PMAGE as a model compound for purification as 
the solubility test showed that it was water soluble.  
Using only SEC we found the ruthenium content to be ~950 ppm, which was expected due 
to LH-20 not being selective for polarity like traditional silica chromatography. Subsequent 
dialysis of same crude polymer allowed for the ruthenium content to be decreased to 289 
ppm. The external body of water was replaced 3 times in order to improve the outwards 
diffusion of the ruthenium, however in theory replacing the water even more times should 
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decrease the final ruthenium content further. We also experimented with CupriSorb™, 
which is a commercial resin designed for use in fish tanks for the removal of copper and 
heavy metals. Interestingly, by stirring the crude reaction mixture with this resin we were 
able to observe a large decrease in the ruthenium content to ~40 ppm.  
 
Purification Method 
Ru content 
(ppm) %RSD
a
 
Sample A – SEC (LH-20) 949.1 0.7 
Sample B – subsequent dialysis* 289.1 1.3 
Sample C – subsequent stirring with CuprisorbTM ** 37.8 3.5 
Table 4.4 - Ruthenium content analysis. *Dialysis using SIGMA benzoylated dialysis tubing 
(D7884) with distilled water replacing external water three times over 48 h. ** Stirring 50 mg 
of polymer in 5 mL of water with 1 g of CuprisorbTM over 48 h. a %RSD = percentage relative 
standard deviation. 
4.2 Conclusion 
In addition to CM, we have investigated other methods of polymer modifications. A novel 
polymer PG-co-PMAGE was synthesised by selective cleavage of the allyl group of PAGE-
co-PMAGE (synthesised in the previous chapter) using Pd(PPh3)4 with barbituric acid 5.2. 
This reduction in the steric hindrance around the polymer backbone allowed for the 
successful conversion with allyl acetate species Z-2.3 to be increased from 23% to 35% 
under comparative conditions.  
Thiol-ene click of BMP onto the polymers was also investigated, which was successful in 
the cases of PAGE and PMAGE, resulting in 100% conversion. Unfortunately, coupling of 
BMP to PCGE, PPGE, as well as PAGE-graft-MA resulted in extensive cross linking, which 
we believe is due to the stabilised nature of the radical, allowing for facile formation of 
intermolecular bonding.  
Use of hydroboration and dihydroxylation was conducted on the newly synthesised polymer 
range (PAGE, PCGE, PPGE, PMAGE, PMAGE-graft-AA). Employment of 9-BBN allowed 
use the reaction time to dictate the degree of hydroboration. This was reflected in the 
solubility tests, which showed that between 55% and 100% hydroboration, the polymer 
switched from being soluble in only organic solvents, to soluble only in more polar systems 
such as MeOH and water. Dihydroxylation was also carried out, which showed full 
conversion after 1 hour. As expected, the resulting polymer showed excellent solubility in 
polar solvents.  
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Chapter 5 : Future Work 
 
To date, we have shown that PMAGE can be very well suited to functionalisation by olefin 
cross metathesis as it eliminated the possibility of self metathesis. Unfortunately, PMAGE 
cannot be fully functionalised, which we believe is due to steric hindrance around the 
polymer backbone. For this reason, we would be eager for future work to focus on the 
synthesis of polymer 5.1 (Scheme 5.1). Such a polymer would not undergo self metathesis 
due to the gem-disubtituted olefin, however the long pendent arm of the polymer should 
prevent crowding around the polymer backbone. This polymer would be preferable to using 
a linker on the coupling partner, as 5.1 would keep the site of cross metathesis away from 
the polymer backbone. 
 
Scheme 5.1 – Future alternative polymer 
If full conversion of polymer 5.1 can be achieved, we will move onto coupling anticancer 
drugs such as Taxol onto the polymer, which will allow us to investigate in vitro activity. 
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Chapter 6 : Experimental 
Apparatus: 
 NMR spectra were recorded using a Bruker DPX-400 spectrometer (1H NMR: 400 
MHz, 13C NMR: 100MHz) and a Bruker DPX-500 spectrometer (1H NMR: 500 MHz, 13C 
NMR: 125 MHz). Deuterated chloroform (CDCl3) was used as the solvent for both 1H and 
13C NMR, with residual solvent peak J7.27 being used for calibration of 1H NMR and CDCl3 
peak at J77.00 for 13C. Signal splitting patterns are described as: singlet, doublet, triplet, 
quartet, multiplet, broad singlet, or any combination of the above. Two dimensional 
experiments (COSY, HMBC, and HMQC) were recorded, where necessary, for assignment. 
IR spectra were recorded using a Golden Gate TM attachment, utilizing a type IIa diamond 
as a single reflection element, allowing for the direct reading of powder and oil samples. 
High resolution mass spectra were recorded under FAB and CI conditions by the University 
of Glasgow analytical service. 
Chromatography: 
Flash chromatography was executed under forced flow conditions, using the 
indicated solvent system and the EMD Guduran silica gel 60 as solid support. Thin 
layer chromatography (TLC) was carried out on Merck silica gel 60 covered 
aluminium sheets, and monitored by UV-light or by staining with a solution of 
anisaldehyde/ KMnO4/ ninhydrin or an iodine/silica powder mixture. 
Size exclusion chromatography was executed under gravity flow conditions 
using Sephadex LH-20 hydroylpropylated dextran beads with a mixed solvent of 
methanol:CH2Cl2 (1:1). 
Gel permeation chromatography (GPC) was carried out using Shimadzu 
LPGE KIT (LC-20AT Pump, CTO-20A Oven, SPD-20A UV detector) fitted with Dr 
Maisch GmbH Repro-Gel GPC 1000, 5 µm column (300 × 8 mm) at 30 °C with a 
flow rate of 1 ml/min in THF. Calibration was carried out using polystyrene standards 
(Polymer Labs) with Mn = 162, 3370, 60450, 915000 g/mol. Ran in unstabilised THF 
(VWR). 
 
Solvents and reagents: 
Reactions were collected from an in-house solvent purification system (THF, 
CH2Cl2, Et2O), with the exception of hexane, which was stored over 4Å MS, in a 
Winchester bottle. Chromatography solvents were HPLC grade solvents, stored in 
Winchester bottles. All reagents were used directly from supplier, unless prior 
purification is explicitly stated. NaH was purchased from Sigma Aldrich as 60% 
dispersed in mineral oil. 
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Polyether:-tert-Butyl-7-hydroxy-poly[2-({allyloxy}methyl)oxirane] 
 
PAGE 
Formula: C4H9O(C6H10O2)x  
To a 1 M solution of potassium tert-butoxide in THF (0.67 mL, 0.67 mmol, 1.0 equiv) was 
added degassed allyl glycidyl ether (7.68 g, 67.3 mmol, 100 equiv) at 2 ml/hour for 4 h. The 
reaction mixture was stirred at 50 °C for 20 h. The reaction mixture was quenched with 
methanol (0.10 mL, 2.4 mmol) and stirred for 1 h. Residual monomer was distilled off to 
afford PAGE (7.91 g, 69.3 mmol, 99%) as a yellow oil.  
IR (K, cm-1): 2906, 2864, 1647, 1087, 920. 
1H NMR (400 MHz, CDCl3) J ppm: Initiator, 1.19 (s, 9H, CH3), Section x, 5.90 (ddt, J = 
17.3, 10.0, 5.5 Hz, 1H, H5), 5.27 (dd, J = 17.3, 1.5 Hz, 1H, H6trans), 5.17 (dd, J = 10.4, 1.5 
Hz, 1H, H6cis), 4.00 (d, J = 5.5 Hz, 2H, H4), 3.72–3.42 (m, 5H, H1-3). 
13C NMR (101 MHz, CDCl3) J ppm: Initiator, not observed. Section x, 134.9 (C5), 116.7 
(C6), 78.8 (C2), 72.3 (OCH2), 70.3 (OCH2), 69.9 (OCH2). 
GPC: Mn = 10009, Mw = 11620,  = 1.16. 
 
 
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2-((But-2-en-1-yloxy)methyl)oxirane[118] 
 
3.18 
Formula: C7H12O2 
Molecular Weight: 128.17 
To a stirring solution of NaH (11.3 g, 472 mmol, 2.00 equiv) in 500 mL of THF was added 
dropwise at 0 °C crotyl alcohol (E/Z 10/1) (34.0, 472 mmol, 1.0 equiv), and the reaction 
mixture allowed to stir for 30 min. To this solution was added epichlorohydrin (18.5 mL, 236 
mmol, 1.00 equiv), and the reaction mixture was allowed to stir at RT for 16 h followed by 4 
h at reflux.  
The reaction mixture was cooled to 0 °C and quenched with water (250 mL), and THF 
removed under vacuum. The aqueous phase was extracted with Et2O (3 × 250 mL), the 
combined organic phases were washed with brine, dried over magnesium sulfate, filtered 
and concentrated under vacuum. The crude material was purified by distillation (bp. 110 °C 
at 100 mbar) followed by column chromatography (95:5, PE:Et2O) to yield compound 3.18 
as a colourless oil (18.1 g, 60%) with an E:Z ratio of 10:1. Data given for the E isomer. 
IR (K, cm-1): 2978, 2862, 1657, 1450, 1111, 964. 
1H NMR (400 MHz, CDCl3) J ppm: 5.67 (dqt, J = 15.3, 6.4, 1.1 Hz, 1H, H6), 5.51 (dtq, J = 
15.3, 6.2, 1.6 Hz, 1H, H5), 3.98–3.82 (m, 2H, H4), 3.62 (dd, J = 11.4, 3.0  Hz, 1H, H3a), 3.31 
(dd, J = 11.4, 5.9 Hz, 1H, H3b), 3.08 (ddt, J = 5.9, 4.1, 3.0 Hz, 1H, H2), 2.73 (dd, J = 5.0, 4.1 
Hz, 1H, H1a), 2.54 (dd, J = 5.0, 2.9 Hz, 1H, H1b), 1.65 (ddt, J = 6.4, 1.6, 1.1 Hz, 3H, H7). 
13C NMR (126 MHz, CDCl3) J ppm: 130.0 (C5), 127.2 (C6), 72.0 (C4), 70.5 (C3), 50.8 (C2), 
44.4 (C1), 17.7 (C7). 
HRMS (ESI) for C7H12NaO2: 151.0735, found: 151.0743.  
In agreement with literature data.[118] 
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Polyether:-tert-Butyl-7-hydroxy-poly[2-({but-2-en-1-yl-oxy}methyl)oxirane] 
 
PCGE 
Formula: C4H9O(C7H12O2)x 
To a 1 M solution of potassium tert-butoxide in THF (0.53 mL, 0.53 mmol, 1.0 equiv) was 
added degassed crotyl glycidyl ether 3.18 (6.86 g, 53.5 mmol, 100 equiv) at 2 ml/hour for 
3.5 h. The reaction mixture was stirred at 45 °C for 20 h. The reaction mixture was quenched 
with methanol (0.10 mL, 2.4 mmol) and stirred for 1 h. Residual monomer was distilled off 
to afford PCGE (5.80 g, 45.2 mmol, 85%) as a yellow oil. 
IR (K, cm-1): 2916, 2858, 1450, 1097, 964. 
1H NMR (400 MHz, CDCl3) J ppm: Initiator, 1.19 (s, 9H, CH3). Section x, 5.78–5.64 (m, 
1H, H6), 5.62–5.51 (m, 1H, H5), 3.93 (d, J = 6.1 Hz, 2H, H4), 3.70–3.40 (m, 5H, H1-3), 1.72 
(dd, J = 6.3, 1.0 Hz, 3H, H7).  
13C NMR (101 MHz, CDCl3) J ppm: Initiator, not observed. Section x, 129.0 (C5), 127.9 
(C6), 78.9 (C2), 77.2 (C4), 72.0, 70.1 (C1 and C3), 17.8 (C7). 
GPC: Mn = 9166, Mw = 11443,  = 1.25. 
 
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2-(((3-Methylbut-2-en-1-yl)oxy)methyl)oxirane 
1
2
3
O
O
45
6
7 8
 
3.20  
Formula: C8H14O2 
Molecular Weight: 142.20 
To a stirring solution of NaH (15.6 g, 649 mmol, 2.00 equiv) in 500 mL of THF was added 
dropwise at 0 °C prenyl alcohol (65.7 mL, 649 mmol, 2.00 equiv), and the reaction mixture 
allowed to stir for 30 min. To this solution was added epichlorohydrin (25.4 mL, 324 mmol, 
1.00 equiv), and the reaction mixture was allowed to stir at RT for 16 h followed by 4 h at 
reflux.  
The reaction mixture was cooled to 0 °C and quenched with water (250 mL), and THF 
removed under vacuum. The aqueous phase was extracted with Et2O (3 × 250 mL), the 
combined organic phases were washed with brine, dried over magnesium sulfate, filtered 
and concentrated under vacuum. The crude material was purified by distillation (bp. 110 °C 
at 90 mbar), followed by column chromatography (95:5, PE:Et2O) to yield compound 3.20 
as a colourless oil (25.0 g, 54%). 
IR (K, cm-1):  2974, 2930, 2863, 1446, 1251, 1350. 
1H NMR (500 MHz, CDCl3) J ppm: 5.29 (t, J = 7.0 Hz, 1H, H5), 4.01–3.91 (m, 2H, H4), 3.62 
(dd, J = 11.4, 3.3 Hz, 1H, H3a), 3.32 (dd, J = 11.4, 5.8 Hz, 1H, H3b), 3.19–3.15 (m, 1H, H2), 
2.73 (dd, J = 5.0, 4.1 Hz, 1H, H1a), 2.54 (dd, J = 5.0, 2.8 Hz, 1H, H1b), 1.68 (s, 3H, H7 or H8), 
1.61 (s, 3H, C7 or C8). 
13C NMR (126 MHz, CDCl3) J ppm: 137.4 (C6), 120.7 (C5), 70.7 (C3), 67.7 (C4), 50.9 (C2), 
44.4 (C1), 25.8 (C7 or C8), 18.0 (C7 or C8). 
HRMS (ESI) for C8H14NaO2: 165.0886, found: 165.0885 
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Polyether:-tert-Butyl-7-hydroxy-poly[2-({3-Methylbut-2-en-1-yl-oxy}methyl)oxirane] 
 
PPGE 
Formula: C4H9O(C8H14O2)x 
To a 1 M solution of potassium tert-butoxide in THF (0.50 mL, 0.50 mmol, 1.0 equiv) was 
added degassed prenyl glycidyl ether 3.20 (7.10 g, 50.0 mmol, 100 equiv) at 2 ml/hour for 
3.5 h. The reaction mixture was stirred at 45 °C for 20 h. The reaction mixture was quenched 
with methanol (0.10 mL, 2.4 mmol) and stirred for 1 h. Residual monomer was distilled off 
to afford PPGE (6.39 g, 45.0 mmol, 90%) as a yellow oil. 
IR (K, cm-1): 2912, 2864, 1448, 1082, 983. 
1H NMR (500 MHz, CDCl3) J ppm: Initiator, 1.19 (s, 9H, CH3). Section x, 5.34 (t, J = 6.5 
Hz, 1H, H5), 3.98 (d, J = 6.5 Hz, 2H, H4), 3.67–3.39 (m, 5H, H1-3), 1.75 (s, 3H, H7 or 8), 1.67 
(s, 3H, H7 or 8). 
13C NMR (126 MHz, CDCl3) J ppm: 136.2 (C6), 121.5 (C5), 78.9* (C2), 78.8* (C2), 70.1, 69.9, 
67.8 (C1 & C3 & C4), 25.8, 18.1 (C7 & C8). 
GPC: Mn = 9980, Mw = 13778,  = 1.38. 
 
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2-Methylprop-2-en-1-ol[119] 
 
3.22  
Formula: C4H8O 
Molecular Weight: 72.11 
To a stirring solution of LiAlH4 (25.0 g, 658 mmol, 1.00 equiv) in 1000 mL of Et2O was added 
dropwise at 0 °C a solution of methyl methacrylate (70.0 ml, 658 mmol) in 200 ml of Et2O, 
and the reaction mixture was allowed to stir for 1 h and warm to RT.  
The reaction mixture was quenched with water (500 mL) at 0 °C, the aqueous phase 
extracted with Et2O (3 × 500 mL), and the combined organic phases were washed with 
brine, dried over sodium sulfate, filtered and concentrated under vacuum. The crude 
material was purified by distillation (bp. 70 °C at 100 mbar) to yield compound 3.22 as a 
colourless oil (34 g, 72%). 
1H NMR (500 MHz, CDCl3) J ppm: 4.98 (s, 1H, H3a), 4.87 (s, 1H, H3b), 4.05 (s, 2H, H1), 2.22 
(br s, 1H, H5), 1.76 (s, 3H, H4). 
13C NMR (126 MHz, CDCl3) J ppm: 145.0 (C2), 109.7 (C3), 66.7 (C1), 19.1 (C4). 
In agreement with literature data.[119] 
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2-(((2-Methallyl)oxy)methyl)oxirane 
 
3.23 
Formula: C7H12O2 
Molecular Weight: 128.17 
To a stirring solution of NaH (11.3 g, 472 mmol, 2.00 equiv) in 500 mL of THF was added 
dropwise at 0 °C 2-methyl-2-propen-1-ol (34.0 g, 472 mmol, 2.00 equiv), and the reaction 
mixture was allowed to stir for 30 min. To this solution was added epichlorohydrin (18.5 mL, 
236 mmol, 1.00 equiv), and the reaction mixture was allowed to stir at RT for 16 h followed 
by 4 h at reflux.  
The reaction mixture was cooled to 0 °C and quenched with water (250 mL), and THF 
removed under vacuum. The aqueous phase was extracted with Et2O (3 × 250 mL), the 
combined organic phases were washed with brine, dried over magnesium sulfate, filtered 
and concentrated under vacuum. The crude material was purified by distillation (bp. 100 °C 
at 85 mbar) followed by column chromatography (95:5, PE:Et2O) to yield compound 3.23 
as a colourless oil (24.2 g, 80%). 
IR (K, cm-1): 2978, 2916, 2862, 1646, 1450, 1095, 902. 
1H NMR (400 MHz, CDCl3) J ppm: 5.01–4.98 (m, 1H, H6a), 4.94–4.91 (m, 1H, H6b), 3.99 (d, 
J = 12.6 Hz, 1H, H4a), 3.94 (d, J = 12.6 Hz, 1H, H4b), 3.71 (dd, J = 11.4, 3.1 Hz, 1H, H3a), 
3.40 (dd, J = 11.4, 5.8 Hz, 1H, H3b), 3.22–3.16 (m, 1H, H2), 2.82 (dd, J = 5.0, 4.2 Hz, 1H, 
H1a), 2.64 (dd, J = 5.0, 2.7 Hz, 1H, H1b), 1.76 (s, 3H, H7). 
13C NMR (101 MHz, CDCl3) J ppm: 141.9 (C5), 112.4 (C6), 75.2 (C4), 70.5 (C3), 50.8 (C2), 
44.3 (C1), 19.4 (C7). 
HRMS (CI) for C7H13O2: 129.0916, found: 129.0922.  
 
 
 
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Polyether:-tert-Butyl-7-hydroxy-poly[2-({2-Methallyl oxy}methyl)oxirane] 
 
PMAGE 
Formula: C4H9O(C7H12O2)x  
To a 1 M solution of potassium tert-butoxide in THF (0.62 mL, 0.62 mmol, 1.0 equiv) was 
added degassed methallyl glycidyl ether 3.23 (8.00 g, 62.4 mmol, 100 equiv) at 2 mL/h for 
4 h. The reaction mixture was stirred at 50 °C for 20 h. The reaction mixture was quenched 
with methanol (0.10 mL, 2.4 mmol) and stirred for 1 h. Residual monomer was distilled off 
to afford PMAGE (7.80 g, 60.8 mmol, 98%) as a yellow oil.  
IR (K, cm-1): 2910, 2866, 1670, 1092, 897. 
1H NMR (400 MHz, CDCl3) J ppm: Initiator, 1.19 (s, 9H, CH3), Section x, 4.96 (s, 1H, H6a), 
4.88 (s, 1H, H6b), 3.89 (s, 2H, H4), 3.70–3.40 (m, 5H, H1-3), 1.73 (s, 3H, H7).  
13C NMR (101 MHz, CDCl3) J ppm: Initiator, not observed, Section x, 142.2 (C5), 111.9 
(C6), 78.8 (C2), 75.2 (C4), 70.2, 69.9 (C1 and C3), 19.4 (H7). 
GPC: Mn = 15849, Mw = 18239,  = 1.15. 
 
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2-(((3-Methylbut-3-en-1-yl)oxy)methyl)oxirane 
 
3.31 
Formula: C8H14O2 
Molecular Weight: 142.20 
To a stirring solution of NaH (8.36 g, 348 mmol, 1.20 equiv) in 1500 mL of THF was added 
dropwise at 0 °C 3-methyl-3-buten-1-ol (35.3 mL, 348 mmol, 1.20 equiv), and the reaction 
mixture allowed to stir for 0.5 h. To this solution was added epichlorohydrin (22.8 mL, 290 
mmol, 1.00 equiv), and the reaction mixture allowed to stir for 24 h at reflux.  
The reaction mixture was cooled to 0 °C and quenched with water (500 mL), and THF 
removed under vacuum. The aqueous phase was extracted with Et2O (3 × 250 mL), the 
combined organic phases were washed with brine, dried over magnesium sulfate, filtered 
and concentrated under vacuum. The crude material was purified by distillation (bp. 120 °C 
at 1 mbar) followed by column chromatography (95:5, PE:Et2O) to yield compound 3.31 as 
a colourless oil (18.6 g, 45%). 
IR (K, cm-1): 2865, 1652, 1456, 1375, 1253, 1107, 888, 850, 760. 
1H NMR (500 MHz, CDCl3) J ppm: 4.78 (s, 1H, H7a), 4.73 (s, 1H, H7b), 3.73 (dd, J = 
11.6, 3.1 Hz, 1H, H3a), 3.63 (dt, J = 9.4, 6.9 Hz, 1H, H4a), 3.59 (dt, J = 9.4, 6.9 Hz, 1H, 
H4b),3.39 (dd, J = 11.6, 5.8 Hz, 1H, H3b), 3.14 (m, 1H, H2), 2.78 (dd, J = 5.0, 4.1 Hz, 1H, 
H1a), 2.60 (dd, J = 5.0, 2.7 Hz, 1H, H1b), 2.31 (t, J = 6.9 Hz, 2H, H5), 1.74 (s, 3H, H8). 
13C NMR (126 MHz, CDCl3) J ppm: 142.6 (C6), 111.5 (C7), 71.5 (C3), 69.9 (C4), 50.8 (C2), 
44.2 (C1), 37.7 (C5), 22.6 (C8). 
HRMS (ESI) for C8H14NaO2: 165.0886, found: 165.0884.  

 

 
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Polyether:-tert-Butyl-7-hydroxy-poly[2-({3-Methylbut-3-en-1-yl-oxy}methyl)oxirane] 
 
PMBGE 
Formula: C4H9O(C8H14O2)x 
To a 1 M solution of potassium tert-butoxide in THF (0.6 mL, 0.60 mmol, 1.0 equiv) was 
added degassed methylbutenyl glycidyl ether (8.50 g, 60.0 mmol, 100 equiv) at 2 mL/hour 
for 4.5 h. The reaction mixture was stirred at 50 °C for 24 h. The reaction mixture was 
quenched with methanol (0.10 mL, 2.4 mmol) and stirred for 1 h. Residual monomer was 
distilled off to afford PMBGE (7.30 g, 51.3 mmol, 91%) as a yellow oil. 
IR (K, cm-1): 2935, 2864, 1649, 1454, 1374, 1109, 886. 
1H NMR (500 MHz, CDCl3) J ppm: Initiator, 1.18 (s, 9H, CH3), Section x, 4.76 (s, 1H, H7a), 
4.71 (s, 1H, H7b), 3.65–3.40 (m, 7H, H1-4), 2.29 (t, J = 6.9 Hz, 2H, H5), 1.75 (s, 3H, H8). 
13C NMR (126 MHz, CDCl3) J ppm: 142.8 (C6), 111.4 (C7), 78.8 (C2), 71.0, 70.1, 70.0 (C1 & 
C3 & C4), 37.8 (C5), 22.8 (C8). 
GPC: Mn = 4867, Mw = 8570,  = 1.76. 
 
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Methyl acryloyl-L-leucinate[120] 
 
2.19 
Formula: C10H17NO3 
Molecular Weight: 199.25
 
To a solution of L-Leucine methyl ester hydrochloride (2.41 g, 14.6 mmol) in 50 mL of 
CH2Cl2 was added triethylamine (2.0 mL, 15 mmol, 1.1 equiv) and acrylic acid (1.0 ml, 15 
mmol, 1.1 equiv). The solution was cooled to 0 °C and DCC (3.28 g, 15.9 mmol, 1.20 equiv) 
was added. The reaction mixture was stirred and allowed to warm to RT over 3 h.  
The reaction mixture was quenched with a 1 M aqueous solution of sodium bicarbonate (50 
mL). The aqueous phase was extracted with CH2Cl2 (3 × 20 mL), the combined organic 
phases were washed with brine, dried over magnesium sulfate, filtered and reduced under 
vacuum. The crude material was purified by column chromatography (7:3 PE/EtOAc) to give 
compound 20.19 as a colourless oil (1.40 g, 51%). 
1H NMR (500 MHz, CDCl3) J ppm: 6.33 (dd, J = 17.0, 1.4 Hz, 1H, H1-trans), 6.15 (dd, J = 
17.0, 10.3 Hz, 1H, H2), 6.05 (br d, J = 8.6 Hz, 1H, NH), 5.70 (dd, J = 10.2, 1.4 Hz, 1H, H1-
cis), 4.76 (dt, J = 8.6, 5.1 Hz, 1H, H4), 3.77 (s, 3H, H6), 1.78–1.65 (m, 2H, H7), 1.65–1.51 (m, 
1H, H8), 0.98 (d, J = 6.2 Hz, 3H, H9), 0.96 (d, J = 6.2 Hz, 3H, H9). 
13C NMR (126 MHz, CDCl3) J ppm: 173.8 (C5), 165.3 (C3), 130.4 (C2), 127.1 (C1), 52.3 (C4), 
50.7 (C6), 41.6 (C7), 24.9 (C8), 22.8 (C9), 21.9 (C9). 
[]D25 −121.5 (c = 1.0, CHCl3), literature []D25 – unspecified. 
In agreement with literature data. [120] 
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Polyether:-oxymethylbenzene-7-hydroxy-poly[(2S)-2-Acryloylamino-4-
methylpentanoate-co-[2-({allyl oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-
ene] 
 
PAGE-graft-2.19 
Formula: C7H7O(C14H23NO5)x(C6H10O2)y(C10H16O4)z 
To a solution of PAGE (100 mg, 0.88 mmol, 1.0 equiv) in 2.2 mL of CH2Cl2 was added 
methyl acryloyl-L-leucinate 2.19 (700 mg, 3.5 mmol, 4.0 equiv) and Hoveyda-Grubbs’ 
second-generation catalyst (28 mg, 0.044 mmol, 0.05 equiv), and the mixture was stirred at 
reflux for 18 h. The reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 
mmol) and stirred for 5 min. The reaction mixture was then purified by size exclusion 
chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PAGE-graft-2.19 as a brown oil (160 
mg, 83%). 
IR (K, cm-1):  3318, 2956, 2928, 2912, 2872, 2249. 
1H NMR (500 MHz, CDCl3) J ppm: Initiator, 7.28–7.21 (m, 5H, Ar-H), 4.62 (s, 2H, H1), 
Section x, 7.07 (br s, 1H, H9), 6.85 (d, J = 16.0 Hz, 1H, H6), 6.25–6.15 (m, 1H, H7), 4.69 (br 
s, 1H, H10), 4.14 (br s, 2H, H5), 3.80–3.45 (m, 5H, H2-H4), 3.76 (s, 3H, H12), 1.75–1.50 (m, 
3H, H13, H14), 0.94 (d, J = 4.8 Hz, 6H, H15). Section y, 5.90-5.75 (m, 1H, H6’), 5.27 (d, J = 
17.0 Hz, 1H, H7trans’), 5.17 (d, J = 9.4 Hz, 1H, H7cis’), 4.05-3.95 (m, 2H, H5’), 3.80–3.45 (m, 
5H, H2’-H4’), Section z, 5.90-5.75 (m, 1H, H6’’), 4.05-3.95 (m, 2H, H5’’), 3.80–3.45 (m, 5H, 
H2’’–H4’’). Overall Ratio (x;y;z) = 64:15:21 (Average Mw per unit = 220.52 g.mol-1) 
13C NMR (126 MHz, CDCl3) J ppm: Initiator, not observed. Section x, 173.7 (C11), 165.6 
(C8), 140.7 (C6), 122.8 (C7), 79.8* (C3), 78.8* (C3), 77.6, 76.6, 70.1 (C2 & C4 & C5), 52.3 
(C10), 50.8 (CH12), 41.3 (C13), 24.9 (CH15), 22.9 (C14), Section y, 129.4 (C6’), 116.7 (H7’), 
79.8* (C3’), 78.8* (C3’), 77.6, 76.6, 70.1 (C2’ & C4’ & C5’), Section z, 127.6 (C6’’), 79.8* (C3’’), 
78.8* (C3’’), 77.6, 76.6, 70.1 (C2’’ & C4’’ & C5’’). 
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GPC: Mn = 7580, Mw = 11900,  = 1.57 
*diastereomers 

Methyl acryloyl-L-alaninate[120] 
 
2.20  
Formula: C7H11NO3 
Molecular Weight: 157.17
 
To a solution of L-Alanine methyl ester hydrochloride (2.04 g, 14.6 mmol, 1.00 equiv) in 50 
mL of CH2Cl2 was added triethylamine (2.0 mL, 15 mmol, 1.1 equiv) and acrylic acid (1.0 
ml, 15 mmol, 1.1 equiv). The solution was cooled to 0 °C and DCC (3.28 g, 15.9 mmol, 1.20 
equiv) was added. The reaction mixture was stirred and allowed to warm to RT over 3 h.  
The reaction mixture was quenched with a 1 M aqueous solution of sodium bicarbonate (50 
mL). The aqueous phase was extracted with CH2Cl2 (3 × 20 mL), the combined organic 
phases were washed with brine, dried over magnesium sulfate, filtered and reduced under 
vacuum. The crude material was purified by column chromatography (7:3 PE/EtOAc) to give 
compound 2.20 as a colourless oil (1.20 g, 65%). 
1H NMR (500 MHz, CDCl3) J ppm: 6.31 (dd, J = 16.9, 1.4 Hz, 1H, H1-trans), 6.14 (dd, J = 
16.9, 10.1 Hz, 1H, H2), 6.00 (br d, J = 8.6 Hz, 1H, NH), 5.70 (dd, J = 10.1, 1.4 Hz, 1H, H1-
cis), 4.92–4.81 (m, 1H, H4), 3.80 (s, 3H, H6), 1.39–1.27 (m, 3H, H7). 
13C NMR (126 MHz, CDCl3) J ppm: 171.1 (C5), 162.9 (C3), 130.3 (C2), 126.9 (C1), 52.5 (C4), 
51.1 (C6), 18.9 (C7). 
[]D25 −155.3 (c = 1.0, CHCl3), literature []D25 – unspecified. 
In agreement with literature data. [120] 
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Polyether:-oxymethylbenzene-7-hydroxy-poly[(methyl (E)-4-(oxiran-2-ylmethoxy)but-2-
enoyl)-L-alaninate-co-[2-({allyl oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-
ene] 
 
PAGE-graft-2.20 
Formula: C7H7O(C11H17NO5)x(C6H10O2)y(C10H16O4)z 
To a solution of PAGE (100 mg, 0.88 mmol, 1.0 equiv) in 2.2 mL of CH2Cl2 was added 
methyl acryloyl-L-alaninate (550 mg, 3.5 mmol, 4.0 equiv) and Hoveyda-Grubbs’ second-
generation catalyst (28 mg, 0.044 mmol, 0.05 equiv), and the mixture was stirred at reflux 
for 18 h. The reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) 
and stirred for 5 min. The reaction mixture was then purified by size exclusion 
chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PAGE-graft-2.20 as a brown oil (180 
mg, 81%). 
IR (K, cm-1):  3320, 2970, 2930, 2903, 2820, 2310. 
1H NMR (500 MHz, CDCl3) J ppm: Initiator, 7.28–7.21 (m, 5H, Ar-H), 4.62 (s, 2H, H1), 
Section x, 7.07 (br s, 1H, H9), 6.89 (d, J = 16.1 Hz, 1H, H6), 6.23–6.12 (m, 1H, H7), 4.69 (br 
s, 1H, H10), 4.14 (br s, 2H, H5), 3.82–3.45 (m, 8H, H2–H4, H12), 1.35–1.25 (m, 3H, H13). 
Section y, 5.88–5.75 (m, 1H, H6’), 5.27 (d, J = 16.8 Hz, 1H, H7trans’), 5.17 (d, J = 9.3 Hz, 1H, 
H7cis’), 4.05–3.95 (m, 2H, H5’), 3.82–3.45 (m, 5H, H2’–H4’), Section z, 5.88–5.75 (m, 1H, H6’’), 
4.05–3.95 (m, 2H, H5’’), 3.82–3.45 (m, 5H, H2’’–H4’’). Overall Ratio (x;y;z) = 30:52:18 
(Average Mw per unit = 150.25 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Initiator, not observed. Section x, 172.0 (C11), 165.7 
(C8), 140.7 (C6), 128.4 (C7), 79.9* (C3), 78.8* (C3), 77.8, 76.6, 70.0 (C2 & C4 & C5), 53.5 
(C10), 52.3 (C12), 22.1 (CH13), Section y, 128.4 (C6’), 116.4 (H7’), 79.8* (C3’), 78.8* (C3’), 
77.8, 76.6, 70.0 (C2’ & C4’ & C5’), Section z, 127.6 (C6’’), 79.8* (C3’’), 78.8* (C3’’), 77.8, 76.6, 
70.0 (C2’’ & C4’’ & C5’’). 
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Methyl pent-4-enoyl-L-leucinate 

2.21 
Formula: C12H21NO3 
Molecular Weight: 227.30 
To a solution of L-Leucine methyl ester hydrochloride (2.00 g, 11.0 mmol, 1.00 equiv) in 35 
mL of CH2Cl2 was added triethylamine (1.60 mL, 12.1 mmol, 1.1 equiv) and 4-pentenoic 
acid (1.33 ml, 12.1 mmol, 1.1 equiv). The solution was cooled to 0 °C and DCC (2.43 g, 
11.8 mmol, 1.2 equiv) was added. The reaction mixture was stirred and allowed to warm to 
RT over 3 h.  
The reaction mixture was quenched with a 1 M aqueous solution of sodium bicarbonate (50 
mL) and filtered. The aqueous phase was extracted with CH2Cl2 (3 × 25 mL), the combined 
organic phases were washed with brine, dried over magnesium sulfate, filtered and 
concentrated under vacuum. The crude material was purified by column chromatography 
(65:35 PE/EtOAc) to give compound 2.21 as a colourless oil (1.70 g, 68%). 
IR (K, cm-1): 3055, 2958, 1741, 1668, 1265, 732. 
1H NMR (400 MHz, CDCl3) J ppm: 5.97–5.77 (m, 2H, H2 and H6), 5.09 (dtd, J = 17.1, 2.0, 
1.6 Hz, 1H, H1-trans), 5.03 (dtd, J = 10.2, 1.6, 1.2 Hz, 1H, H1-cis), 4.67 (dt, J = 8.7, 5.0 Hz, 1H, 
H7), 3.75 (s, 3H, H9), 2.46–2.37 (m, 2H, H4), 2.37–2.29 (m, 2H, H3), 1.75–1.60 (m, 2H, H10), 
1.60–1.46 (m, 1H, H11), 0.98 (d, J = 6.2, 2.7 Hz, 6H, H12), 0.95 (d, J = 6.2, 2.7 Hz, 6H, H12).
13C NMR (101 MHz, CDCl3) J ppm: 173.7 (C5 or C8), 172.0 (C5 or C8), 136.9 (C2), 115.6 (C1), 
52.2 (C7), 50.6 (C9), 41.8 (C10), 35.7 (C4), 29.4 (C3), 24.9 (C11), 22.8 (C12), 22.0 (C12). 
HRMS (ESI) for C12H21NNaO3: 250.1414, found: 250.1403. 
[]D25 −165.2 (c = 1.0, CHCl3). 
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Polyether:-oxymethylbenzene-7-hydroxy-poly[methyl 6-(oxiran-2-ylmethoxy)hex-4-enoyl-
L-leucinate-co-[2-({allyl oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-ene] 
 
PAGE-graft-2.21 
Formula: C7H7O(C16H27NO5)x(C6H10O2)y(C10H16O4)z 
 
To a solution of PAGE (100 mg, 0.88 mmol, 1.0 equiv) in 2.2 mL of CH2Cl2 was added 
methyl pent-4-enoyl-L-leucinate 2.21 (795 mg, 3.5 mmol, 4.0 equiv) and Hoveyda-Grubbs’ 
second-generation catalyst (28 mg, 0.044 mmol, 0.05 equiv), and the mixture was stirred at 
reflux for 18 h. The reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 
mmol) and stirred for 5 min. The reaction mixture was then purified by size exclusion 
chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PAGE-graft-2.21 as a brown oil 
(93.8 mg, 68%). 
IR (K, cm-1):  3491, 3010, 2866, 2910, 2844, 1610, 1090. 
1H NMR (500 MHz, CDCl3) J ppm: Initiator, 7.28–7.21 (m, 5H, Ar-H), 4.61 (s, 2H, H1), 
Section x, 7.44 (br s, 1H, NH), 5.65-5.54 (m, 1H, H6), 5.25–5.19 (m, 1H, H7), 4.74 (br s, 1H, 
H11), 4.25 (br s, 2H, H5), 3.80–3.45 (m, 8H, H2-H4, H13), 2.51–2.40 (m, 2H, H9), 2.39–2.28 
(m, 2H, H8), 1.75–1.48 (m, 3H, H14, H15), 0.95 (br s, 6H, H16). Section y, 5.85-5.74 (m, 1H, 
H6’), 5.27 (br d, J = 16.8 Hz, 1H, H7trans’), 5.17 (br d, J = 9.4 Hz, 1H, H7cis’), 4.05-3.95 (m, 2H, 
H5’), 3.80–3.45 (m, 5H, H2’-H4’), Section z, 5.92-5.78 (m, 1H, H6’’), 4.05-3.95 (m, 2H, H5’’), 
3.80–3.45 (m, 5H, H2’’–H4’’). Overall Ratio (x;y;z) = 24:40:36 (Average Mw per unit = 156.78 
g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Initiator, not observed. Section x, 173.7 (C12), 165.6 
(C10), 115.4 (C6), 110.7 (C7), 79.5* (C3), 78.8* (C3), 77.6, 76.6, 70.0 (C2 & C4 & C5), 51.2 
(C11), 50.8 (CH13), 41.3 (C14), 35.8 (C8), 29.7 (C9), 24.8 (CH15), 21.4 (C16), Section y, 128.4 
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(C6’), 116.7 (C7’), 79.5* (C3’), 78.8* (C3’), 77.6, 76.6, 70.0 (C2’ & C4’ & C5’), Section z, 128.4 
(C6’’), 79.5* (C3’’), 78.8* (C3’’), 77.6, 76.6, 70.0 (C2’’ & C4’’ & C5’’). 
 
Methyl (S)-2-Aminopent-4-enoate.hydrogen chloride[121] 
 
2.13a  
Formula: C6H12NO2Cl 
To a solution of allyl glycine (300 mg, 2.6 mmol, 1.0 equiv) in 6 mL of MeOH, was added 
freshly distilled thionyl chloride (0.25 mL, 2.9 mmol, 1.1 equiv), and the mixture was stirred 
at reflux for 3 h. The reaction mixture was reduced under vacuum and the product 
recrystallised from Et2O, furnishing product 2.13a as a light pink solid (399 mg, 93%). 
1H NMR (500 MHz, CDCl3) J ppm: 8.74 (s, 3H, NH3), 6.10–5.64 (m, 1H, H4), 5.32 (d, J = 
16.9 Hz, 1H, H5trans), 5.25 (d, J = 10.0 Hz, 1H, H5cis), 4.29 (br s, 1H, H2), 3.80 (s, 3H, H6), 
2.90-2.82 (m, 2H, H3). 
13C NMR (126 MHz, CDCl3) J ppm: 169.3 (C1), 130.7 (C4), 121.2 (C5), 53.1 (C2), 53.0 (C6), 
34.5 (C3). 
Melting Point: 166 °C 
[]D25 +15.5 (c = 1.0, CHCl3), literature []D25 – unspecified. 
In agreement with literature data. [121] 
 
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Methyl (S)-2-((tert-Butoxycarbonyl)amino)pent-4-enoate[121] 
 
2.13  
Formula: C11H19NO2Cl 
To a solution of allyl glycine methyl ester 2.13a (400 mg, 2.4 mmol, 1.0 equiv) in 10 mL of 
CH2Cl2, was added Boc2O (1.05 g, 4.8 mmol, 2.0 equiv), and triethylamine (670 µL, 4.8 
mmol, 2.0 equiv), and the mixture was stirred for 24 h at RT. The reaction mixture was then 
diluted with H2O (25 mL) then extracted with CH2Cl2 (3 × 20 mL), the combined organic 
phases were washed with brine, dried over sodium sulfate, filtered and concentrated under 
vacuum. The crude material was purified by column chromatography (70:30 PE/EtOAc) to 
give compound 2.13 as a clear oil (3.7 g, 70%). 
1H NMR (500 MHz, CDCl3) J ppm: 5.69–5.56 (ddt, J = 17.1, 9.7, 7.2 Hz, 1H, H4), 5.08 (d, J 
= 17.1 Hz, 1H, H5trans), 5.05 (d, J = 9.7 Hz, 1H, H5cis), 4.98 (d, J = 6.7 Hz, 1H, NH), 4.29 (app 
q, J = 6.2 Hz, 1H, H2), 3.80 (s, 3H, H6), 2.55-2.45 (m, 1H, H3a), 2.44-2.37 (m, 1H, H3b), 1.37 
(s, 9H, H9). 
13C NMR (126 MHz, CDCl3) J ppm: 172.5 (C1), 155.2 (C7), 132.3 (C4), 119.0 (C5), 79.9 (C8), 
52.9 (C2), 52.2 (C6), 36.8 (C3), 28.3 (C9). 
[]D25 +42.8 (c = 1.0, CHCl3), literature []D25 – unspecified. 
In agreement with literature data. [121] 
 
 
 
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Methyl (S)-2-((tert-Butoxycarbonyl)amino)-5-methylhex-4-enoate 
 
2.16  
Formula: C13H23NO4 
Molecular Weight: 257.33 
To a solution of 2.13 (100 mg, 0.44 mmol, 1.0 equiv) in 5 mL of 2-methylbut-2-ene was 
added Grubbs’ second generation catalyst (4.0 mg, 4.7 mmol, 0.01 equiv), and the mixture 
was stirred at reflux for 12 h. The reaction mixture was then reduced under vacuum and 
purified by column chromatography (9:1 PE/EtOAc) to give compound 2.16 as a colourless 
oil (70 mg, 73%). 
IR (K, cm-1):  3445, 3360, 3349, 2976, 2955, 2931, 2861, 1746, 1717, 1501, 1437, 1393, 
1366, 1354, 1275, 1248, 1207, 1165, 1111, 1059, 1024. 
1H NMR (500 MHz, CDCl3) J ppm: 5.02–4.84 (m, 2H, NH and H4), 4.27 (dd, J = 13.6, 5.7 
Hz, 1H, H2), 3.66 (s, 3H, H8), 2.58–2.19 (m, 2H, H3), 1.64 (s, 3H, H6 or H7), 1.54 (s, 3H, H6 
or H7), 1.37 (s, 9H, H11). 
13C NMR (126 MHz, CDCl3) J ppm: 172.9 (C1), 155.2 (C9), 136.3 (C5), 117.6 (C4), 79.8 (C10) 
53.4 (C2), 52.2 (C8), 31.0 (C3), 28.3 (C11), 25.9 (C6 or C7), 17.8 (C6 or C7). 
HRMS (ESI) for C13H23NNaO4: 258.1519, found: 258.1514.  
[]D25 +6.7 (c = 1.0, CHCl3). 
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Polyether:-oxymethylbenzene-7-hydroxy-poly[(2S)-2-amino-6-(oxiran-2-ylmethoxy)hex-
4-enoic acid]-co-[2-({allyl oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-ene] 
 
PAGE-graft-2.11 
Formula: C7H7O(C9H15NO4)x(C6H10O2)y(C10H16O4)z 
To a solution of PAGE (100 mg, 0.88 mmol, 1.0 equiv) in 2.2 mL of CH2Cl2 was added allyl 
glycine 2.11 (405 mg, 3.5 mmol, 4.0 equiv) and Hoveyda-Grubbs’ second-generation 
catalyst (28 mg, 0.044 mmol, 0.05 equiv), and the mixture was stirred at reflux for 18 h. The 
reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 
min. The reaction mixture was then purified by size exclusion chromatography, LH-20 (1:1 
MeOH/CH2Cl2) furnishing PAGE-graft-2.11 as a brown oil (52 mg, 50%). 
IR (K, cm-1):  3475, 3410, 3010, 2771, 1635, 1115. 
1H NMR (500 MHz, CDCl3) J ppm: Initiator, 7.28–7.21 (m, 5H, Ar-H), 4.61 (s, 2H, H1), 
Section x, 7.10 (br s, 2H, NH), 5.65-5.54 (m, 1H, H6), 5.25–5.19 (m, 1H, H7), 4.45 (br s, 1H, 
H9), 4.24 (br s, 2H, H5), 3.88–3.39 (m, 5H, H2-H4), 2.65–2.42 (m, 2H, H8). Section y, 5.99-
5.86 (m, 1H, H6’), 5.31 (br d, J = 16.9 Hz, 1H, H7trans’), 5.17 (br d, J = 9.4 Hz, 1H, H7cis’), 4.05-
3.95 (m, 2H, H5’), 3.88–3.39 (m, 5H, H2’-H4’). Section z, 5.99-5.86 (m, 1H, H6’’), 4.05-3.95 
(m, 2H, H5’’), 3.88–3.39 (m, 5H, H2’’–H4’’). Overall Ratio (x;y;z) = 5:90:5 (Average Mw per 
unit = 117.83 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Initiator, not observed. Section x, 175.0 (C10), 125.1 
(C6), 121.9 (C7), 79.5* (C3), 78.7* (C3), 77.6, 76.1, 70.2, 68.2 (C2 & C4 & C5), 50.1 (C9), 37.2 
(C8). Section y, 128.3 (C6’), 116.9 (H7’), 79.5* (C3’), 78.7* (C3’), 77.6, 76.1, 70.2, 68.2 (C2’ & 
C4’ & C5’). Section z, 128.4 (C6’’), 79.5* (C3’’), 78.7* (C3’’), 77.6, 76.1, 70.2, 68.2 (C2’’ & C4’’ & 
C5’’). 
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Polyether:-oxymethylbenzene-7-hydroxy-poly [methyl (2S)-2-((tert-
butoxycarbonyl)amino)-6-(oxiran-2-ylmethoxy)hex-4-enoate]-co-[2-({allyl 
oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-ene] 
 
PAGE-graft-2.13 
Formula: C7H7O(C15H25NO6)x(C6H10O2)y(C10H16O4)z 
To a solution of PAGE (50.0 mg, 0.44 mmol, 1.0 equiv) in 5 mL of CH2Cl2 was added Boc-
ALG-OMe 2.13 (200 mg, 0.88 mmol, 2.0 equiv) and Hoveyda-Grubbs’ second-generation 
catalyst (14 mg, 0.022 mmol, 0.05 equiv), and the mixture was stirred at reflux for 18 h. The 
reaction mixture was quenched with dimethylsulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 
min. The reaction mixture was then concentrated under vacuum and the product purified by 
size exclusion chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PAGE-graft-2.13 as 
a brown oil (52 mg, 68%). 
IR (K, cm-1):  2918, 2866, 1717, 1667, 1366, 1252, 1215, 1161, 1103, 1018. 
1H NMR (400 MHz, CDCl3) J ppm: Initiator, 7.28–7.21 (m, 5H, Ar-H), 4.61 (s, 2H, H1), 
Section x, 5.72–5.68 (m, 1H, H6), 5.55–5.51 (m, 1H, H7), 4.28–4.27 (m, 1H, NH), 3.91–3.90 
(m, 2H, H5), 3.86 (s, 1H, H9), 3.77–3.02 (m, 5H, H2-4), 3.67 (s, 3H, H11), 2.66–2.48 (m, 1H, 
H8a), 2.47–2.30 (m, 1H, H8b), 1.37 (s, 9H, H14). Section y, 5.97-5.85 (m, 1H, H6’), 5.31–5.27 
(m, 1H, H7trans’), 5.17-5.16 (m, 1H, H7cis’), 4.05–3.95 (m, 2H, H5’), 3.88–3.39 (m, 5H, H2’-H4’), 
Section z, 5.99-5.86 (m, 1H, H6’’), 4.05–3.95 (m, 2H, H5’’), 3.88–3.39 (m, 5H, H2’’–H4’’). 
Overall Ratio (x;y;z) = 35:5:60 (Average Mw per unit = 176.09 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Initiator, not observed. Section x, 173.1 (C10), 155.3 
(C12) 125.2 (C6), 121.9 (C7), 80.2 (C13), 79.4* (C3), 78.7* (C3), 77.5, 76.1, 70.2, 68.2 (C2 & 
C4 & C5), 51.1 (C9), 50.3 (C11), 37.2 (C8), 28.9 (C14). Section y, 128.9 (C6’), 116.7 (H7’), 79.4* 
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(C3’), 78.7* (C3’), 77.5, 76.1, 70.2, 68.2 (C2’ & C4’ & C5’). Section z, 128.4 (C6’’), 79.4* (C3’’), 
78.7* (C3’’), 77.5, 76.1, 70.2, 68.2 (C2’’ & C4’’ & C5’’). 
 
Polyether:-oxymethylbenzene-7-hydroxy-poly [(2S)-2-((tert-butoxycarbonyl)amino)-6-
(oxiran-2-ylmethoxy)hex-4-enoic acid]-co-[2-({allyl oxy}methyl)oxirane]-co-[1,4-bis(oxiran-
2-ylmethoxy)but-2-ene] 
 
PAGE-graft-2.12 
Formula: C7H7O(C14H23NO6)x(C6H10O2)y(C10H16O4)z 
To a solution of PAGE (50.0 mg, 0.44 mmol, 1.0 equiv) in 5 mL of CH2Cl2 was added Boc-
ALG-OH 2.12 (189 mg, 0.88 mmol, 2.0 equiv) and Hoveyda-Grubbs’ second-generation 
catalyst (14 mg, 0.022 mmol, 0.05 equiv), and the mixture was stirred at reflux for 18 h. The 
reaction mixture was quenched with dimethylsulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 
min. The reaction mixture was then concentrated under vacuum and the product purified by 
size exclusion chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PAGE-graft-2.12 as 
a brown oil (32 mg, 45%). 
IR (K, cm-1):  2918, 2711, 1748, 1621, 1252, 1211, 1161, 1018, 927. 
1H NMR (400 MHz, CDCl3) J ppm: Initiator, 7.28–7.21 (m, 5H, Ar-H), 4.61 (s, 2H, H1), 
Section x, 5.75 (br s, 1H, H6), 5.60–5.52 (m, 1H, H7), 5.33 (s, 1H, NH), 3.91 (s, 2H, H5), 
3.86 (s, 1H, H9), 3.63–3.02 (m, 5H, H2-4), 2.70-2.50 (m, 1H, H8a), 2.49–2.31 (m, 1H, H8b), 
1.37 (s, 9H, H14). Section y, 5.97-5.85 (m, 1H, H6’), 5.31-5.27 (m, 1H, H7trans’), 5.17-5.14 (br 
s, 1H, H7cis’), 4.05-3.92 (m, 2H, H5’), 3.63–3.02 (m, 5H, H2’-H4’), Section z, 5.97-5.85 (m, 
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1H, H6’’), 4.05-3.92 (m, 2H, H5’’), 3.63–3.02  (m, 5H, H2’’–H4’’). Overall Ratio (x;y;z) = 30:5:65 
(Average Mw per unit = 161.10 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Initiator, not observed. Section x, 171.0 (C10), 155.7 
(C12) 125.1 (C6), 122.3 (C7), 81.1 (C13), 79.4* (C3), 78.7* (C3), 77.7, 76.1, 70.2, 68.3 (C2 & 
C4 & C5), 51.1 (C9), 37.2 (C8), 28.9 (C14). Section y, 128.8 (C6’), 116.7 (H7’), 79.4* (C3’), 
78.7* (C3’), 77.7, 76.1, 70.2, 68.3 (C2’ & C4’ & C5’). Section z, 128.4 (C6’’), 79.4* (C3’’), 78.7* 
(C3’’), 77.7, 76.1, 70.2, 68.3 (C2’’ & C4’’ & C5’’). 
 
Polyether:-Oxymethylbenzene-7-hydroxy-poly [methyl (2S)-2-[({[9-fluoren-9-
yl]methoxy}carbonyl)amino]-6-(oxiran-2-ylmethoxy)hex-4-enoic acid]-co-[2-({allyl 
oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-ene] 
 
PAGE-graft-2.14 
Formula: C7H7O(C24H25NO6)x(C6H10O2)y(C10H16O4)z 
To a solution of p(AGE) (100 mg, 0.88 mmol, 1.0 equiv) in 5 mL of CH2Cl2 was added Fmoc-
ALG-OH (1.2 g, 3.5 mmol, 4.0 equiv) and Hoveyda-Grubbs’ second-generation catalyst (28 
mg, 0.044 mmol, 0.05 equiv), and the mixture was stirred at reflux for 18 h. The reaction 
mixture was quenched with dimethylsulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 min. The 
reaction mixture was then concentrated under vacuum and the product purified by size 
exclusion chromatography, LH-20 (1:1 MeOH/ CH2Cl2) furnishing PAGE-graft-2.14 as a 
very viscous brown oil (111 mg, 74%). 
IR (K, cm-1):  3063, 3040, 3018, 2915, 2868, 2803, 1719, 1609, 1510, 1478, 1464, 1451, 
1408, 1331, 1302, 1248, 1221, 1103, 1082, 1009. 
1H NMR (400 MHz, CDCl3) J ppm: Initiator, 4.61 (s, 2H, H1), Section x, 7.74 (br s, 2H, Ar-
H), 7.58 (br s, 2H, Ar-H), 7.46–7.15 (br m, 4H, Ar-H), 5.76-5.73 (m, 1H, H6), 5.64-5.60 (m, 
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1H, H7), 4.52-4.98 (m, 2H, H13), 4.45-4.38 (m, 2H, H9 and H14), 4.21-4.19 (m, 2H, H5), 4.11-
4.08 (m, 1H, NH), 3.82–2.95 (m, 5H, H2-4), 2.60 (br s, 2H, H8). Section y, 5.99-5.81 (m, 1H, 
H6’), 5.32-5.29 (m, 1H, H7trans’), 5.18-5.15 (m, 1H, H7cis’), 4.05-3.92 (m, 2H, H5’), 3.82–2.95 
(m, 5H, H2’-H4’), Section z, 5.99-5.81 (m, 1H, H6’’), 4.05-3.92 (m, 2H, H5’’), 3.82–2.95  (m, 
5H, H2’’–H4’’). Overall Ratio (x;y;z) = 22:7:71 (Average Mw per unit = 161.10 g.mol-1). 
13C NMR (101 MHz, CDCl3) J ppm: Initiator, not observed. Section x, 171.9 (C10), 154.8 
(C12), 143.9 (ArC), 143.7 (ArC), 141.3 (ArC), 128.4 (C6), 127.7 (C7), 127.1 (ArCH), 125.1 
(ArCH), 120.0 (ArCH), 79.4* (C3), 78.7* (C3), 77.6, 76.2, 71.1, 69.9 (C2 & C4 & C5), 67.0 
(C13), 53.5 (C9), 47.2 (C14), 35.3 (C8). Section y, 128.2 (C6’), 116.7 (H7’), 79.4* (C3’), 78.7* 
(C3’), 77.6, 76.1, 71.1, 69.9 (C2’ & C4’ & C5’). Section z, 128.5 (C6’’), 79.4* (C3’’), 78.7* (C3’’), 
77.6, 76.1, 71.1, 69.9 (C2’’ & C4’’ & C5’’). 
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Polyether:-Oxymethylbenzene-7-hydroxy-poly [methyl (2S)-2-[({[9-fluoren-9-
yl]methoxy}carbonyl)amino]-6-(oxiran-2-ylmethoxy)hex-4-enoate]-co-[2-({allyl 
oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-ene] 
 
PAGE-graft-2.15 
Formula: C7H7O(C25H27NO6)x(C6H10O2)y(C10H16O4)z 
To a solution of p(AGE) (100 mg, 0.88 mmol, 1.0 equiv) in 5 mL of CH2Cl2 was added Fmoc-
ALG-OMe (1.25 g, 3.50 mmol, 4.00 equiv) and Hoveyda-Grubbs’ second-generation 
catalyst (28 mg, 0.044 mmol, 0.05 equiv), and the mixture was stirred at reflux for 18 h. The 
reaction mixture was quenched with dimethylsulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 
min. The reaction mixture was then concentrated under vacuum and the product purified by 
size exclusion chromatography, LH-20 (1:1 MeOH/ CH2Cl2) furnishing PAGE-graft-2.15 as 
a viscous brown oil (133 mg, 80%). 
IR (K, cm-1):  3041, 2920, 2720, 1775, 1601, 1595, 1455, 1375, 1322, 1299, 1221, 1103, 
989. 
1H NMR (400 MHz, CDCl3) J ppm: Initiator, 4.61 (s, 2H, H1), Section x, 7.79 (br s, 2H, Ar-
H), 7.55 (br s, 2H, Ar-H), 7.45–7.15 (br m, 4H, Ar-H), 5.75 (br s, 1H, H6), 5.65 (br s, 1H, H7), 
4.50 (br s, 2H, H13), 4.45-4.38 (m, 2H, H9 and H14), 4.22-4.19 (m, 2H, H5), 4.12-4.09 (m, 1H, 
NH), 3.79–2.90 (m, 5H, H2-4), 3.65 (s, 3H, H21), 2.61-2.58 (m, 2H, H8). Section y, 5.89-5.81 
(m, 1H, H6’), 5.32-5.28 (m, 1H, H7trans’), 5.18-5.15 (m, 1H, H7cis’), 4.05-3.92 (m, 2H, H5’), 3.79–
2.90 (m, 5H, H2’-H4’), Section z, 5.89-5.81 (m, 1H, H6’’), 4.05-3.92 (m, 2H, H5’’), 3.79–2.90  
(m, 5H, H2’’–H4’’). Overall Ratio (x;y;z) = 26:3:71 (Average Mw per unit = 188.17 g.mol-1). 
13C NMR (101 MHz, CDCl3) J ppm: Initiator, not observed. Section x, 164.8 (C10), 154.8 
(C12), 144.0 (ArC), 143.8 (ArC), 141.5 (ArC), 128.7 (C6), 127.5 (C7), 127.1 (ArCH), 125.2 
(ArCH), 120.4 (ArCH), ), 79.4* (C3), 78.7* (C3), 77.7, 72.7, 70.9, 68.9 (C2 & C4 & C5), 67.0 
(C13), 53.5 (C9), 50.2 (C21), 47.2 (C14), 35.8 (C8). Section y, 128.2 (C6’), 116.7 (H7’), 79.4* 
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(C3’), 78.7* (C3’), 77.7, 72.7, 70.9, 68.9 (C2’ & C4’ & C5’). Section z, 128.5 (C6’’), 79.4* (C3’’), 
78.7* (C3’’), 77.7, 72.7, 70.9, 68.9 (C2’’ & C4’’ & C5’’). 
 
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(2S,3R,4S,5S,6R)-2-(Allyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol[122] 

2.35 
Formula: C9H16O6 
Molecular Weight: 220.22 
To a dry flask charged with allyl alcohol (17 mL, 250 mmol, 15 equiv) was added dropwise 
acetyl chloride (1.5 mL, 22 mmol, 1.3 equiv) at 0 °C, and the resulting mixture was allowed 
to stir for 5 min. To this solution was added D-Glucose (3.00 g, 17 mmol, 1.0 equiv), and 
the reaction mixture was stirred at 50 °C for 18 h.  
The reaction mixture was quenched with sodium bicarbonate (5 g) and filtered through celite 
using CH2Cl2, and the filtrate concentrated under vacuum. The crude material was 
recrystallised from acetone to yield compound 2.35 as a white solid (1.3 g, 73%). 
1H NMR (400 MHz, D2O) J ppm: 5.98–5.83 (m, 1H, H12), 5.30 (d, J = 17.3 Hz, 1H, H13-trans), 
5.19 (d, J = 10.4 Hz, 1H, H13-cis), 4.89 (d, J = 3.8 Hz, 1H, H1), 4.21–4.10 (m, 2H, OCH2), 
3.88–3.73 (m, 2H, OCH2), 3.73 – 3.13 (m, 5H, H2-5). 
13C NMR (101 MHz, D2O) J ppm: 133.6 (C12), 118.2 (C13), 101.2 (C1), 73.1 (CH), 71.9 
(CH), 71.3 (CH), 69.6 (CH), 68.5 (C11), 60.5 (C6). 
[]D25 -48.0 (c = 0.5, CHCl3), literature []D25 -41.4 (c = 0.43, CHCl3). 
In agreement with literature data. [122] 
 
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(2R,3R,4S,5R,6S)-2-(Acetoxymethyl)-6-(allyloxy)tetrahydro-2H-pyran-3,4,5-triyl 
triacetate[123] 

2.36 
Formula: C17H24O10 
Molecular Weight: 388.37 
To solution of allyl glucose (3.00 g, 13.6 mmol, 1 equiv) and pyridine (22 mL, 270 mmol, 20 
equiv) was added DMAP (170 mg, 1.4 mmol, 0.1 equiv) at 0 °C, and the resulting mixture 
was allowed to stir for 5 min. To this solution was added acetic anhydride (26 mL, 270 mmol, 
20 equiv), and the reaction mixture was allowed to warm to RT over 18 h.  
The reaction mixture was cooled to 0 °C, quenched with 1 N aqueous HCl (25 ml) and the 
aqueous phase was extracted with CH2Cl2 (3 × 20 mL), the combined organic phases were 
washed with brine, dried over magnesium sulfate, filtered and concentrated under vacuum. 
The crude material was purified by column chromatography (70:30 PE/EtOAc) to give 
compound 2.36 as a clear oil (3.7 g, 70%). 
1H NMR (400 MHz, CDCl3) J ppm: 5.98–5.80 (m, 1H, H8), 5.34 (d, J = 17.2 Hz, 1H, H9-trans), 
5.25 (d, J = 10.4 Hz, 1H, H9-cis), 5.08 (d, J = 9.5 Hz, 1H, H1), 4.34–3.97 (m, 8H, CH2-7), 2.12 
(s, 3H, CH3), 2.09 (s, 3H, CH3), 2.05 (s, 3H, CH3), 2.03 (s, 3H, CH3). 
13C NMR (101 MHz, CDCl3) J ppm: 170.6 (CO), 170.2 (CO) 170.1 (CO), 169.6 (CO), 
133.1 (C8), 118.2 (C9), 94.8 (C1), 70.7 (CH), 70.1 (CH), 68.8 (OCH2), 68.5 (CH), 67.3 
(CH), 61.9 (OCH2), 20.7 (CH3), 20.6 (CH3), 20.5 (CH3), 20.4 (CH3). 
HRMS (ESI) for C17H24NaO10: 411.1262, Mass found: 411.1247 
[]D25 -19.2 (c = 1.0, CHCl3), literature []D25 -26.1 (c = 0.96, CHCl3). 
In agreement with literature data. [123] 

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Polyether:-oxymethylbenzene-7-hydroxy-poly[(2R,3R,4S,5R,6S)-2-(acetoxymethyl)-6-
((4-(oxiran-2-ylmethoxy)but-2-en-1-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate]-co-[2-
({allyl oxy}methyl)oxirane]-co-1,4-bis(oxiran-2-ylmethoxy)but-2-ene] 

PAGE-graft-2.66 
Formula: C7H7O(C21H30O12)x(C6H10O2)y(C10H16O4)z 
To a solution of PAGE (50 mg, 0.44 mmol, 1.0 equiv) in 1.1 mL of CH2Cl2 was added allyl 
glucose derivative 46 (680 mg, 1.75 mmol, 4.0 equiv) and Hoveyda-Grubbs’ second-
generation catalyst (13 mg, 0.022 mmol, 0.05 equiv), and the mixture was stirred at reflux 
for 18 h. The reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) 
and stirred for 5 min. The reaction mixture was then purified by size exclusion 
chromatography, LH-20 (1:1 MeOH/ CH2Cl2) furnishing PAGE-graft-2.66 as a brown oil (70 
mg, 98%). 
IR (K, cm-1): 3055, 2922, 2872, 1751, 1265, 1089.  
1H NMR (400 MHz, CDCl3) J ppm: Initiator, 7.35–7.33 (m, 5 H, Ar-H), H1 not observable. 
Section x, 5.98 (s, 1H, H6 or H7), 5.56–5.47 (m, 1H, H6 or H7), 5.06-5.03 (m, 1H, H9), 4.20–
4.05 (m, 4H, H5 and H8), 3.93–3.29 (m, 11H, H2-4 and H10-13 and H16), 2.12 (s, 3H, CH3), 2.09 
(s, 3H, CH3), 2.05 (s, 3H, CH3), 2.03 (s, 3H, CH3). Section y, 5.95–5.85 (m, 1H, H6’), 5.28 
(d, J = 17.6 Hz, 1H, H7’-trans), 5.18 (d, J = 10.7 Hz, 1H, H7’-cis), 4.05–3.95 (m, 2H, H5’), 3.93–
3.29 (m, 5H, H2’-4’). Section z, 5.95–5.85 (m, 1H, H6’’), 4.05–3.95 (m, 2H, H5’’), 3.93–3.29 
(m, 5H, H2’’-4’’). Overall Ratios (x;y;z) = 15:30:55 (Average Mw per unit = 163.11 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Initiator, not observed. Section x, 170.9 (CO), 170.1 
(CO) 170.0 (CO), 169.6 (CO), 125.9 (C6), 121.4 (C7), 94.8 (C9), 79.5* (C3), 78.7* (C3), 77.6 
(OCH2), 76.1 (OCH2), 72.3 (OCH), 70.0 (OCH), 68.8 (OCH2), 68.2 (OCH2), 67.3 (OCH), 
67.1 (OCH), 66.6 (OCH), 61.7 (OCH2), 20.8 (CH3), 20.6 (CH3), 20.5 (CH3), 20.1 (CH3). 
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Section y, 128.5 (C6’), 116.7 (H7’), 79.5* (C3’), 78.7* (C3’), 77.6, 76.1, 70.0, 68.2 (C2’ & C4’ & 
C5’). Section z, 128.5 (C6’’), 79.5* (C3’’), 78.7* (C3’’), 77.6, 76.1, 70.0, 68.2 (C2’’ & C4’’ & C5’’). 
GPC: Mn = 7690, Mw = 16190,  = 2.10. 
 
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(2S,3R,4S,5R,6R)-2-(Allyloxy)-3,4,5-tris(benzyloxy)-6-((benzyloxy)methyl)tetrahydro-2H-
pyran[124] 

2.39 
Formula: C37H40O6 
Molecular Weight: 580.72 
To solution of allyl glucose (0.77 g, 3.5 mmol, 1.0 equiv) and TBAB (1.47 g, 4.55 mmol, 1.30 
equiv) in aqueous sodium hydroxide solution (33% w/w) at 0 °C, was added dropwise benzyl 
bromide (5.0 mL, 42 mmol, 12 equiv). The reaction mixture was heated at 55 °C for 18 h.  
The reaction mixture was neutralised to pH 7 with 1 N aqueous HCl, then the aqueous 
phase was extracted with toluene (3 × 25 mL), the combined organic phases were washed 
with brine, dried over magnesium sulfate, filtered and concentrated under vacuum. The 
crude material was purified by column chromatography (85:15 PE/EtOAc) to give compound 
2.39 as a clear oil (1.1 g, 56%). 
 IR (K, cm-1): 3063, 3030, 2912, 2866, 1726, 1068. 
1H NMR (400 MHz, CDCl3) J ppm: 7.43–7.24 (m, 20H, ArH), 6.06–5.88 (m, 1H, H3), 5.34 
(ddd, J = 17.4, 3.1, 1.6 Hz, 1H, H4-trans), 5.23 (ddd, J = 10.3, 2.7, 1.4 Hz, 1H, H4-cis), 5.02 (d, 
J = 11.0 Hz, 1H, H1), 4.90–4.42 (m, 8H, ArCH2), 4.23–4.13 (m, 2H, OCH2), 4.08–3.99 (m, 
2H, OCH2), 3.90–3.44 (m, 4H, H5-8). 
13C NMR (101 MHz, CDCl3) J ppm:  138.9 (Ar), 138.3 (Ar), 138.3 (Ar), 138.0 (Ar), 
133.8 (C3), 128.4 (Ar-H), 128.3 (Ar-H), 128.2 (Ar-H), 128.1 (Ar-H), 127.9 (Ar-H), 127.8 
(Ar-H), 127.7 (Ar-H), 127.6 (Ar-H), 127.5 (Ar-H), 118.1 (C4), 95.8 (C1), 82.1 (CH), 79.9 
(CH), 77.8 (CH), 77.2 (CH), 75.7 (ArCH2), 75.1 (ArCH2), 73.5 (ArCH2), 73.2 (ArCH2), 68.5 
(OCH2), 68.2 (OCH2). 
HRMS (ESI) for [C37H40NaO6]: 603.2717, found: 603.2695 
[]D25 -150.7 (c = 1.0, CHCl3), literature []D25 not specified. 
In agreement with literature data. [124]
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(2S,3R,4S,5R,6R)-2-(Allyloxy)-3,4,5-tris(benzyloxy)-6-((benzyloxy)methyl)tetrahydro-2H-
pyran dimer  

2.40 
Formula: C72H76O12 
Molecular Weight: 1133.39 
To a degassed solution of Bn-allyl glucose 2.39 (1.00 g, 1.72 mmol, 1.00 equiv) in CH2Cl2 
(10 mL) was added Hoveyda-Grubbs’ second-generation catalyst (54 mg, 0.086 mmol, 0.05 
equiv), and the mixture was stirred at reflux for 16 h.  
The reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred 
for 5 min. The crude material was purified by column chromatography (90:10 PE/EtOAc) to 
give compound 2.40 as a clear oil (0.85 g, 87%) with an E:Z ratio of 20:1. 
IR (K, cm-1): 3063, 3030, 2912, 2866, 1726, 1068. 
1H NMR (400 MHz, CDCl3) J ppm: 7.40–7.21 (m, 40H, ArH), 5.87–5.75 (m, 2H, H8), 5.12-
5.01 (m, 2H, H1), 4.88–4.40 (m, 16H, ArCH2), 4.21–4.13 (m, 4H, OCH2), 4.10–4.00 (m, 4H, 
OCH2), 3.81–3.40 (m, 8H, H2-5). 
13C NMR (101 MHz, CDCl3) J ppm:  138.7 (Ar), 138.3 (Ar), 138.2 (Ar), 138.0 (Ar), 131.6 
(C8), 128.6 (Ar-H), 128.3 (Ar-H), 128.2 (Ar-H), 128.0 (Ar-H), 127.9 (Ar-H), 127.8 (Ar-H), 
127.7 (Ar-H), 127.6 (Ar-H), 127.5 (Ar-H), 99.1 (C1), 82.4 (CH), 79.9 (CH), 77.8 (CH), 77.2 
(CH), 75.7 (ArCH2), 75.1 (ArCH2), 73.5 (ArCH2), 73.2 (ArCH2), 68.5 (OCH2), 68.0 (OCH2). 
 
HRMS (ESI) for C72H76NaO12: 1155.5234, found: 1155.5247 
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
(2R,3R,4S,5R,6S)-2-(Acetoxymethyl)-6-(allyloxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate 
dimer 

2.38 
Formula: C32H44O20 
Molecular Weight: 748.68 
To degassed solution of Ac-allyl glucose 2.36 (1.00 g, 2.57 mmol, 1.00 equiv) in CH2Cl2 (15 
mL) was added Hoveyda-Grubbs’ second-generation catalyst (80 mg, 0.129 mmol, 0.05 
equiv), and the mixture was stirred at reflux for 16 h.  
The reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred 
for 5 min. The crude material was purified by column chromatography (70:30 PE/EtOAc) to 
give compound 2.38 as a clear oil (0.91 g, 95%) %) with an E:Z ratio of 20:1. 
IR (K, cm-1): 3078, 3005, 2912, 2890, 1746, 1159, 1068. 
1H NMR (400 MHz, CDCl3) J ppm: 5.74–5.62 (m, 2H, H8), 5.10 (d, J = 9.5 Hz, 2H, H1), 4.40–
3.99 (m, 16H, CH2-7), 2.12 (s, 6H, CH3), 2.06 (s, 6H, CH3), 2.01 (s, 6H, CH3), 1.92 (s, 6H, 
CH3). 
13C NMR (101 MHz, CDCl3) J ppm: 170.6 (CO), 170.2 (CO) 170.1 (CO), 169.6 (CO), 
131.9 (C8), 94.8 (C1), 70.7 (CH), 70.1 (CH), 68.8 (OCH2), 68.5 (CH), 66.2 (CH), 61.9 
(OCH2), 20.2 (CH3), 19.8 (CH3), 19.2 (CH3), 18.7 (CH3). 
 
HRMS (ESI) for C32H44NaO20: 771.2324, found: 771.2345. 
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Polyether:-tert-Butyl-7-hydroxy-poly[methyl 4-(oxiran-2-ylmethoxy)but-2-enoate]-co-[2-
({allyl oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-ene] 
 
PAGE-graft-MA 
Formula: C4H9O(C8H12O4)x(C6H10O2)y(C10H16O4)z 
To a solution of PAGE (50 mg, 0.44 mmol, 1.0 equiv) in 1.1 mL of CH2Cl2 was added methyl 
acrylate (0.16 mL, 1.8 mmol, 4.0 equiv), Hoveyda-Grubbs’ second-generation catalyst (14 
mg, 0.02 mmol, 0.05 equiv) and the mixture was stirred at reflux for 18 h. The reaction 
mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 min. The 
reaction mixture directly purified by size exclusion chromatography, LH-20 (1:1 
MeOH/CH2Cl2) furnishing PAGE-graft-MA as a brown oil (74 mg, 92%) exclusively as the 
E isomer. 
IR (K, cm-1): 2872, 1720, 1662, 1273, 1109, 729. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.19 (s, 9H, CH3). Section x, 6.86 (dt, J = 
15.8, 4.1 Hz, 1H, H5), 5.99 (d, J = 15.8 Hz, 1H, H6), 4.09 (br s, 2H, H4), 3.76–3.34 (m, 5H, 
H1-3), 3.66 (s, 3H, H8). Section y, 5.71-5.87 (m, 1H, H5’), 5.59-5.42 (m, 2H, H6’), 4.05–3.95 
(m, 2H, H4’), 3.84–3.32 (m, 5H, H1’-3’) Section z, 5.94–5.71 (m, 1H, H5’’), 4.05–3.95 (m, 2H, 
H4’’), 3.84–3.32 (m, 5H, H1’’-3’’) Overall Ratio (x;y;z) = 85:5:10 (Average Mw per unit = 
173.88 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm:  Initiator, not observed. Section x, 166.6 (C7), 144.7 
(C5), 120.6 (C6), 79.4* (C2), 78.7* (C2), 77.7, 72.8, 70.9, 69.9, 69.4 (C1 & C3 & C4), 51.5 (C8). 
Section y, 128.2 (C5’), 116.7 (C6’), 79.4* (C2’), 78.7* (C2’), 77.7, 72.8, 70.9, 69.9, 69.4 (C1’ 
& C3’ & C4’). Section z, 128.5 (C5’’), 79.4* (C2’’), 78.7* (C2’’), 77.7, 72.8, 70.9, 69.9, 69.4 (C1’’ 
& C3’’ & C4’’).  
GPC: Mn = 13896, Mw = 29295,  = 2.11. 
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Polyether:-tert-Butyl-7-hydroxy-poly[methyl 4-(oxiran-2-ylmethoxy)but-2-enoate]-co-[2-
({but-2-en-1-yl-oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-ene] 
 
PCGE-graft-MA 
Formula: C4H9O(C8H12O4)x(C7H12O2)y(C10H16O4)z 
To a solution of PCGE (50 mg, 0.39 mmol, 1.0 equiv) in 1 mL of CH2Cl2 was added methyl 
acrylate (0.14 mL, 1.6 mmol, 4.0 equiv), Hoveyda-Grubbs’ second-generation catalyst (12 
mg, 0.02 mmol, 0.05 equiv) and the mixture was stirred at reflux for 18 h. The reaction 
mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 min. The 
reaction mixture directly purified by size exclusion chromatography, LH-20 (1:1 
MeOH/CH2Cl2) furnishing the PCGE-graft-MA as a brown oil (63 mg, 95%). 
IR (K, cm-1): 2870, 1720, 1667, 1281, 1102, 745. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.19 (s, 9H, CH3). Section x, 6.86 (dt, J = 
15.6, 3.5 Hz, 1H, H5), 5.99 (d, J = 15.6 Hz, 1H, H6), 4.11-4.08 (m, 2H, H4), 3.76–3.34 (m, 
5H, H1-3), 3.66 (s, 3H, H8). Section y, not observed, Section z, 5.94–5.71 (m, 1H, H5’’), 
4.05–3.95 (m, 2H, H4’’), 3.84–3.32 (m, 5H, H1’’-3’’) Overall Ratio (x;y;z) = 80:0:20 (Average 
Mw per unit = 168.87 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Initiator, not observed. Section x, 166.6 (C7), 144.7 
(C5), 120.6 (C6), 78.7 (C2), 71.0, 69.9, 69.3 (C1 & C3 & C4), 51.5 (C8). Section y, not 
observed. Section z, 128.4 (C5’’), 78.7 (C2’’), 71.0, 69.9, 69.3 (C1’’ & C3’’ & C4’’). 
GPC: Mn = 13939, Mw = 30811,  = 2.21. 
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Polyether:-tert-Butyl-7-hydroxy-poly[methyl 4-(oxiran-2-ylmethoxy)but-2-enoate]-co-[2-
({3-Methylbut-2-en-1-yl-oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-ene] 
 
PPGE-graft-MA 
Formula: C4H9O(C8H12O4)x(C8H14O2)y(C10H16O4)z 
To a solution of PPGE (50 mg, 0.35 mmol, 1.0 equiv) in 0.9 mL of CH2Cl2 was added methyl 
acrylate (0.13 mL, 1.5 mmol, 4.0 equiv), Hoveyda-Grubbs’ second-generation catalyst (11 
mg, 0.018 mmol, 0.05 equiv) and the mixture was stirred at reflux for 18 h. The reaction 
mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 min. The 
reaction mixture directly purified by size exclusion chromatography, LH-20 (1:1 
MeOH/CH2Cl2) furnishing PPGE-graft-MA as a brown oil (54 mg, 84%).  
IR (K, cm-1): 2868, 1719, 1686, 1266, 1199, 756. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.19 (s, 9H, CH3). Section x, 6.86 (d, J = 15.7 
Hz, 1H, H5), 5.99 (d, J = 15.7 Hz, 1H, H6), 4.09 (s, 2H, H4), 3.76–3.34 (m, 5H, H1-3), 3.65 (s, 
3H, H8). Section y, 5.23 (s, 1H, H5’), 4.05–3.95 (m, 2H, H4’), 3.84–3.32 (m, 5H, H1’-3’), 1.66 
(s, 3H, H7 or 8), 1.58 (s, 3H, H7 or 8). Section z, 5.75–5.65 (m, 1H, H5’’), 4.05–3.95 (m, 2H, 
H4’’), 3.84–3.32 (m, 5H, H1’’-2’’) Overall Ratio (x;y;z) = 95:2:3 (Average Mw per unit = 182.65 
g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Section x, 166.6 (C7), 144.7 (C5), 120.6 (C6), 78.8 (C2), 
71.0, 69.9, 67.8 (C1 & C3 & C4), 51.5 (C8). Section y, not observable, Section z, not 
observable. 
GPC: Mn = 14831, Mw = 29745,  = 2.00. 
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(E)-But-2-ene-1,4-diyl diacetate[125] 
 
E-2.3  
Formula: C8H12O4 
Molecular Weight: 172.18
 
To a solution of allyl acetate (0.40 mL, 3.7 mmol) in 5 mL of degassed benzene was added 
Grubbs’ first-generation catalyst (150 mg, 0.19 mmol, 0.04 equiv) and the mixture was 
stirred at RT for 14 h. The reaction mixture was concentrated under vacuum and the crude 
material was purified by column chromatography (7:3 PE/EtOAc) to give compound E-2.3 
as the major isomer (E:Z, 6:1), as a colourless oil (160 mg, 42%). Data for E isomer: 
1H NMR (500 MHz, CDCl3) J ppm: 5.88 (tt, J = 3.0, 1.4 Hz, 2H, H4), 4.60 (dd, J = 3.0, 1.4 
Hz, 4H, H3), 2.10 (s, 6H, H1)  
13C NMR (126 MHz, CDCl3) J ppm: 170.6 (C2), 128.1 (C4), 63.9 (C3), 20.9 (C1). 
 
In agreement with literature data. [125] 
 
 
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(Z)-But-2-ene-1,4-diyl diacetate[126] 
 
Z-2.3 
Formula: C8H12O4 
Molecular Weight: 172.18
 
To a solution of (Z)-but-2-ene-1,4-diol (1.0 mL, 12 mmol) in 70 mL of CH2Cl2 was added 
triethylamine (5.1 mL, 37 mmol, 3.0 equiv) and DMAP (150 mg, 1.22 mmol, 0.10 equiv). 
The solution was cooled to 0 °C and acetyl chloride (3.5 mL, 48 mmol, 4.0 equiv) was added 
dropwise over 10 min. The reaction mixture was stirred and allowed to warm to RT 
overnight.  
The reaction mixture was quenched with a 1 M aqueous solution of sodium bicarbonate (50 
mL). The aqueous phase was extracted with CH2Cl2 (3 × 20 mL), the combined organic 
phases were washed with brine, dried over magnesium sulfate, filtered and reduced under 
vacuum. The crude material was purified by column chromatography (7:3 PE/EtOAc) to give 
compound Z-2.3 as a colourless oil (460 mg, 85%). 
1H NMR (400 MHz, CDCl3) J ppm: 5.78 (t, J = 4.1 Hz, 2H, H4), 4.70 (dd, J = 4.0, 1.2 Hz, 
4H, H3), 2.09 (s, 6H, H1). 
13C NMR (126 MHz, CDCl3) J ppm: 170.7 (C2), 128.0 (C4), 60.0 (C3), 20.9 (C1). 
In agreement with literature data. [126] 
 
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Polyether:-tert-Butyl-7-hydroxy-poly[(E)-4-(oxiran-2-ylmethoxy)but-2-en-1-yl acetate]-co-
[2-({allyl oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-ene] 
3
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PAGE-graft-AA 
Formula: C4H9O(C9H14O4)x(C6H10O2)y(C10H16O4)z 
To a solution of PAGE (50 mg, 0.44 mmol, 1.0 equiv) in 1.1 mL of CH2Cl2 was added allyl 
acetate dimer Z-2.3 (300 mg, 1.7 mmol, 4.0 equiv), Hoveyda-Grubbs’ second-generation 
catalyst (14 mg, 0.022 mmol, 0.05 equiv) and the mixture was stirred at reflux for 18 h. The 
reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 
min. The reaction mixture was then concentrated under vacuum and the product purified by 
size exclusion chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PAGE-graft-AA as a 
brown oil (65 mg, 90%) with an E:Z ratio of 3:1. 
IR (K, cm-1): 2910, 2868, 1737, 1365, 1230, 1107. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.19 (s, 9H, CH3). Section x, 5.94–5.71 (m, 
2H, H6 & H7), 4.55 (d, J = 4.1 Hz, 2H, H8), 4.05–3.95 (m, 2H, H5), 3.84–3.32 (m, 5H, H2-4), 
2.07 (s, 3H, H10) Section y, 5.94–5.71 (m, 1H, H6’), 5.25 (d, J = 17.3 Hz, 1H, H7’-trans), 5.16 
(d, J = 10.4 Hz, 1H, H7’-cis), 4.05–3.95 (m, 2H, H5’), 3.84–3.32 (m, 5H, H2’-4’) Section z, 5.94–
5.71 (m, 1H, H6’’), 4.05–3.95 (m, 2H, H5’’), 3.84–3.32 (m, 5H, H2’’-4’’) Overall Ratio (x;y;z) = 
87:4:9 (Average Mw per unit = 163.20 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Section x, 170.6 (C9), 131.1 (C6), 126.2 (C7), 79.4* (C3), 
78.8* (C3), 77.7, 72.7 (C2 & C4), 71.0 (C8), 70.4 (C5), 20.9 (C10). Section y, 128.1 (C6’), 116.7 
(C7’), 79.4* (C3’), 78.8* (C3’), 77.7, 72.7, 70.0 (C2’ & C4’ & C5’). Section z, 128.6 (C6’’), 79.4* 
(C3’’), 78.8* (C3’’), 77.7, 72.7, 70.0 (C2’’ & C4’’ & C5’’). 
GPC:. Mn = 12315, Mw = 18011,  = 1.46.  
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Polyether:-tert-Butyl-7-hydroxy-poly[(E)-4-(oxiran-2-ylmethoxy)but-2-en-1-yl acetate]-co-
[2-({but-2-en-1-yl-oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-ene] 
 
PCGE-graft-AA 
Formula: C4H9O(C9H14O4)x(C7H12O2)y(C10H16O4)z 
To a solution of PCGE (50 mg, 0.39 mmol, 1.0 equiv) in 1.1 mL of CH2Cl2 was added allyl 
acetate dimer Z-2.3 (270 mg, 1.6 mmol, 4.0 equiv), Hoveyda-Grubbs’ second-generation 
catalyst (14 mg, 0.022 mmol, 0.05 equiv) and the mixture was stirred at reflux for 18 h. The 
reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 
min. The reaction mixture was then concentrated under vacuum and the product purified by 
size exclusion chromatography, LH-20 (1:1 MeOH/ CH2Cl2) furnishing PCGE-graft-AA as a 
brown oil (51 mg, 83%) with an E:Z ratio of 3:1. 
IR (K, cm-1): 2910, 2868, 1737, 1365, 1230, 1107. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.19 (s, 9H, CH3). Section x, 5.94–5.65 (m, 
2H, H6 & H7), 4.55 (d, J = 4.1 Hz, 2H, H8), 4.05–3.95 (m, 2H, H5), 3.84–3.32 (m, 5H, H2-4), 
2.07 (s, 3H, H10) Section y, 5.94–5.65 (m, 1H, H7’), 5.62–5.51 (m, 1H, H6’), 3.94-3.90 (m, 
2H, H5), 3.84–3.32 (m, 5H, H2-4), 1.71 (dd, J = 6.3, 1.0 Hz, 3H, H8). Section z, 5.94–5.65 
(m, 1H, H6’’), 4.05–3.95 (m, 2H, H5’’), 3.84–3.32 (m, 5H, H2’’-4’’) Overall Ratio (x;y;z) = 
73:12:15 (Average Mw per unit = 155.92 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: 170.6 (C9), 131.1 (C6), 128.3, (C7), 78.8 (C3), 77.2 (C5), 
70.9 (C8), 70.4, 70.0, 64.2 (C2 & C4), 20.9 (C10). Section y, 129.1 (C6’), 127.9 (C7’), 78.8 
(C3’), 77.2 (C5’), 70.4, 70.0, 64.2 (C2’ & C4’), 17.5 (C8’). Section z, 128.5 (C6’’), 78.8 (C3’’), 
77.2 (C5’’), 70.4, 70.0, 64.2 (C2’’ & C4’’). 
GPC: Mn = 15590, Mw = 30922,  = 1.98.

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Polyether:-tert-Butyl-7-hydroxy-poly[(E)-4-(oxiran-2-ylmethoxy)but-2-en-1-yl acetate]-co-
[2-({3-Methylbut-2-en-1-yl-oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-ene] 
 
PPGE-graft-AA 
Formula: C4H9O(C9H14O4)x(C8H14O2)y(C10H16O4)z 
To a solution of PPGE (50 mg, 0.35 mmol, 1.0 equiv) in 0.9 mL of CH2Cl2 was added allyl 
acetate Z-2.3 (240 mg, 1.4 mmol, 4.0 equiv), Hoveyda-Grubbs’ second-generation catalyst 
(11 mg, 0.018 mmol, 0.05 equiv) and the mixture was stirred at reflux for 18 h. The reaction 
mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 min. The 
reaction mixture was then concentrated under vacuum and the product purified by size 
exclusion chromatography, LH-20 (1:1 MeOH/ CH2Cl2) furnishing PPGE-graft-AA as a 
brown oil (52 mg, 95%) with an E:Z ratio of 3:1. 
IR (K, cm-1): 2914, 2861, 1738, 1365, 1228, 1089. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.10 (s, 9H, CH3). Section x, 5.85–5.49 (m, 
2H, H6 & H7), 4.55 (d, J = 4.2 Hz, 2H, H8), 4.05–3.95 (m, 2H, H5), 3.84–3.32 (m, 5H, H2-4), 
2.00 (s, 3H, H10) Section y, 5.24 (t, J = 6.9 Hz, 1H, H6’), 4.05–3.95 (m, 2H, H5’), 3.84–3.32 
(m, 5H, H2’-4’), 1.66 (s, 3H, H8’ or 9’), 1.59 (s, 3H, H8’ or 9’).Section z, 5.94–5.71 (m, 1H, H6’’), 
4.05–3.95 (m, 2H, H5’’), 3.84–3.32 (m, 5H, H2’’-4’’) Overall Ratio (x;y;z) = 60:30:10 (Average 
Mw per unit = 155.80 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: 170.6 (C9), 131.1 (C6), 126.2, (C7), 78.8 (C3), 77.2 (C5), 
71.0 (C8), 70.4, 70.0, 67.8, 64.2 (C2 & C4), 20.9 (C10). Section y, 136.4 (C6’), 121.4 (C7’), 
78.8 (C3’), 77.2 (C5’), 70.4, 70.0, 67.8 ,64.2 (C2’ & C4’), 25.7 (C8’ or 9’), 18.1 (C8’ or 9’). Section 
z, 128.4 (C6’’), 78.8 (C3’’), 77.2 (C5’’), 70.4, 70.0, 67.8 ,64.2 (C2’’ & C4’’) 
GPC:. Mn = 12813, Mw = 22594,  = 1.76.   
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Polyether:-tert-Butyl-7-hydroxy-poly[(E)-3-methyl-4-(oxiran-2-ylmethoxy)but-2-en-1-yl 
acetate]-co-[2-({2-methylallyl oxy}methyl)oxirane] 
3
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PMAGE-graft-AA 
Formula: C4H9O(C10H16O4)x(C7H12O2)y(C10H16O4)z 
To a solution of PMAGE (50 mg, 0.39 mmol, 1.0 equiv) in 1.0 mL of CH2Cl2 was added allyl 
acetate dimer Z-2.3 (269 mg, 1.6 mmol, 4.0 equiv), Hoveyda-Grubbs’ second-generation 
catalyst (12 mg, 0.020 mmol, 0.05 equiv) and the mixture was stirred at reflux for 18 h. The 
reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 
min. The reaction mixture was then concentrated under vacuum and the product purified by 
size exclusion chromatography, LH-20 (1:1 MeOH/ CH2Cl2) furnishing PMAGE-graft-AA as 
a brown oil (62 mg, 97%) with an E:Z ratio of 3:1. 
IR (K, cm-1): 2911, 2862, 2358, 1732, 1448, 1236, 1094, 908, 731. 
1H NMR (400 MHz, CDCl3) J ppm:  Initiator, 1.10 (s, 9H, CH3). Section x, 5.50 (t, J = 7.0 
Hz, 1H, H7), 4.55 (d, J = 7.0 Hz, 2H, H8), 3.86 (s, 2H, H5), 3.64–3.27 (m, 5H, H2-4), 1.98 (s, 
3H, H10), 1.64 (s, 3H, H11). Section y, 4.93 (s, 1H, H7’a), 4.85 (s, 1H, H7’b), 3.86 (s, 2H, H5’), 
3.70–3.40 (m, 5H, H2’-4’), 1.70 (s, 3H, H8’). Section z, Not observed, Overall Ratio (x;y;z) 
= 50:50: 0. (Average Mw per unit = 164.00 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: 170.9 (C9), 138.3 (C6), 120.4 (C7), 78.9* (C3), 78.8* 
(C3), 76.7, 76.1 (C2 & C4 & C5), 70.1 (C8), 69.8, 69.5, 60.8 (C2 & C4 & C5), 20.9 (C10), 14.0 
(C11). Section y, 142.2 (H6’), 111.9 (H7’), 78.9* (C3’), 78.8* (C3’), 76.7, 76.1, 69.8, 69.5, 
60.8 (C2’ & C4’ & C5’), 19.4 (C8’). Section z, Not observed, 
GPC:. Mn = 15944, Mw = 17364,  = 1.09 
 
Polyether:-tert-Butyl-7-hydroxy-poly[(E)-3-methyl-4-(oxiran-2-ylmethoxy)pent-2-en-1-yl 
acetate]-co-[2-({3-Methylbut-3-en-1-yl-oxy}methyl)oxirane] 
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PBMGE-graft-AA 
Formula: C4H9O(C11H18O4)x(C8H14O2)y(C14H24O4)z 
To a solution of PMBGE (50 mg, 0.35 mmol, 1.0 equiv) in 0.9 mL of toluene was added allyl 
acetate dimer Z-2.3 (240 mg, 1.4 mmol, 4.0 equiv), Hoveyda-Grubbs’ second-generation 
catalyst (11 mg, 0.018 mmol, 0.050 equiv) and the mixture was stirred at reflux for 18 h. 
The reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred 
for 5 min. The reaction mixture was then concentrated under vacuum and the product 
purified by size exclusion chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PBMGE-
graft-AA as a brown oil (55 mg, 95%) with an E:Z ratio of 3:1. 
IR (K, cm-1): 2910, 2864, 2360, 1734, 1230, 1108, 1023, 887. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.10 (s, 9H, CH3). Section x, 5.36 (t, J = 7.1 
Hz, 1H, H8), 4.57 (d, J = 7.1 Hz, 2H, H9), 3.66–3.37 (m, 7H, H2-5), 2.33–2.24 (m, 2H, H6), 
2.04 (s, 3H, H12), 1.71 (s, 3H, H10). Section y, 4.75 (s, 1H, H8’a), 4.70 (s, 1H, H8’b), 3.66–
3.37 (m, 7H, H2’-5’), 2.33–2.24 (m, 2H, H6’), 1.73 (s, 3H, H9’). Section z, Not observed, 
Overall Ratio (x;y;z) = 35:65:0. (Average Mw per unit = 163.00 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Section x: 171.0 (C11), 139.2 (C7), 120.9 (C8), 78.9 (C3), 
78.7, 71.0 , 70.1, 69.8 (C2 & C4 & C5 & C9), 39.5 (C6), 24.1 (C12), 14.0 (C10). Section y: 
142.8 (C7’), 111.4 (C7), 78.7 (C3’), 78.7, 71.0 , 70.1, 69.8 (C2’ & C4’ & C5’), 37.8 (C6’), 22.8 
(C9’). Section z: not observed 
GPC:. Mn = 6511, Mw = 10054,  = 1.54  
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Methyl glycinate[127] 
 
2.24a 
Formula: C3H8NO2Cl 
Molecular Weight: 125.55 
To a solution of glycine (5.00 g, 66.6 mmol, 1.00 equiv) in 100 mL of methanol was added 
dropwise freshly distilled SOCl2 (5.4 mL, 73 mmol, 1.1 equiv), and the solution was stirred 
at reflux for 3 h. The reaction mixture was reduced under vacuum to yield compound 2.24a 
as a white solid (8.3 g, 99%). 
1H NMR (400 MHz, D2O) J ppm: 3.85 (s, 2H, H1), 3.75 (s, 3H, H3), 3.26 (br s, 3H, NH3). 
13C NMR (101 MHz, D2O) J ppm: 168.7 (C2), 53.2 (C3), 40.1 (C1). 
Melting Point: 171 °C 
In agreement with literature data. [127] 

 
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Methyl (tert-Butoxycarbonyl)-L-alanylglycinate[128] 
 
 
2.28  
Formula: C11H20N2O5 
Molecular Weight: 260.29 
To a solution of methyl glycinate hydrochloride (1.00 g, 7.96 mmol, 1.00 equiv) in 150 mL 
of THF was added Boc-Ala-OH (1.51 g, 7.96 mmol, 1.00 equiv) and BOP (3.87 g, 8.76 
mmol, 1.10 equiv), and the solution cooled to 0 °C. To this solution was added dropwise 
DIPEA (3.5 ml, 20 mmol, 2.5 equiv). The solution stirred and allowed to warm to RT over 
18 h.  
The reaction mixture was quenched with saturated aqueous ammonium chloride then the 
aqueous phases extracted with CH2Cl2 (3 × 25 mL). The combined organic layers were 
washed with a saturated aqueous solution of sodium bicarbonate then brine, dried over 
magnesium sulfate, filtered and concentrated under vacuum. The crude material was 
purified by column chromatography (70:30 PE/EtOAc) to give compound 2.28 as a clear oil 
(2.1 g, 99%). 
1H NMR (400 MHz, CDCl3) J ppm: 6.58 (br s, 1H, NH), 4.90–4.80 (m, 1H, H5), 4.15 (s, 1H, 
NH), 4.05–3.89 (m, 2H, H9), 3.69 (s, 3H, H11), 1.39 (s, 9H, H1), 1.36–1.25 (m, 3H, H6). 
13C NMR (126 MHz, CDCl3) J ppm: 173.2 (C10), 170.2 (C7), 155.6 (C3), 80.2 (C2), 52.3 (C11), 
49.9 (C5), 41.1 (C9), 28.3 (C1), 18.3 (C6). 
HRMS (ESI) for C11H20N2NaO5: 283.1264, found: 283.1251.  
[]D25 +96.7 (c = 1.0, CHCl3), literature []D25 not specified. 
In agreement with literature data. [128] 
 
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(tert-Butoxycarbonyl)-L-Alanylglycine[129] 
 
 
2.29 
Formula: C10H18N2O5 
Molecular Weight: 246.26 
To a stirring solution of Boc-Ala-Gly-OMe (1.00 g, 3.84 mmol, 1.00 equiv) in 20 mL of 
methanol was added at 0 °C 1 N aqueous NaOH (12 mL, 12 mmol, 3.1 equiv). The solution 
was stirred and allowed to warm to RT over 18 h. 
Methanol was removed under vacuum, and the reaction mixture then acidified with 1 N 
aqueous HCl to pH 2. The aqueous phase was extracted with ethyl acetate (3 × 10 mL), the 
organic phases were dried over magnesium sulfate, filtered and concentrated under 
vacuum. The crude material was purified by precipitation in PE to yield compound 2.29 as 
white crystals (620 mg, 65%). 
1H NMR (500 MHz, DMSO) J ppm: 12.55 (br s, 1H, H11), 8.02 (dd, J = 5.9, 5.4 Hz, 1H, H8), 
6.93 (d, J = 7.8 Hz, 1H, H4), 4.01–3.96 (m, 1H, H5), 3.78 (dd, J = 17.6, 5.9 Hz, 1H, H9), 3.69 
(dd, J = 17.6, 5.4 Hz, 1H, H9), 1.38 (s, 9H, H1), 1.17 (d, J = 7.2 Hz, 3H, H6). 
13C NMR (126 MHz, DMSO) 184.0 (C10), 173.4 (C7 or C3), 169.1 (C7 or C3), 78.5 (C2), 49.9 
(C5), 41.1 (C9), 28.7 (C1), 18.7 (C6). 
HRMS (ESI) calculated for C10H17N2O5: 245.1143, Mass Found: 245.1125.  
Melting Point: 69 °C 
In agreement with literature data. [129] 
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(Z)-But-2-ene-1,4-diyl bis(2-((tert-butoxycarbonyl)amino)acetate) 
 
2.24  
Formula: C18H30N2O8 
Molecular Weight: 402.44 
To a solution of Boc-Gly-OH (2.80 g, 17.1 mmol, 3.00 equiv) in 25 mL of CH2Cl2 was added 
DMAP (200 mg, 1.71 mmol, 0.30 equiv) and (Z)-but-2-ene-1,4-diol (0.47 mL, 5.71 mmol, 
1.00 equiv). The solution was cooled to 0 °C and EDCI (3.58 g, 20.0 mmol, 3.50 equiv) was 
added. The reaction mixture was stirred and allowed to warm to RT over 18 h.  
Water (100 ml) was then added and the aqueous phase extracted with CH2Cl2 (3 × 50 mL), 
the combined organic phases were washed with brine, dried over magnesium sulfate, 
filtered and concentrated under vacuum. The crude material was purified by column 
chromatography (70:30 PE/EtOAc) to give compound 2.24 as a thick white oil (3.16 g, 
100%). 
IR (K, cm-1): 3368, 2978, 2933, 1697, 1510, 1155. 
1H NMR (500 MHz, CDCl3) J ppm: 5.77 (t, J = 5.2 Hz, 2H, H8), 5.08-5.02 (m, 2H, H4), 4.76 
(d, J = 5.2 Hz, 4H, H7), 3.93 (d, J = 5.8 Hz, 4H, H5), 1.45 (s, 18H, H1). 
13C NMR (126 MHz, CDCl3) J ppm: 170.1 (C6), 155. 7 (C3), 128.0 (C8), 80.1 (C2), 60.6 (C7), 
42.4 (C5), 28.3 (C1). 
HRMS (ESI) – for C18H30N2O8Na: 425.1894, found: 425.1876. 
 
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(Z)-But-2-ene-1,4-diyl bis(2-((S)-2-((tert-Butoxycarbonyl)amino)propanamido)acetate) 
 
2.30  
Formula: C24H40N4O10 
Molecular Weight: 544.60 
To a solution of Boc-Ala-Gly-OH (1.00 g, 4.06 mmol, 3.00 equiv) in 25 mL of CH2Cl2 was 
added DMAP (48 mg, 0.39 mmol, 0.30 equiv) and (Z)-but-2-ene-1,4-diol (0.11 mL, 1.4 
mmol, 1.0 equiv). The solution was cooled to 0 °C and EDCI (0.85 g, 4.4 mmol, 3.3 equiv) 
was added. The reaction mixture was stirred and allowed to warm to RT over 18 h.  
Water (100 ml) was then added and the aqueous phase extracted with CH2Cl2 (3 × 25 mL), 
the combined organic phases were washed with brine, dried over magnesium sulfate, 
filtered and concentrated under vacuum. The crude material was purified by column 
chromatography (65:35 PE/Acetone) to give compound 2.30 as a thick white oil (760 mg, 
99%). 
IR (K, cm-1): 3316, 2980, 2933, 2249, 1750, 1664, 1508, 1376, 1163, 729. 
1H NMR (500 MHz, CDCl3) J ppm: 6.86–8.78 (m, 2H, NH), 5.80 (t, J = 5.2 Hz, 2H, H12), 5.13 
(br s, 2H, NH), 4.78 (d, J = 5.2 Hz, 4H, H11), 4.31–4.21 (m, 2H, H5), 4.11 (dd, J = 18.2, 5.4 
Hz, 2H, H9a), 4.04 (dd, J = 18.2, 5.2 Hz, 2H, H9b), 1.47 (s, 18H, H1), 1.40 (d, J = 7.1 Hz, 6H, 
H6). 
13C NMR (126 MHz, CDCl3) J ppm: 173.4 (C10), 169.5 (C7), 155.6 (C3), 128.0 (C12), 80.0 
(C2), 60.6 (C11), 49.9 (C5), 41.2 (C9), 28.3 (C1), 18.4 (C6). 
M/S (ESI) – for C24H41N4NaO10: 567.2642, found: 567.2659. 
[]D25 +5.8 (c = 1.0, CHCl3). 

 
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Polyether:-oxymethylbenzene-7-hydroxy-poly[(E)-4-(oxiran-2-ylmethoxy)but-2-en-1-yl 
(tert-butoxycarbonyl)-L-alanylglycinate]-co-[2-({allyl oxy}methyl)oxirane]-co-[1,4-bis(oxiran-
2-ylmethoxy)but-2-ene] 

PAGE-graft-2.30 
Formula: C7H7O(C17H28N2O7)x(C6H10O2)y(C10H16O4)z 
To a solution of PAGE (25 mg, 0.22 mmol, 1.0 equiv) in 1 mL of CH2Cl2 was added diester 
2.30 (480 mg, 0.88 mmol, 4.0 equiv) and Hoveyda-Grubbs’ second-generation catalyst (7 
mg, 0.011 mmol, 0.05 equiv), and the mixture was stirred at reflux for 8 h. The reaction 
mixture was quenched with tosylmethyl isocyanide (20 mg, 0.1 mmol, 0.45 equiv) and 
stirred for 5 min. The reaction mixture was then purified by size exclusion chromatography, 
LH-20 (1:1 MeOH/ CH2Cl2) furnishing PAGE-graft-2.30 as a brown oil (35 mg, 87%). 
(Average Mw per unit = 181.73 g.mol-1). 
IR (K, cm-1): 3400, 3055, 2983, 2931, 2868, 1747, 1680, 1265. 
 
1H NMR (400 MHz, CDCl3) J ppm: Initiator, none observed Section x, 7.10 (br s, 1H, 
NH), 5.84–5.63 (m, 2H, H6 and H7), 5.38-5.35 (m, 1H, NH), 4.57-4.53 (m, 2H, H8), 4.22-
4.19 (m, 1H, H13), 4.05–3.85 (m, 4H, H5 and H10), 3.77–3.19 (m, 5H, H2-4), 1.37 (s, 9H, 
H17), 1.31 (d, J = 7.0 Hz, 3H, H18). Section y, not observed. Section z, 5.84–5.63 (m, 1H, 
H6’’), 4.05–3.85 (m, 2H, H5’’), 3.77–3.19 (m, 5H, H2’’-4’’) Overall Ratio (x;y;z) = 30:0:70 
(Average Mw per unit = 181.73 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: 173.3 (C9), 169.6 (C12), 155.6 (C15), 131.8 (C6), 129.5 
(C7), 80.1 (C16), 78.9 (C3), 71.5, 70.8, 70.0, 65.1 (C2 & C4 & C5), 49.9 (C13), 41.2 (C10), 28.4 
(C17), 18.5 (C18). Section y, not observed, Section z, 125.4 (C6’’), 78.9 (C3’’), 71.5, 70.8, 
70.0, 65.1 (C2’’ & C4’’ & C5’’). 
GPC: Mn = 9855, Mw = 16556,  = 1.68  
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Polyether:-tert-Butyl-7-hydroxy-poly[4-(oxiran-2-ylmethoxy)but-2-en-1-yl (tert-
butoxycarbonyl)glycinate]-co-[2-({allyl oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-
ylmethoxy)but-2-ene] 
 
PAGE-graft-Gly-Boc 
Formula: C4H9O(C14H23NO6)x(C6H10O2)y(C10H16O4)z 
To a solution of PAGE (50 mg, 0.44 mmol, 1.0 equiv) in 1.1 mL of CH2Cl2 was added Boc-
Gly-dimer 2.24 (350 mg, 0.88 mmol, 2.00 equiv), Hoveyda-Grubbs’ second-generation 
catalyst (14 mg, 0.022 mmol, 0.05 equiv) and the mixture was stirred at reflux for 18 h. The 
reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 
min. The reaction mixture was then concentrated under vacuum and the product purified by 
size exclusion chromatography, LH-20 (1:1 MeOH/ CH2Cl2) furnishing the PAGE-graft-Gly-
Boc as a brown oil (67 mg, 94%) with an E:Z ratio of 3:1. 
IR (K, cm-1): 3459, 3015, 2970, 2864, 1728, 1365, 1228. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.19 (s, 9H, CH3). Section x, 5.90–5.70 (m, 
2H, H6&7), 5.04 (s, 1H, H11), 4.76 (d, J = 5.3 Hz, 2H, H8), 3.94 (d, J = 5.8 Hz, 2H, H5), 3.84–
3.32 (m, 7H, H2-4&10), 1.45 (s, 9H, H14). Section y, 5.90–5.70 (m, 1H, H6’), 5.24 (d, J = 17.3 
Hz, 1H, H7’-trans), 5.14 (d, J = 10.4 Hz, 1H, H7’-cis), 4.03–3.93 (m, 2H, H5’), 3.84–3.32 (m, 5H, 
H2’-4’) Section z, 5.90–5.70 (m, 1H, H6’’), 4.03–3.93 (m, 2H, H5’’), 3.84–3.32 (m, 5H, H2’’-4’’) 
Overall Ratio (x;y;z) = 30:7:63 (Average Mw per unit = 161.38 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Section x, 170.1 (C9), 155.8 (C12), 131.7 (C6), 125.5 
(C7), 79.9 (C13), 78.8* (C3), 77.4* (C3), 77.0, 76.7, 70.8 (C2 and C4), 70.5 (C5), 65.0 (C8), 
42.4 (C10), 28.3 (C14).Section y, 129.3 (C6’), 116.7 (C7’), 78.8* (C3’), 77.4* (C3’), 77.0, 76.7, 
70.8 (C2’ and C4’ and C5’). Section z, 128.7 (C6’’), 78.8* (C3’’), 77.4* (C3’’), 77.0, 76.7, 70.8 
(C2’ and C4’ and C5’). 
GPC:. Mn = 22704, Mw = 41057,  = 1.81 
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
Polyether:-tert-Butyl-7-hydroxy-poly[4-(oxiran-2-ylmethoxy)but-2-en-1-yl (tert-
butoxycarbonyl)glycinate-co-[2-({but-2-en-1-yl-oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-
ylmethoxy)but-2-ene] 
 
PCGE-graft-Gly-Boc 
Formula: C4H9O(C14H23NO6)x(C7H12O2)y(C10H16O4)z 
To a solution of PCGE (50 mg, 0.39 mmol, 1.0 equiv) in 1.0 mL of CH2Cl2 was added Boc-
Gly-dimer 2.24 (310 mg, 0.78 mmol, 2.00 equiv), Hoveyda-Grubbs’ second-generation 
catalyst (12 mg, 0.020 mmol, 0.05 equiv) and the mixture was stirred at reflux for 18 h. The 
reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 
min. The reaction mixture was then concentrated under vacuum and the product purified by 
size exclusion chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PCGE-graft-Gly-Boc 
as a brown oil (58 mg, 82%) with an E:Z ratio of 3:1. 
IR (K, cm-1): 3455, 3017, 2971, 2865, 1738, 1366, 1217. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.19 (s, 9H, CH3). Section x, 5.88–5.78 (m, 
2H, H6&7), 5.20 (s, 1H, H11), 4.62 (d, J = 5.0 Hz, 2H, H8), 3.93 (d, J = 5.8 Hz, 2H, H5), 3.75–
3.30 (m, 7H, H2-4&10), 1.45 (s, 9H, H14). Section y, 5.78–5.64 (m, 1H, H7’), 5.62–5.51 (m, 
1H, H6’), 4.03–3.93 (m, 2H, H5’), 3.75–3.30 (m, 5H, H2’-4’), 1.69 (d, J = 6.5, 3H, H8’). Section 
z, 5.88–5.78 (m, 1H, H6’’), 4.03–3.93 (m, 2H, H5’’), 3.75–3.30 (m, 5H, H2’’-4’’) Overall Ratio 
(x;y;z) = 40:7:53 (Average Mw per unit = 182.50 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Section x, 170.1 (C9), 155.8 (C12), 131.7 (C6), 125.5 
(C7), 79.9 (C13), 78.8* (C3), 77.4* (C3), 77.0, 72.8, 70.8 (C2 and C4), 70.5 (C5), 65.0 (C8), 
42.4 (C10), 28.3 (C14). Section y, 129.0 (C6’), 127.9 (C7’), 78.8* (C3’), 77.4* (C5’), 77.0, 72.8, 
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70.8 (C2’ and C4’ and C5’), 17.9 (C8’). Section z, 128.7 (C6’’), 78.8* (C3’’), 77.4* (C3’’), 77.0, 
72.8, 70.8 (C2’’ and C4’’ and C5’’). 
GPC:. Mn = 17089, Mw = 29319,  = 1.72 
  
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Polyether:-tert-Butyl-7-hydroxy-poly[4-(oxiran-2-ylmethoxy)but-2-en-1-yl (tert-
butoxycarbonyl)glycinate]-co-[2-({3-Methylbut-2-en-1-yl-oxy}methyl)oxirane]-co-[1,4-
bis(oxiran-2-ylmethoxy)but-2-ene] 
 
PPGE-graft-Gly-Boc 
Formula: C4H9O(C14H23NO6)x(C8H14O2)y(C10H16O4)z 
To a solution of PPGE (50 mg, 0.35 mmol, 1.0 equiv) in 0.9 mL of CH2Cl2 was added Boc-
Gly-dimer 2.24 (280 mg, 0.70 mmol, 2.0 equiv), Hoveyda-Grubbs’ second-generation 
catalyst (11 mg, 0.018 mmol, 0.05 equiv) and the mixture was stirred at reflux for 18 h. The 
reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 
min. The reaction mixture was then concentrated under vacuum and the product purified by 
size exclusion chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PPGE-graft-Gly-Boc 
as a brown oil (63 mg, 95%) with an E:Z ratio of 3:1. 
IR (K, cm-1): 3455, 3017, 2970, 2864, 1738, 1366, 1228. 
1H NMR (500 MHz, CDCl3) J ppm: Initiator, 1.19 (s, 9H, CH3). Section x, 5.89–5.72 (m, 
2H, H6&7), 5.41–5.11 (m, 1H, H11), 4.63 (d, J = 5.1 Hz, 2H, H8), 3.90 (d, J = 5.5 Hz, 2H, H5), 
3.79–3.38 (m, 7H, H2-4&10), 1.45 (s, 9H, H14). Section y, 5.41–5.11 (m, 1H, H6’), 4.03–3.93 
(m, 2H, H5’), 3.79–3.38 (m, 5H, H2’-4’), 1.72 (s, 3H, H8’ or H9’), 1.63 (s, 3H, H8’ or H9’). Section 
z, 5.89–5.72 (m, 1H, H6’’), 4.03–3.93 (m, 2H, H5’’), 3.79–3.38 (m, 5H, H2’’-4’’) Overall Ratio 
(x;y;z) = 38:27:35 (Average Mw per unit = 187.85 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Section x, 170.1 (C9), 155.8 (C12), 131.7 (C6), 125.5 
(C7), 79.9 (C13), 78.8* (C3), 77.4* (C3), 77.0, 76.7, 72.8, 70.8 (C2 and C4), 70.5 (C5), 65.0 
(C8), 42.4 (C10), 28.3 (C14). Section y, 136.2 (C7’), 121.3 (C6’), 78.8* (C3’), 77.4* (C5’), 77.0, 
76.7, 72.8, 70.8 (C2’ and C4’ and C5’), 25.8 (C8’ or C9’), 18.1 (C8’ or C9’). Section z, 128.7 
(C6’’), 78.8* (C3’’), 77.4* (C3’’), 77.0, 76.7, 72.8, 70.8 (C2’’ and C4’’ and C5’’). 
GPC:. Mn = 16445, Mw = 30314,  = 1.84. 
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
Polyether:-tert-Butyl-7-hydroxy-poly[4-(oxiran-2-ylmethoxy)3-methyl-but-2-en-1-yl (tert-
butoxycarbonyl)glycinate]-co-[2-({2-Methylallyl oxy}methyl)oxirane] 
 
PMAGE-graft-Gly-Boc 
Formula: C4H9O(C15H25NO6)x(C7H12O2)y(C12H20O4)z 
To a solution of PMAGE (50 mg, 0.39 mmol, 1.0 equiv) in 1.0 mL of CH2Cl2 was added Boc-
Gly-dimer 2.24 (310 mg, 0.78 mmol, 2.00 equiv), Hoveyda-Grubbs’ second-generation 
catalyst (12 mg, 0.020 mmol, 0.05 equiv) and the mixture was stirred at reflux for 18 h. The 
reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 
min. The reaction mixture was then concentrated under vacuum and the product purified by 
size exclusion chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PMAGE-graft-Gly-
Boc as a brown oil (70 mg, 97%) with an E:Z ratio of 3:1. 
IR (K, cm-1): 3450, 2917, 2868, 2360, 1268, 1162, 1090. 
1H NMR (500 MHz, CDCl3) J ppm: Initiator, 1.19 (s, 9H, CH3). Section x, 5.56 (t, J = 6.9 
Hz, 1H, H7), 5.15 (s, 1H, H11), 4.70 (d, J = 6.9 Hz, 2H, H8), 3.88–3.80 (m, 2H, H5), 3.70–
3.36 (m, 7H, H2-4&10), 1.68 (s, 3H, H15), 1.45 (s, 9H, H14). Section y, 4.93 (s, 1H, H7’a), 4.85 
(s, 1H, H7’b), 3.88–3.80 (m, 2H, H5’), 3.70–3.36 (m, 5H, H2’-4’), 1.70 (s, 3H, H8’). Section z, 
not observed. Overall Ratio (x;y;z) = 30:70:0 (Average Mw per unit = 184.10 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Section x, 170.3 (C9), 155.7 (C12), 139.1 (C6), 119.6 
(C7), 79.8 (C13), 78.8 (C3), 76.0, 75.2, 70.1, 69.8 (C2 and C4 and C5), 61.5(C8), 42.4 (C10), 
28.3 (C14), 21.5 (C15). Section y, 142.2 (H6’), 111.9 (H7’), 78.8 (C3’), 76.0, 75.2, 70.1, 69.8 
(C2’ and C4’ and C5’), 19.4 (C8’). Section z, Not observed. 
GPC:. Mn = 19016, Mw = 20688,  = 1.09 

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
Polyether:-tert-Butyl-7-hydroxy-poly[4-(oxiran-2-ylmethoxy)3-methyl-pent-2-en-1-yl (tert-
butoxycarbonyl)glycinate]-co-[2-({3-Methylbut-3-en-1-yl-oxy}methyl)oxirane] 
 
PBMGE-graft-Gly-Boc 
Formula: C4H9O(C16H27NO6)x(C8H14O2)y(C14H24O4)z 
To a solution of PMBGE (50 mg, 0.35 mmol, 1.0 equiv) in 0.9 mL of toluene was added 
Boc-Gly-dimer 2.24 (280 mg, 0.70 mmol, 2.0 equiv), Hoveyda-Grubbs’ second-generation 
catalyst (11 mg, 0.018 mmol, 0.050 equiv) and the mixture was stirred at reflux for 18 h. 
The reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred 
for 5 min. The reaction mixture was then concentrated under vacuum and the product 
purified by size exclusion chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PBMGE-
graft-Gly-Boc as a brown oil (59 mg, 90%) with an E:Z ratio of 3:1. 
IR (K, cm-1): 3460, 2932, 2865, 2355, 1718, 1365, 1269, 1111, 1031, 887. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.17 (s, 9H, CH3). Section x, 5.36 (t, J = 7.0 
Hz, 1H, H8), 5.12 (s, 1H, H13), 4.65 (d, J = 7.0 Hz, 2H, H9), 3.67–3.40 (m, 9H, H2-5&12), 2.32–
2.25 (m, 2H, H6), 1.71 (s, 3H, H10), 1.45 (s, 9H, H16). Section y, 4.76 (s, 1H, H8’a), 4.70 (s, 
1H, H8’b), 3.67–3.40 (m, 7H, H2’-5’), 2.32–2.25 (m, 2H, H6’), 1.74 (s, 3H, H9’). Section z, Not 
abserved, Overall Ratio (x;y;z) = 24:76:0 (Average Mw per unit = 186.40 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Section x: 170.9 (C11), 155.7 (C14), 138.3 (C7), 120.9 
(C8), 78.9 (C3), 78.7 (C5), 78.5 (C15), 71.0, 70.1, 69.8 (C2 & C4 & C9), 42.5 (C12), 39.5 (C6), 
24.1 (C16), 14.0 (C10). Section y: 142.2 (C7’), 111.9 (C8’), 78.9 (C3’), 71.0, 70.1, 69.8 (C2’ & 
C4’ & C5’), 37.6 (C6’), 19.4 (C9’). Section z: not observed. 
GPC:. Mn = 7664, Mw = 11517,  = 1.50 
  
183 
 
1-Allyl 4-(tert-butyl) (((9H-fluoren-9-yl)methoxy)carbonyl)-L-aspartate[130] 
 
3.40 
Formula: C26H29NO6 
Molecular Weight: 451.52 
To a solution of Fmoc-Asp(OtBu)-OH (1.00 g, 2.43 mmol, 1.00 equiv) in 12 mL of CH2Cl2 
was added DMAP (60 mg, 0.45 mmol, 0.20 equiv) and allyl alcohol (0.20 mL, 2.9 mmol, 1.2 
equiv). The solution was cooled to 0 °C and EDCI (0.56 g, 2.9 mmol, 1.2 equiv) was added. 
The reaction mixture was stirred and allowed to warm to RT over 4 h.  
Water (12 ml) was then added and the aqueous phase extracted with CH2Cl2 (3 × 10 mL), 
the combined organic phases were washed with brine, dried over magnesium sulfate, 
filtered and concentrated under vacuum. The crude material was purified by column 
chromatography (75:25 PE/Et2O) to give compound 3.40 as a thick clear oil (720 mg, 66%). 
IR (K, cm-1): 3440, 2966, 1725, 1514, 1463, 1375, 1322. 
1H NMR (400 MHz, CDCl3) J ppm: 7.69 (d, J = 7.5 Hz, 2H, H14), 7.56–7.50 (m, 2H, H11), 
7.33 (t, J = 7.5 Hz, 2H, H13), 7.24 (t, J = 7.5 Hz, 2H, H14), 5.83 (ddt, J = 16.3, 10.7, 5.7 Hz, 
1H, H2), 5.74 (d, J = 8.3 Hz, 1H, H6), 5.26 (dd, J = 17.2, 1.5 Hz, 1H, H1trans), 5.18 (dd, J = 
10.4, 1.2 Hz, 1H, H1cis), 4.67–4.50 (m, 3H, H3&5), 4.35 (dd, J = 10.5, 7.2 Hz, 1H, H8a), 4.27 
(dd, J = 10.5, 7.2 Hz, 1H, H8b), 4.18 (t, J = 7.2 Hz, 1H, H9), 2.90 (dd, J = 16.9, 4.7 Hz, 1H, 
H16a), 2.71 (dd, J = 16.9, 4.6 Hz, 1H, H16b), 1.38 (s, 9H, H19). 
13C NMR (126 MHz, CDCl3) J ppm: 170.6 (C4 or 17), 170.0 (C4 or 17), 156.0 (C7), 143.9 (ArC), 
141.3 (ArC), 131.5 (C2), 127.7 (ArCH), 127.1 (ArCH), 125.2 (ArCH), 120.0 (ArCH), 118.8 
(C1), 81.9 (C18), 67.3 (C8), 66.3 (C3), 50.6 (C5), 47.1 (C9), 37.8 (C16), 28.1 (C19). 
[]D25 -12.5 (c = 1.0, CHCl3), literature []D25 -19.0 (c = 1.0, CHCl3). 
In agreement with literature data. [130] 
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1-Allyl 4-(tert-butyl)-L-aspartate[130] 
 
3.37 
Formula: C11H19NO4 
Molecular Weight: 229.28 
To a solution of piperidine (2 mL) in DMF (8 mL) was added dropwise Fmoc-Asp(OtBu)-
Oallyl 3.40 (1.00 g, 2.21 mmol, 1.0 equiv) in 2 mL of DMF. The reaction mixture was stirred 
for 5 min. Brine (10 ml) was then added and the aqueous phase extracted with CH2Cl2 (3 × 
10 mL), the combined organic phases were washed with saturated aqueous LiCl (10 mL), 
dried over magnesium sulfate, filtered and concentrated under vacuum. The crude material 
was purified by column chromatography (75:25 PE/Et2O) to give compound 3.37 as a yellow 
oil (205 mg, 41%). 
1H NMR (400 MHz, CDCl3) J ppm: 5.98–5.85 (m, 1H, H2), 5.33 (dd, J = 17.0, 1.1 Hz, 1H, 
H1trans), 5.26 (dd, J = 10.5, 1.0 Hz, 1H, H1cis), 4.64 (d, J = 5.8 Hz, 2H, H3), 3.78 (dd, J = 6.8, 
4.9 Hz, 1H, H5), 2.74 (dd, J = 16.4, 4.9 Hz, 1H, H6a), 2.66 (dd, J = 16.4, 6.8 Hz, 1H, H6b), 
1.75 (s, 2H, NH), 1.45 (s, 9H, H9). 
13C NMR (101 MHz, CDCl3) J ppm: 174.1 (C7), 170.3 (C4), 131.8 (C2), 118.6 (C1), 81.2 (C8), 
65.8 (C3), 51.4 (C5), 40.1 (C6), 28.1 (C9). 
HRMS (ESI) – for C11H17NNaO4: 226.1050, found: 226.1045. 
[]D25 +87.1 (c = 1.0, CHCl3), literature []D25 not specified. 
In agreement with literature data.[130]

 
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Methyl N2-(tert-Butoxycarbonyl)-Nw-tosyl-L-arginylglycinate 
 
3.45 
Formula: C21H33N5O7S 
Molecular Weight: 499.58 
To a solution of Boc-Arg(Tos)-OH (1.00 g, 2.33 mmol, 1.00 equiv) in 12 mL of THF was 
added H-Gly-OMe.HCl (300 mg, 2.33 mmol, 1.00 equiv) and BOP (1.14 g, 2.57 mmol, 1.1 
equiv). The solution was stirred while DIPEA (1.0 ml, 5.8 mmol, 2.5 equiv) was added 
dropwise. The reaction mixture was stirred for 18 h at RT.  
The reaction mixture was concentrated under vacuum, then redissolved in EtOAc (20 mL). 
The organic phase was washed with saturated aqueous NH4Cl, a saturated aqueous 
solution of sodium bicarbonate then brine, dried over sodium sulfate, filtered and 
concentrated under vacuum. The crude material was purified by column chromatography 
(96:4 CH2Cl2/MeOH) to give compound 3.45 as a white foam (720 mg, 92%). 
IR (K, cm-1): 3330, 3010, 2490, 1741, 1655, 822. 
1H NMR (400 MHz, CDCl3) J ppm: 7.78 (d, J = 7.0 Hz, 2H, H14), 7.42 (br s, 1H, NH), 7.26 
(d, J = 7.0 Hz, 2H, H15), 6.41 (br s, 1H, NH), 5.55 (br s, 1H, NH), 4.31 (br s, 1H, NH), 4.10 
(dd, J = 17.2, 5.9 Hz, 1H, H3a), 3.95 (dd, J = 17.2, 5.6 Hz, 1H, H3b), 3.73 (s, 3H, H1), 3.44-
3.34 (m, 2H, NH and H6), 3.29-3.21 (m, 2H, H9), 2.42 (s, 3H, H17), 1.89-1.85 (m, 1H, H7a), 
1.66-1.58 (m, 3H, H7b and H8), 1.44 (s, 9H, H21). 
13C NMR (126 MHz, CDCl3) J ppm: 177.7 (C2), 172.9 (C5), 157.0 (C11 or C19), 156.0 (C11 or 
C19), 142.1 (ArC), 140.6 (ArC), 129.3 (C14), 126.0 (C15), 77.2 (C20), 53.5 (C6), 52.3 (C1), 41.1 
(C3 or C9), 41.0 (C3 or C9), 30.3 (C7), 28.3 (C21), 25.16 (C8), 21.4 (C17). 
M/S (ESI) – for C21H33N5O7SNa: 522.1993, found: 522.1999. 
[]D25 -11.6 (c = 1.0, CHCl3). 
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Methyl N2-(tert-Butoxycarbonyl)-Nw-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-
yl)sulfonyl)-L-arginylglycinate 

3.49 
Formula: C27H43N5O8S 
Molecular Weight: 597.73 
To a solution of Boc-Arg(Pbf)-OH (2.00 g, 3.80 mmol, 1.00 equiv) in 20 mL of THF was 
added H-Gly-OMe.HCl (520 mg, 4.18 mmol, 1.10 equiv) and BOP (1.85 g, 4.18 mmol, 1.1 
equiv). The solution was stirred while DIPEA (1.3 ml, 7.60 mmol, 2.5 equiv) was added 
dropwise. The reaction mixture was stirred for 18 h at RT.  
The reaction mixture was concentrated under vacuum, then redissolved in EtOAc (50 mL). 
The organic phase was washed with a saturated aqueous solution of NH4Cl, then sodium 
bicarbonate and brine, dried over sodium sulfate, filtered and concentrated under vacuum. 
The crude material was purified by column chromatography (97.5:2.5 CH2Cl2/MeOH) to give 
compound 3.49 as a white foam (1.50 g, 66%). 
IR (K, cm-1): 3317, 2978, 2360, 2152, 2021, 1967, 1534, 1175, 748. 
1H NMR (400 MHz, CDCl3) J ppm: 7.48 (s, 1H, NH), 6.25 (s, 1H, NH), 6.07 (s, 1H, NH), 
5.63 – 5.45 (m, 1H, NH), 4.28 (s, 1H, NH), 4.09 (dd, J = 17.9, 5.6 Hz, 1H, H3a), 3.93 (dd, J 
= 17.9, 5.3 Hz, 1H, H3b), 3.73 (s, 3H, H1), 3.32-3.25 (m, 3H, H6 and H16), 2.99-2.91 (m, 2H, 
H9), 2.58 (s, 3H, H21 or H23 or H24), 2.51 (s, 3H, H21 or H23 or H24), 2.10 (s, 3H, H21 or H23 or 
H24), 1.97–1.83 (m, 1H, H7a), 1.67–1.61 (m, 3H, H7b and H8), 1.47 (s, 6H, H22), 1.42 (s, 9H, 
H28). 
13C NMR (126 MHz, CDCl3) J ppm: 172.9 (C2), 170.7 (C5), 158.8 (C11 or C18 or C26), 156.4 
(C11 or C18 or C26), 155.7 (C11 or C18 or C26), 138.4 (ArC), 132.3 (ArC), 125.7 (ArC), 124.7 
(ArC), 117.5 (ArC), 86.4 (C17), 77.2 (C27), 53.5 (C6), 52.3 (C1), 43.3 (C9), 41.1 (C3), 40.5 
(C16), 30.6 (C7), 28.6 (C22 or C28), 28.4 (C22 or C28), 25.1 (C8), 19.3 (C21 or C23 or C24), 17.9 
(C21 or C23 or C24), 12.5 (C21 or C23 or C24). 
HRMS (ESI) – for C27H43N5NaO8S: 620.2725, found: 620.2698. 
[]D25 +9.5 (c = 1.0, CHCl3). 
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N2-(tert-Butoxycarbonyl)-Nw-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)-
L-arginylglycine 

3.50 
Formula: C26H41N5O8S 
Molecular Weight: 583.70 
To a stirring solution of Boc-Arg(Pbf)-Gly-OMe 3.49 (1.50 g, 2.51 mmol, 1.00 equiv) in 10 
mL of mwthanol was added at 0 °C, 1 N NaOH in methanol (12 mL, 12 mmol, 3.1 equiv). 
The solution was stirred and allowed to warm to RT over 4 h. 
10 mL of water was then added and the methanol was removed under vacuum. The reaction 
mixture then acidified with 1 N aqueous HCl to pH 2. The aqueous phase was extracted 
with CH2Cl2 (3 × 10 mL), the organic phases were dried over magnesium sulfate, filtered 
and concentrated under vacuum. The crude material was purified by precipitation column 
chromatography (95:5 CH2Cl2/MeOH) to give compound 3.50 as a white foam (1.10 g, 
75%). 
IR (K, cm-1): 3287, 2970, 1681, 1543, 1365, 1250, 1175, 1103. 
1H NMR (500 MHz, DMSO-d6) J 12.84 (br s, 1H, H1), 7.88 (t, J = 5.6 Hz, 1H, H4), 6.97 (s, 
1H, H10), 6.91 (d, J = 8.3 Hz, 1H, H25), 6.51 (s, 2H, NH), 3.92 (td, J = 8.3, 4.8 Hz, 1H, H6), 
3.69 (dd, J = 17.4, 5.6 Hz, 1H, H3a), 3.62 (dd, J = 17.4, 5.4 Hz, 1H, H3b), 3.04–2.99 (m, 2H, 
H9), 2.97 (s, 2H, H16), 2.51 (s, 3H, H21 or H23 or H24), 2.49 (s, 3H, H21 or H23 or H24), 2.43 (s, 
3H, H21 or H23 or H24), 1.68–1.56 (m, 1H, H7a), 1.49 – 1.30 (m, 18H, H7b & H8 & H22 & H28). 
13C NMR (126 MHz, DMSO-d6) J ppm: 172.4 (C5), 172.0 (C2), 157.9 (C11 or C18 or C26), 
156.6 (C11 or C18 or C26), 155.7 (C11 or C18 or C26), 137.7 (ArC), 134.6 (ArC), 131.9 (ArC), 
124.8 (ArC), 116.7 (ArC), 86.7 (C17), 78.5 (C17), 54.3 (C6), 42.9 (C9), 42.0 (C3), 40.6 (C16), 
29.8 (C7), 28.8 (C22 or C28), 28.7 (C22 or C28), 25.9 (C8), 19.4 (C21 or C23 or C24), 18.1 (C21 or 
C23 or C24), 12.7 (C21 or C23 or C24). 
HRMS (CI) – for C26H40N5O8S: 582.2603, found: 582.2597. 
[]D25 +52.5 (c = 1.0, CHCl3). 
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4-(tert-Butyl) 1-(hex-5-en-1-yl) (((9H-fluoren-9-yl)methoxy)carbonyl)-L-aspartate 
 
3.46 
Formula: C29H35NO6 
Molecular Weight: 493.60 
To a solution of Fmoc-Asp(OtBu)-OH (5.71 g, 13.9 mmol, 1.00 equiv) in 50 mL of CH2Cl2 
was added DMAP (340 mg, 2.78 mmol, 0.20 equiv) and 5-hexen-1-ol (2.00 mL, 16.7 mmol, 
1.20 equiv). The solution was cooled to 0 °C and EDCI (4.00 g, 20.9 mmol, 1.50 equiv) was 
added. The reaction mixture was stirred and allowed to warm to RT over 18 h.  
Water (100 ml) was then added and the aqueous phase extracted with CH2Cl2 (3 × 50 mL), 
the combined organic phases were washed with brine, dried over magnesium sulfate, 
filtered and concentrated under vacuum. The crude material was purified by column 
chromatography (80:20 PE/Et2O) to give compound 3.46 as a thick clear oil (6.28 g, 92%). 
IR (K, cm-1): 3460, 2812, 1731, 1719, 1693, 1462, 1375, 1319, 877. 
1H NMR (400 MHz, CDCl3) J 7.77 (d, J = 7.5 Hz, 2H, H17), 7.61 (t, J = 7.5 Hz, 2H, H14), 7.41 
(t, J = 7.5 Hz, 2H, H16), 7.32 (t, J = 7.5 Hz, 2H, H15), 5.85–5.70 (m, 1H, H2), 5.01 (d, J = 17.1 
Hz, 1H, H1trans), 4.96 (d, J = 10.0 Hz, 1H, H1cis), 4.60 (dt, J = 9.0, 4.4 Hz, 1H, H5’), 4.43 (dd, 
J = 10.9, 6.9 Hz, 1H, H11a), 4.35 (dd, J = 10.9, 6.9 Hz, 1H, H11b), 4.26 (t, J = 6.9 Hz, 1H, 
H12), 4.23-4.11 (m, 2H, H6), 2.96 (dd, J = 16.9, 4.7 Hz, 1H, H6a’), 2.79 (dd, J = 16.9, 4.5 Hz, 
1H, H6b’), 2.12-2.08 (m, 2H, H3), 1.72-64 (m, 4H, H4 and H5), 1.42 (m, 9H, H9). 
13C NMR (101 MHz, CDCl3) J ppm: 170.9 (C4’ or 7), 170.0 (C4’ or 7), 156.0 (C10), 143.7 (C13 or 
C18), 141.3 (C13 or C18), 138.1 (C2), 127.7 (C16), 127.1 (C15), 125.1 (C14), 120.0 (C17), 115.0 
(C1), 81.8 (C8), 67.3 (C11), 65.7 (C6), 50.6 (C5’), 47.1 (C12), 37.8 (C6’), 33.2 (C3), 28.1 (C4 or 
C5), 27.9 (C4 or C5), 25.1 (C9).  
HRMS (ESI) – for C29H35NNaO6: 516.2357, found: 516.2341. 
[]D25 -28.4 (c = 1.0, CHCl3). 
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4-(tert-Butyl) 1-(hex-5-en-1-yl)-L-aspartate 

3.47 
Formula: C14H25NO4 
Molecular Weight: 271.36 
To a solution of piperidine (10 mL) in DMF (15 mL) was added dropwise Fmoc-Asp(OtBu)-
O-hexyl 3.46 (4.00 g, 8.10 mmol, 1.0 equiv) in 15 mL of DMF. The reaction mixture was 
stirred for 5 min. Brine (50 ml) was then added and the aqueous phase extracted with 
CH2Cl2 (3 × 10 mL), the combined organic phases were washed with saturated aqueous 
LiCl (10 mL), dried over magnesium sulfate, filtered and concentrated under vacuum. The 
crude material was purified by column chromatography (95:5 CH2Cl2/MeOH) to give 
compound 3.47 as a yellow oil (2.00 g, 91%). 
IR (K, cm-1): 3356, 2978, 2361, 1745, 1505, 1450, 1149.  
1H NMR (400 MHz, Chloroform-d) J 5.81 (ddt, J = 17.1, 10.2, 6.7 Hz, 1H, H2), 5.04 (d, J = 
17.1 Hz, 1H, H1trans), 4.99 (d, J = 10.2 Hz, 1H, H1cis), 4.18-4.14 (m, 2H, H6), 3.76 (t, J = 6.3 
Hz, 1H, H8), 2.74 (dd, J = 16.2, 6.3 Hz, 1H, H9a), 2.66 (dd, J = 16.2, 6.3 Hz, 1H, H9b), 2.13-
2.07 (m, 2H, H3), 1.84–1.62 (m, 4H, H4 or H5 and NH2), 1.54–1.40 (m, 11H, H4 or H5 and 
H12). 
13C NMR (101 MHz, CDCl3) J ppm: 174.5 (C7 or C10), 170.4 (C7 or C10), 138.2 (C2), 114.9 
(C1), 81.2 (C11), 65.1 (C6), 51.4 (C8), 40.1 (C9), 33.2 (C3), 28.1 (C4 or C5), 28.0 (C4 or C5), 
25.1 (C12). 
HRMS (CI) – for C14H26NO4: 272.1856, found: 272.1879. 
[]D25 -44.8 (c = 1.0, CHCl3). 
 

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4-(tert-Butyl) 1-(hex-5-en-1-yl) N2-(tert-butoxycarbonyl)-Nw-((2,2,4,6,7-pentamethyl-2,3-
dihydrobenzofuran-5-yl)sulfonyl)-L-arginylglycyl-L-aspartate 
 
3.44 
Formula: C40H64N6O11S 
Molecular Weight: 837.04 
To a solution of Boc-Arg(Pbf)-Gly-OH 3.50 (1.10 g, 1.88 mmol, 1.00 equiv) in 20 mL of THF 
was added H-Asp(OtBu)O-hex  3.47 (610 mg, 2.26 mmol, 1.20 equiv) and BOP (1.00 g, 
2.26 mmol, 1.2 equiv). The solution was stirred while DIPEA (0.82 mL, 4.7 mmol, 2.5 equiv) 
was added dropwise. The reaction mixture was stirred for 18 h at RT.  
The reaction mixture was concentrated under vacuum, then redissolved in EtOAc (50 mL). 
The organic phase was washed with a saturated aqueous solution of NH4Cl, then saturated 
aqueous sodium bicarbonate then brine, dried over sodium sulfate, filtered and 
concentrated under vacuum. The crude material was purified by column chromatography 
(98:2 CH2Cl2/MeOH) to give compound 3.44 as a white foam (1.57 mg, 75%). 
IR (K, cm-1): 3321, 3108, 2970, 2363, 1748, 1680, 1505, 1452, 1365, 1232, 1182, 1155.  
1H NMR (400 MHz, Chloroform-d) J 7.48 (s, 1H, H4’), 7.17 (d, J = 8.1 Hz, 1H, H1’), 6.27 (s, 
2H, NH), 6.13 (s, 1H, NH), 5.78 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H, H2), 5.57 (d, J = 8.0 Hz, 
1H, NH), 5.02 (dd, J = 17.1, 1.9 Hz, 1H, H1trans), 4.98 (dd, J = 10.2, 2.0 Hz, 1H, H1cis), 4.79 
(dt, J = 8.1, 4.9 Hz, 1H, H8), 4.29-4.24 (m, 1H, H6’), 4.19–4.08 (m, 2H, H6), 4.05 (dd, J = 
16.7, 5.7 Hz, 1H, H3a’), 3.96 (dd, J = 16.7, 5.7 Hz, 1H, H3b’), 3.28 (s, 2H, H16’), 2.99-2.95 
(m, 2H, H9’), 2.90 (dd, J = 17.0, 4.9 Hz, 1H, H9a), 2.76 (dd, J = 17.0, 4.9 Hz, 1H, H9b), 2.60 
(s, 3H, H21’ or H23’ or H24’), 2.53 (s, 3H, H21’ or H23’ or H24’), 2.11 (s, 3H, H21’ or H23’ or H24’), 
2.10-2.06 (m, 2H, H3), 1.92 (d, J = 7.1 Hz, 1H, H7’a), 1.73–1.55 (m, 7H, H7’b & H8’ & H4 & 
H5), 1.48 (s, 6H, H22), 1.45-1.40 (m, 18H, H12 & H28’). 
13C NMR (101 MHz, CDCl3) J ppm: 170.8 (C7 or C10 or C2’ or C5’), 170.0 (C7 or C10 or C2’ or 
C5’), 169.2 (C7 or C10 or C2’ or C5’), 169.1 (C7 or C10 or C2’ or C5’), 158.7 (C11’ or C18’ or C26’), 
156.4 (C11’ or C18’ or C26’), 155.9 (C11’ or C18’ or C26’), 138.4 (ArC), 138.1 (C2), 132.9 (ArC), 
132.3 (ArC), 124.6 (ArC), 117.5 (ArC), 115.0 (C1), 86.3 (C17’), 81.9 (C11), 77.2 (C27’), 65.9 
(C6), 53.7 (C6’), 48.9 (C8), 43.3 (C9’), 42.9 (C3’), 40.4 (C16’), 37.3 (C9), 33.2 (C3), 30.2 (C7’), 
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28.6 (C22’ or C28’), 28.4 (C22’ or C28’), 28.0 (C4 or C5), 27.9 (C4 or C5), 25.1 (C8’), 25.0 (C12), 
19.3 (C21’ or C23’ or C24’), 17.9 (C21’ or C23’ or C24’), 12.5 (C21’ or C23’ or C24’).  
HRMS (ESI) – for C40H64N6NaO11S: 859.4246, found: 859.4209. 
[]D25 -93.2 (c = 1.0, CHCl3). 
 
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RGD-hexenyl-dimer 

3.51 
Formula: C78H124N12O22S2 
Molecular Weight: 1646.03 
To a solution of RGD-hexenyl 3.44 (500 mg, 0.57 mmol, 1.0 equiv) in 3.0 mL of CH2Cl2 was 
added Hoveyda-Grubbs’ second-generation catalyst (19 mg, 0.030 mmol, 0.050 equiv) and 
the mixture was stirred at reflux for 16 h. The reaction mixture was quenched with dimethyl 
sulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 min. The reaction mixture was then 
concentrated under vacuum and the product purified by column chromatography, (98:2 
CH2Cl2/MeOH) to give compound 3.51 as a white foam (350 mg, 75%) in an E:Z ratio of 
3:1. 
IR (K, cm-1): 3330, 3112, 2970, 2363, 1748, 1628, 1505, 1452, 1367, 1232, 1182, 989. 
1H NMR (400 MHz, Chloroform-d) J 7.50 (br s, 2H, H4’), 7.42-7.31 (m, 2H, H1’), 6.33-6.23 
(m, 4H, NH), 6.16 (br s, 2H, NH), 5.75-5.70 (m, 2H, H2), 5.39-5.32 (m, 2H, NH), 4.89-4.74 
(m, 2H, H8), 4.26-4.21 (m, 2H, H6’), 4.19–4.08 (m, 4H, H6), 4.02-3.94 (m, 4H, H3), 3.26 (br 
s, 4H, H16’), 2.99-2.92 (m, 4H, H9’), 2.90 (d, J = 17.0 Hz, 2H, H9a), 2.74 (dd, J = 17.0 Hz, 
2H, H9b), 2.58 (s, 6H, H21’ or H23’ or H24’), 2.51 (s, 6H, H21’ or H23’ or H24’), 2.09 (s, 6H, H21’ 
or H23’ or H24’), 2.06-1.96 (m, 4H, H3), 1.96-1.85 (m, 2H, H7’a), 1.76–1.53 (m, 14H, H7’b & 
H8’ & H4 & H5), 1.46 (s, 12H, H22), 1.45-1.38 (m, 36H, H12 & H28’). 
 
13C NMR (101 MHz, CDCl3) J ppm: 171.8 (C7 or C10 or C2’ or C5’), 170.8 (C7 or C10 or C2’ or 
C5’), 170.0 (C7 or C10 or C2’ or C5’), 169.1 (C7 or C10 or C2’ or C5’), 158.7 (C11’ or C18’ or C26’), 
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156.4 (C11’ or C18’ or C26’), 154.7 (C11’ or C18’ or C26’), 138.4 (ArC), 132.9 (ArC), 132.3 
(ArC), 130.1 (C2), 124.4 (ArC), 117.4 (ArC), 86.3 (C17’), 81.9 (C11), 77.2 (C27’), 65.9 (C6), 
53.7 (C6’), 48.9 (C8), 43.3 (C9’), 42.9 (C3’), 40.4 (C16’), 37.3 (C9), 32.9 (C3), 30.2 (C7’), 28.6 
(C22’ or C28’), 28.4 (C22’ or C28’), 28.0 (C4 or C5), 27.9 (C4 or C5), 25.1 (C8’), 25.0 (C12), 19.3 
(C21’ or C23’ or C24’), 17.9 (C21’ or C23’ or C24’), 12.5 (C21’ or C23’ or C24’).  
HRMS (ESI) – for C78H124N12NaO22S2: 1667.8292, found: 1667.8281. 
[]D25 +8.5 (c = 1.0, CHCl3). 
 
 
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1-Allyl 4-(tert-Butyl) N2-(tert-butoxycarbonyl)-Nw-tosyl-L-arginylglycyl-L-aspartate 
 
3.35 
Formula: C31H48N6O10S 
Molecular Weight: 696.82 
To a solution of Boc-Arg(Tos)-Gly-OH 3.36 (1.06 g, 2.18 mmol, 1.00 equiv) in 12.5 mL of 
THF was added H-Asp(OtBu)O-allyl  3.37 (500 mg, 2.18 mmol, 1.20 equiv) and BOP (1.10 
g, 2.50 mmol, 1.1 equiv). The solution was stirred while DIPEA (1.00 mL, 5.34 mmol, 2.5 
equiv) was added dropwise. The reaction mixture was stirred for 18 h at RT.  
The reaction mixture was concentrated under vacuum, then redissolved in EtOAc (50 mL). 
The organic phase was washed with a saturated aqueous solution of NH4Cl, then saturated 
aqueous sodium bicarbonate then brine, dried over sodium sulfate, filtered and 
concentrated under vacuum. The crude material was purified by column chromatography 
(98:2 CH2Cl2/MeOH) to give compound 3.44 as a white foam (1.20 mg, 79%). 
IR (K, cm-1): 3335, 3010, 2966, 2491, 1749, 1671,1239, 1181, 822. 
1H NMR (400 MHz, Chloroform-d) J 7.78 (d, J = 8.2 Hz, 2H, H14’), 7.31 (br s, 2H, NH), 7.24 
(d, J = 8.2 Hz, 2H, H15’), 7.13 (br s, 1H, H1’), 6.35 (br s, 2H, NH), 5.86 (ddt, J = 17.1, 10.5, 
5.8 Hz, 1H, H2), 5.45 (d, J = 7.8 Hz, 1H, NH), 5.31 (d, J = 17.1 Hz, 1H, H1trans), 5.24 (d, J = 
10.5 Hz, 1H, H1cis), 4.81 (dt, J = 7.8, 4.6 Hz, 1H, H5), 4.65 (dd, J = 12.8, 6.0 Hz, 1H, H3a), 
4.59 (dd, J = 12.8, 6.0 Hz, 1H, H3b), 4.27 (s, 1H, H6’), 4.05 (dd, J = 16.6, 5.5 Hz, 1H, H3a’), 
3.92 (dd, J = 16.6, 5.5 Hz, 1H, H3b’), 3.39-3.18 (m, 2H, H9’), 2.92 (dd, J = 16.7, 4.5 Hz, 1H, 
H6a), 2.75 (dd, J = 16.7, 4.5 Hz, 1H, H6b), 2.40 (s, 3H, H17’), 1.94-1.80 (m, 1H, H7’a), 1.73–
1.53 (m, 3H, H7’b and H8’), 1.44-1.41 (m, 18H, H9 and H21’). 
13C NMR (101 MHz, CDCl3) J ppm: 170.4 (C4 or C7 or C2’ or C5’), 170.1 (C4 or C7 or C2’ or 
C5’), 169.0 (C4 or C7 or C2’ or C5’), 166.54 (C4 or C7 or C2’ or C5’), 158.5 (C11’ or C19’), 158.5 
(C11’ or C19’), 141.9 (C13’), 140.8 (C16’), 131.3 (C2), 129.2 (C14’), 126.0 (C15’), 119.0 (C1), 81.1 
(C8), 77.2 (C20’), 65.9 (C3), 53.6 (C6’), 48.9 (C5), 44.7 (C9’), 42.9 (C3’), 37.2 (C6), 30.0 (C7’), 
28.4 (C21’), 28.0 (C9), 25.0 (C8’), 21.4 (C17’). 
HRMS (ESI) – for C31H48N6NaO10S: 719.3045, found: 719.3013 
[]D25 +73.1 (c = 1.0, CHCl3). 
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RGD-allyl-dimer 
 
 
3.34 
Formula: C60H92N12O20S2 
Molecular Weight: 1365.58 
To a solution of RGD-allyl 3.35 (600 mg, 0.86 mmol, 1.0 equiv) in 4.3 mL of CH2Cl2 was 
added Hoveyda-Grubbs’ second-generation catalyst (27 mg, 0.043 mmol, 0.050 equiv) and 
the mixture was stirred at reflux for 16 h. The reaction mixture was quenched with dimethyl 
sulfoxide (0.1 mL, 1.4 mmol) and stirred for 5 min. The reaction mixture was then 
concentrated under vacuum and the product purified by column chromatography, (97:3 
CH2Cl2/MeOH) to give compound 3.34 as a white foam (401 mg, 68%) in an E:Z ratio of 
10:1 
IR (K, cm-1): 3335, 3019, 2966, 2491, 1749, 1666, 1239, 1180, 898. 
1H NMR (400 MHz, Chloroform-d) J 7.72 (d, J = 8.1 Hz, 4H, H14’), 7.53 (br s, 4H, NH), 7.21 
(d, J = 8.1 Hz, 4H, H15’), 6.50 (br s, 4H, NH), 6.36 (br s, 2H, H1’), 5.79 (br s, 2H, NH), 5.77-
5.69 (m, 2H, H2), 4.81 (d, J = 8.6 Hz, 2H, H5), 4.59 (d, J = 13.8 Hz, 2H, H3a), 4.52 (d, J = 
13.8 Hz, 2H, H3b), 4.18 (s, 2H, H6’), 3.94 (br s, 4H, H3’), 3.37-3.05 (m, 4H, H9’), 2.86-2.68 
(m, 4H, H6), 2.37 (s, 6H, H17’), 1.90-1.75 (m, 2H, H7’a), 1.65–1.50 (m, 6H, H7’b and H8’), 1.47-
1.30 (m, 36H, H9 and H21’). 
 
13C NMR (101 MHz, CDCl3) J ppm: 173.4 (C4 or C7 or C2’ or C5’), 170.4 (C4 or C7 or C2’ or 
C5’), 169.9 (C4 or C7 or C2’ or C5’), 169.7 (C4 or C7 or C2’ or C5’), 157.1 (C11’ or C19’), 156.0 (C11’ 
or C19’), 142.0 (C13’), 140.7 (C16’), 129.2 (C14’), 127.3 (C2), 126.0 (C15’), 81.8 (C8), 79.9 (C20’), 
64.7 (C3), 54.1 (C6’), 49.0 (C5), 43.0 (C9’), 40.1 (C3’), 37.1 (C6), 29.5 (C7’), 28.4 (C21’), 28.0 
(C9), 25.3 (C8’), 21.4 (C17’). 
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HRMS (ESI) – for C60H92N12NaO20S2: 1387.5884, found: 1387.5817. 
[]D25 +13.7 (c = 1.0, CHCl3). 
 
 

 
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Polyether:-tert-Butyl-7-hydroxy-poly[4-(tert-butyl) 1-((E)-6-methyl-7-(oxiran-2-
ylmethoxy)hept-5-en-1-yl) N2-(tert-butoxycarbonyl)-Nw-((2,2,4,6,7-pentamethyl-2,3-
dihydrobenzofuran-5-yl)sulfonyl)-L-arginylglycyl-L-aspartate]-co-[2-({3-methylbut-3-en-1-
yl-oxy}methyl)oxirane] 
 
PMAGE-graft-hexenyl-RGD-Boc 
Formula: C4H9O(C45H72N6O13S)x(C7H12O2)y 
To a solution of PMAGE (50 mg, 0.39 mmol, 1.0 equiv) in 1.0 mL of CH2Cl2 was added 
RGD-hexenyl 3.44 (327 mg, 0.39 mmol, 1.00 equiv), Hoveyda-Grubbs’ second-generation 
catalyst (12.2 mg, 0.020 mmol, 0.05 equiv) and the mixture was stirred at reflux for 18 h. 
The reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred 
for 5 min. The reaction mixture was then concentrated under vacuum and the product 
purified by size exclusion chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PMAGE-
graft-hexenyl-RGD-Boc as a brown oil (125 mg, 85%) with an E:Z ratio of 3:1. 
IR (K, cm-1): 3330, 3108, 2970, 2363, 1749, 1649, 1505, 1452, 1367, 1232, 1182, 991. 
1H NMR (500 MHz, CDCl3) J ppm: Initiator, 1.17 (s, 9H, CH3). Section x, 7.70 (br s, 1H, 
H4’’), 7.36 (br s, 1H, H1’’), 6.32 (br s, 2H, NH), 6.24-6.11 (m, 2H, NH), 5.72 (br s, 1H, H2’), 
5.39-5.32 (m, 1H, NH), 4.82 (br s, 1H, H8’), 4.23 (s, 1H, H6’’), 4.16–4.03 (m, 2H, H6’), 4.01-
3.92 (m, 2H, H3’), 3.82 (br s, 2H, H5), 3.76-3.33 (m, 5H, H2-4), 3.26 (br s, 2H, H16’’), 2.95 (br 
s, 2H, H9’’), 2.85 (d, J = 16.2 Hz, 1H, H9’a), 2.74 (d, J = 16.2 Hz, 1H, H9’b), 2.57 (s, 3H, H21’’ 
or H23’’ or H24’’), 2.50 (s, 3H, H21’’ or H23’’ or H24’’), 2.08 (s, 3H, H21’’ or H23’’ or H24’’), 2.05-1.99 
(m, 2H, H3’), 1.95-1.81 (m, 1H, H7’’a), 1.76–1.52 (m, 7H, H7’’b & H8’’ & H4’ & H5’), 1.46 (s, 6H, 
H22’), 1.44-1.39 (m, 18H, H12’ and H28’’). Section y, 4.93 (s, 1H, H7’’’a), 4.85 (s, 1H, H7’’’b), 
3.90–3.84 (m, 2H, H5’’’), 3.76–3.33 (m, 5H, H2’’’-4’’’), 1.71 (s, 3H, H8’’’). Overall Ratio (x;y) = 
31:69 (Average Mw per unit = 380.12 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Section x, 173.0 (C7’ or C10’ or C2’’ or C5’’), 170.9 (C7’ or 
C10’ or C2’’ or C5’’), 169.8 (C7’ or C10’ or C2’’ or C5’’), 169.3 (C7’ or C10’ or C2’’ or C5’’), 158.7 (C11’’ 
or C18’’ or C26’’), 156.5 (C11’’ or C18’’ or C26’’), 155.9 (C11’’ or C18’’ or C26’’), 138.4 (C6), 138.3 
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(ArC), 133.0 (ArC), 132.3 (ArC), 130.4 (C2’), 124.6 (ArC), 117.4 (ArC), 86.3 (C17’’), 81.7 
(C11’), 79.9* (C3), 78.8* (C3), 77.2 (C27’’), 75.2 (C2 or C4), 70.2 (C2 or C4), 69.8 (C5), 65.8 (C6’), 
53.9 (C6’’), 48.9 (C8’), 43.3 (C9’’), 43.0 (C3’’), 40.4 (C16’’), 37.4 (C9’), 32.9 (C3’), 31.8 (C7’’), 28.6 
(C22’’ or C28’’), 28.4 (C22’’ or C28’’), 28.0 (C4’ or C5’), 27.2 (C4’ or C5’), 25.7 (C8’’), 25.3 (C12’), 19.4 
(C21’’ or C23’’ or C24’’), 18.0 (C21’’ or C23’’ or C24’’), 13.9 (C7), 12.5 (C21’’ or C23’’ or C24’’). Section 
y, 142.2 (C6’’’), 111.9 (C7’’’), 79.9* (C3’’’), 78.8* (C3’’’), 75.2 (C2’’’ or C4’’’), 70.2 (C2’’’ or C4’’’), 70.0 
(C5’’’), 14.0 (C8’’’).  
GPC: Mn = 19576, Mw = 21725,  = 1.10 
 
 
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Polyether:-tert-Butyl-7-hydroxy-poly[4-(tert-butyl) 1-((E)-6-methyl-7-(oxiran-2-
ylmethoxy)hept-5-en-1-yl) L-arginylglycyl-L-aspartate]-co-[2-({3-methylbut-3-en-1-yl-
oxy}methyl)oxirane] 
 
PMAGE-graft-hexenyl-RGD 
Formula: C4H9O(C27H48N6O8)x(C7H12O2)y 
To a solution of PMAGE-graft-hexene-RGD-Boc (44 mg, 0.047 mmol, 1.0 equiv) in 2.0 mL 
of CH2Cl2 was added triisopropylsilane (0.1 mL, 0.5 mmol, 10 equiv) and TFA (1.0 mL, 13 
mmol, 275 equiv) the mixture was stirred for 2 h at RT. The reaction mixture was then 
concentrated under vacuum and the product purified by SEC chromatography, LH-20 (1:1 
CH2Cl2/MeOH) to give PMAGE-graft-hexenyl-RGD as a brown oil (17 mg, 60%) with an 
E:Z ratio of 3:1. 
IR (K, cm-1): 3297, 2970, 2363, 1749, 1649, 1457, 1367, 1232, 1184. 
1H NMR (500 MHz, CDCl3) J ppm: Initiator, 1.17 (s, 9H, CH3). Section x, 5.43 (t, J = 5.9 
Hz 1H, H2’), 5.37** (t, J = 5.9 Hz 1H, H2’), 4.65 (br s, 1H, H8’), 4.18–4.05 (m, 3H, H6’ and 
H6’’), 4.03-3.95 (m, 2H, H3’’), 3.88 (br s, 2H, H5), 3.80-3.38 (m, 5H, H2-4), 3.26-3.18 (m, 2H, 
H9’’), 2.86 (d, J = 16.6 Hz, 1H, H9’a), 2.54 (d, J = 16.6 Hz, 1H, H9’b), 2.13-2.04 (m, 2H, H3’), 
1.91-1.80 (m, 1H, H7’’a), 1.65 (s, 3H, H7), 1.58-1.51 (m, 1H, H7’’b), 1.49-1.31 (m, 6H, H4’ and 
H5’ and H8’’), 1.20 (s, 9H, H12’). Section y, 4.98 (s, 1H, H7’’’a), 4.89 (s, 1H, H7’’’b), 3.92 (br s, 
2H, H5’’’), 3.80-3.38 (m, 5H, H2’’’-4’’’), 1.74 (s, 3H, H8’’’). Overall Ratio (x;y) = 30:70 (Average 
Mw per unit = 264.8 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Section x, 172.6 (C7’ or C10’ or C2’’ or C5’’), 170.0 (C7’ or 
C10’ or C2’’ or C5’’), 169.1 (C7’ or C10’ or C2’’ or C5’’), 160.0 (C7’ or C10’ or C2’’ or C5’’), 158.0 (C11’’), 
134.0 (C6), 130.3 (C2’), 128.9** (C2’), 81.2 (C11’), 80.2* (C3), 79.5* (C3), 76.3 (C2 or C4), 71.3 
(C2 or C4), 69.9 (C5), 66.3 (C6’), 58.6 (C6’’), 50.8 (C8’), 40.9 (C9’’), 40.1 (C3’’), 37.4 (C9’), 32.9 
(C3’), 31.8 (C7’’), 28.3 (C4’ or C5’), 27.2 (C4’ or C5’), 27.0 (C8’’), 20.0 (C12’), 14.0 (C7) Section 
y, 143.7 (C6’’’), 112.7 (C7’’’), 80.2* (C3’’’), 79.5* (C3’’’), 76.3 (C2’’’ or C4’’’), 71.3 (C2’’’ or C4’’’), 70.0 
(C5’’’), 14.4 (C8’’’).  
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**Z isomer 
GPC: Mn = 18790, Mw = 20796,  = 1.11. 
 

 
201 
 
Polyether:-tert-Butyl-7-hydroxy-poly[4-(tert-butyl) 1-((E)-3-methyl-4-(oxiran-2-
ylmethoxy)but-2-en-1-yl) N2-(tert-butoxycarbonyl)-Nw-tosyl-L-arginylglycyl-L-aspartate]-co-
[2-({3-methylbut-3-en-1-yl-oxy}methyl)oxirane]
 
PMAGE-graft-ally-RGD-Boc 
Formula: C4H9O(C36H58N6O12S)x(C7H12O2)y 
To a solution of PMAGE (50 mg, 0.39 mmol, 1.0 equiv) in 1.0 mL of CH2Cl2 was added 
RGD-allyl 3.34 (272 mg, 0.39 mmol, 1.00 equiv), Hoveyda-Grubbs’ second-generation 
catalyst (12.2 mg, 0.020 mmol, 0.05 equiv) and the mixture was stirred at reflux for 18 h. 
The reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 mmol) and stirred 
for 5 min. The reaction mixture was then concentrated under vacuum and the product 
purified by size exclusion chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PMAGE-
graft-ally-RGD-Boc as a brown oil (47 mg, 75%) with an E:Z ratio of 3:1. 
IR (K, cm-1): 2907, 2864, 1651, 1087, 921. 
1H NMR (500 MHz, CDCl3) J ppm: Initiator, 1.17 (s, 9H, CH3). Section x, mostly 
unobservable, except; 7.82-7.78 (m, 2H, H14’’), 7.26-7.22 (m, 2H, H13’’), 5.35-5.30 (m, 1H, 
H2), 3.77-3.36 (m, 5H, H2-4), 3.22-3.18 (br s, 2H, H6’), 2.89-2.85 (m, 1H, H9’’a), 2.82-2.79 (m, 
1H, H9’’b), 1.49-1.39 (m, 18H, H9’ and H28’’). Section y, 4.93 (s, 1H, H7’’’a), 4.85 (s, 1H, H7’’’b), 
3.89 (br s, 2H, H5’’’), 3.77-3.36 (m, 5H, H2’’’-4’’’), 1.73 (s, 3H, H8’’’). Overall Ratio (x;y) = 5:95 
(Average Mw per unit = 161.40 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm: Section x, mostly unobservable except polymer 
backbone; 79.0* (C3), 78.8* (C3), 75.2 (C2 or C4), 70.2 (C2 or C4), 70.0 (C5), Section y, 142.2 
(C6’’’), 111.9 (C7’’’), 79.0* (C3’’’), 78.8* (C3’’’), 75.2 (C2’’’ or C4’’’), 70.2 (C2’’’ or C4’’’), 70.0 (C5’’’), 
19.4 (C8’’’).  
*diastereomers 
GPC: Mn = 10823, Mw = 12540,  = 1.16. 
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Polyether:-tert-Butyl-7-hydroxy-poly[2-({allyloxy}methyl)oxirane]-co-[2-({2-
Methallyloxy}methyl)oxirane] 
 
PAGE-co-PMAGE 
Formula: C4H9O(C6H10O2)m(C7H12O2)n 
To a 1 M solution of potassium tert-butoxide in THF (0.18 mL, 0.175 mmol, 1.0 equiv) was 
added a degassed mixture of allyl glycidyl ether (2.00 g, 17.5 mmol, 100 equiv) and 
methallyl glycidyl ether (2.25 g, 17.5 mmol, 100 equiv) at 2 mL/hour for 4 h. The reaction 
mixture was stirred at 45 °C for 20 h. The reaction mixture was quenched with methanol 
(0.10 mL, 2.4 mmol) and stirred for 1 h. Residual monomers were distilled off to afford 
PAGE-co-PMAGE (4.20 g, 99% brsm) as a yellow oil.  
IR (K, cm-1): 2910, 2864, 1654, 1089, 920, 889. 
1H NMR (400 MHz, CDCl3) J ppm: Initiator, 1.18 (s, 9H, CH3), Section m, 5.89 (ddt, J = 
17.3, 10.8, 5.5 Hz, 1H, H6), 5.27 (dd, J = 17.3, 1.5 Hz, 1H, H7trans), 5.17 (dd, J = 10.8, 1.5 
Hz, 1H, H7cis), 3.99 (d, J = 5.5 Hz, 2H, H5), 3.75–3.32 (m, 5H, H2-4). Section n, 4.95 (s, 1H, 
H7’a), 4.87 (s, 1H, H7’b), 3.88 (s, 2H, H5’), 3.75–3.32 (m, 5H, H2’-4’), 1.72 (s, 3H, H8’). 
13C NMR (101 MHz, CDCl3) J ppm: Section m, 134.9 (C6), 116.7 (C7), 78.9 (C3), 72.3 (C5), 
72.2, 70.2, 69.9 (C2 & C4). Section n, 142.2 (C6’), 111.9 (C7’), 78.9 (C3’), 75.2 (C5’), 72.2, 
70.2, 69.9 (C2’ & C4’), 19.4 (C8’). 
GPC: Mn = 12505, Mw = 16665,  = 1.33. 
 
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Polyether:-tert-Butyl-7-hydroxy-poly[2-({3-Methylbut-2-en-1-yl-oxy}methyl)oxirane]-co-[2-
({2-Methallyloxy}methyl)oxirane] 
 
PPGE-co-PMAGE 
Formula: C4H9O(C8H14O2)m(C7H12O2)n 
To a 1 M solution of potassium tert-butoxide in THF (0.12 mL, 0.11 mmol, 1.0 equiv) was 
added a degassed mixture of prenyl glycidyl ether (1.50 g, 10.6 mmol, 100 equiv) and 
methyl allyl glycidyl ether (1.35 g, 10.6 mmol, 100 equiv) at 1 mL/hour for 3 h. The reaction 
mixture was stirred at 45 °C for 20 h. The reaction mixture was quenched with methanol 
(0.10 mL, 2.4 mmol) and stirred for 1 h. Residual monomers were distilled off to afford 
PPGE-co-PMAGE (2.80 g, 95% brsm) as a yellow oil.  
IR (K, cm-1): 2910, 2865, 1670, 1099, 899 
1H NMR (400 MHz, CDCl3) J ppm: Initiator, 1.19 (s, 9H, CH3), Section x, 5.34 (t, J = 6.7 
Hz, 1H, H6), 3.98 (d, J = 6.7 Hz, 2H, H5), 3.67–3.39 (m, 5H, H2-4), 1.72 (s, 3H, H8 or 9), 1.67 
(s, 3H, H8 or 9). Section y, 4.96 (s, 1H, H7’a), 4.88 (s, 1H, H7’b), 3.88 (s, 2H, H5’), 3.67–3.39 
(m, 5H, H2’-4’), 1.75 (s, 3H, H8’).  
13C NMR (101 MHz, CDCl3) J ppm: Section x: 136.3 (C7), 121.5 (C6), 78.8 (C3), 70.1, 69.8, 
67.8 (C2 & C4), 25.8 (C7 or C8), 18.1 (C7 or C8). Section y: 142.3 (C6’), 111.9 (C7’), 78.8 (C3’), 
75.2 (C5’), 70.1, 69.8, 67.8 (C2’ & C4’), 19.4 (C8’). 
GPC: Mn = 12480, Mw = 13870,  = 1.18 
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Polyether:-tert-Butyl-7-hydroxy-poly[methyl 4-(oxiran-2-ylmethoxy)but-2-enoate]-co-[2-
({allyl oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-ene]-co-[2-({2-
Methallyloxy}methyl)oxirane] 
 
PAGE-co-PMAGE-graft-MA 
Formula: C4H9O(C8H12O4)x(C6H10O2)y(C10H16O4)z(C7H12O2)a 
To a solution of PAGE-co-PMAGE (54:46) (53 mg, 0.44 mmol, 1.0 equiv) in 1.1 mL of 
CH2Cl2 was added methyl acrylate (0.16 mL, 1.8 mmol, 4.0 equiv), Hoveyda-Grubbs’ 
second-generation catalyst (14 mg, 0.02 mmol, 0.05 equiv) and the mixture was stirred at 
reflux for 18 h. The reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 
mmol) and stirred for 5 min. The reaction mixture directly purified by size exclusion 
chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PAGE-co-PMAGE-graft-MA as a 
brown oil (51 mg, 90%). 
IR (K, cm-1): 2875, 1722, 1668, 1255, 1066, 880. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.19 (s, 9H, CH3). Section x, 6.93 (dt, J = 
15.8, 4.1 Hz, 1H, H6), 6.07 (d, J = 15.7 Hz, 1H, H7), 4.16 (br s, 2H, H5), 3.97–3.31 (m, 8H, 
H2-4 & 9). Section y, 5.77 (br s, 1H, H6’), 5.59-5.42 (m, 2H, H7’), 4.05–3.95 (m, 2H, H5’), 3.97–
3.31 (m, 5H, H2’-4’) Section z, 5.95–5.91 (m, 1H, H6’’), 4.05–3.95 (m, 2H, H5’’), 3.97–3.31 (m, 
5H, H2’’-4’’). Section a, 4.94 (s, 1H, H7a’’’), 4.87 (s, 1H, H7b’’’), 3.88 (s, 2H, H5’’’), 3.97–3.31 (m, 
5H, H2’’’-4’’’), 1.71 (s, 3H, H8’’’). Overall Ratio (x;y;z:a) = 18:12:18:52 (Average Mw per unit 
= 129.30 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm:  Initiator, not observed. Section x, 166.9 (C8), 144.9 
(C6), 120.8 (C7), 79.4* (C3), 78.9* (C3), 70.4, 72.9, 69.9, 69.4 (C2 & C4 & C5), 51.5 (C9). 
Section y, 128.2 (C6’), 116.7 (C7’), 79.4* (C3’), 78.9* (C3’), 70.4, 72.9, 69.9, 69.4 (C2’ & C4’ & 
C5’). Section z, 128.5 (C6’’), 79.4* (C3’’), 78.9* (C3’’), 70.4, 72.9, 69.9, 69.4 (C2’ & C4’ & 
C5’).Section a, 142.2 (H6’’’), 111.9 (H7’’’), 79.4* (C3’’’), 78.9* (C3’’’), 72.9, 70.4, 72.9, 69.9, 69.4 
(C2’ & C4’ and C5’), 19.5 (H8’’’). 
205 
 
GPC: Mn = 13270, Mw = 23223,  = 1.75. 
 
Polyether:-tert-Butyl-7-hydroxy-poly[methyl-4-(oxiran-2-ylmethoxy)but-2-enoate]-co-[2-
({allyloxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-ene]-co-[2-({2-
Methallyloxy}methyl)oxirane]-co-[(E)-3-methyl-4-(oxiran-2-ylmethoxy)but-2-en-1-yl 
acetate]-co-[(E)-4-(oxiran-2-ylmethoxy)but-2-en-1-yl-acetate]-co-[2-
({allyloxy}methyl)oxirane] 
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PAGE-co-PMAGE-graft-MA-graft-AA 
Formula: C4H9O(C8H12O4)x(C6H10O2)y(C10H16O4)z(C7H12O2)a(C10H16O4)b(C9H14O4)c 
To a solution of PAGE-co-PMAGE-graft-MA (51 mg, 0.21 mmol, 1.0 equiv, w.r.t PMAGE) 
in 1.1 mL of CH2Cl2 was added allyl acetate 2.3 (140 mg, 0.84 mmol, 4.0 equiv), Hoveyda-
Grubbs’ second-generation catalyst (6.3 mg, 0.01 mmol, 0.05 equiv) and the mixture was 
stirred at reflux for 18 h. The reaction mixture was quenched with dimethyl sulfoxide (0.1 
mL, 1.4 mmol) and stirred for 5 min. The reaction mixture directly purified by size exclusion 
chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PAGE-co-PMAGE-graft-MA-graft-
AA as a brown oil (52 mg, 80%). 
IR (K, cm-1): 2873, 1722, 1666, 1254, 1066, 910. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.19 (s, 9H, CH3). Section x, 6.92 (dt, J = 
15.7, 4.3 Hz, 1H, H6), 6.06 (d, J = 15.8 Hz, 1H, H7), 4.18-4.12 (m, 2H, H5), 3.80–3.32 (m, 
8H, H2-4 & 9). Section y, 5.87–5.69 (m, 1H, H6’), 5.24 (d, J = 17.1 Hz, 1H, H7’a), ), 5.14 (d, J 
= 10.2 Hz, 1H, H7’b), 4.01–3.95 (m, 2H, H5’), 3.80–3.32 (m, 5H, H2’-4’) Section z, 5.87–5.69 
(m, 1H, H6’’), 4.01–3.95 (m, 2H, H5’’), 3.80–3.32 (m, 5H, H2’’-4’’). Section a, 4.93 (s, 1H, H7a’’’), 
4.85 (s, 1H, H7b’’’), 3.86 (s, 2H, H5’’’), 3.80–3.32 (m, 5H, H2’’’-4’’’), 1.70 (s, 3H, H8’’’). Section b, 
5.68–5.50 (m, 1H, H27), 4.61 (d, J = 6.7 Hz, 2H, H29), 4.01–3.95 (m, 2H, H25), 3.80–3.32 (m, 
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5H, H22-24), 2.04 (s, 3H, H28), 1.70 (s, 3H, H31). Section c, 5.87–5.69 (m, 2H, H46 & H47), 4.54 
(d, J = 4.6 Hz, 2H, H48), 4.01–3.95 (m, 2H, H45), 3.80–3.32 (m, 5H, H42-44), 2.04 (s, 3H, H50). 
Overall Ratio (x;y;z:a:[b+c]) = 19:4:10:51:15 (Average Mw per unit = 161.10 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm:  Initiator, not observed. Section x, 166.6 (C8), 144.8 
(C6), 120.8 (C7), 79.9* (C3), 78.8* (C3), 78.6* (C3), 72.2, 71.0, 70.1, 69.9, 69.4, 66.9 (C2 & 
C4 & C5), 51.5 (C9). Section y, 129.2 (C6’ or C6’’), 128.0 (C6’ or C6’’), 118.9 (C7’), 79.9* (C3’), 
78.8* (C3’), 78.6* (C3’), 72.2, 71.0, 70.1, 69.9, 69.4, 66.9 (C2’ & C4’ & C5’). Section z, 129.2 
(C6’ or C6’’), 128.0 (C6’ or C6’’), 79.9* (C3’’), 78.8* (C3’’), 78.6* (C3’’), 72.2, 71.0, 70.1, 69.9, 
69.4, 66.9 (C2’’ & C4’’ & C5’’). Section a, 142.2 (H6’’’), 111.9 (H7’’’), 79.9* (C3’’’), 78.8* (C3’’’), 
78.6* (C3’’’), 72.2, 71.0, 70.1, 69.9, 69.4, 66.9 (C2’’’ & C4’’’ & C5’’’), 19.5 (H8’’’).  Section b, 
170.6 (C30), 142.2 (C26), 120.6 (C27), 79.9* (C23), 78.8* (C23), 78.6* (C23), 75.8 (C25), 72.2, 
71.0, 70.1, 69.9, 69.4, 66.9 (C22 & C24 & C25), 60.2 (C29), 20.9 (C31), 19.4 (C28). Section c, 
170.6 (C49), 131.1 (C46), 126.2 (C47), 79.9* (C43), 78.8* (C43), 78.6* (C43), 72.2, 71.0, 70.1, 
69.9, 69.4, 66.9 (C42 & C44 & C45), 64.3 (C48), 20.9 (C50). 
GPC: Mn = 14891, Mw = 22845,  = 1.53. 
 
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Polyether:-tert-Butyl-7-hydroxy-poly[methyl 4-(oxiran-2-ylmethoxy)but-2-enoate]-co-[2-
({3-Methylbut-2-en-1-yl-oxy}methyl)oxirane]-co-[1,4-bis(oxiran-2-ylmethoxy)but-2-ene]-co-
[2-({2-Methallyloxy}methyl)oxirane] 

 
PPGE-co-PMAGE-graft-MA 
Formula: C4H9O(C8H12O4)x(C8H14O2)y(C10H16O4)z(C7H12O2)a 
To a solution of PPGE-co-PMAGE (50:50) (60 mg, 0.44 mmol, 1.0 equiv) in 1.1 mL of 
CH2Cl2 was added methyl acrylate (0.16 mL, 1.8 mmol, 4.0 equiv), Hoveyda-Grubbs’ 
second-generation catalyst (14 mg, 0.02 mmol, 0.05 equiv) and the mixture was stirred at 
reflux for 18 h. The reaction mixture was quenched with dimethyl sulfoxide (0.1 mL, 1.4 
mmol) and stirred for 5 min. The reaction mixture directly purified by size exclusion 
chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing the product PPGE-co-PMAGE-graft-
MA as a brown oil (52 mg, 85%). 
IR (K, cm-1): 2942, 1737, 1737, 1228, 1026. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.19 (s, 9H, CH3). Section x, 6.92 (dt, J = 
15.8, 4.5 Hz, 1H, H6), 6.05 (d, J = 15.8 Hz, 1H, H7), 4.18-4.14 (m, 2H, H5), 3.99–3.41 (m, 
8H, H2-4 & 9). Section y, 5.35-5.29 (m, 1H, H6’), 4.05–3.95 (m, 2H, H5’), 3.99–3.41 (m, 5H, 
H2’-4’), 1.75 (s, 3H, H8’ or H9’), 1.67 (s, 3H, H8’ or H9’). Section z, 5.35-5.29 (m, 1H, H6’’), 
4.05–3.95 (m, 2H, H5’’), 3.99–3.41 (m, 5H, H2’’-4’’). Section a, 4.93 (s, 1H, H7a’’’), 4.85 (s, 1H, 
H7b’’’), 3.88 (s, 2H, H5’’’), 3.99–3.41 (m, 5H, H2’’’-4’’’), 1.71 (s, 3H, H8’’’). Overall Ratio (x;y;z:a) 
= 18:12:18:52 (Average Mw per unit = 139.90 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm:  Initiator, not observed. Section x, 166.6 (C8), 144.7 
(C6), 120.6 (C7), 78.9* (C3), 78.8* (C3), 77.7, 75.2, 72.9, 70.2, 70.0, 69.4 (C2 & C4 & C5), 
51.5 (C9). Section y, 137.3 (C7’), 121.8 (C6’), 78.9* (C3’), 78.8* (C3’), 77.7, 75.2, 72.9, 70.2, 
70.0, 69.4 (C2’ & C4’ & C5’), 25.8 (C8’ or C9’), 15.7 (C8’ or C9’). Section z, 128.5 (C6’’), 78.9* 
208 
 
(C3’’), 78.8* (C3’’), 77.7, 75.2, 72.9, 70.2, 70.0, 69.4 (C2’’ & C4’’ & C5’’). Section a, 142.2 (H6’’’), 
111.9 (H7’’’), 78.9* (C3’’’), 78.8* (C3’’’), 77.7, 75.2, 72.9, 70.2, 70.0, 69.4 (C2’’’ & C4’’’ & C5’’’), 
19.4 (H8’’’). 
GPC: Mn = 23749, Mw = 44716,  = 1.88. 
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Polyether:-tert-Butyl-7-hydroxy-poly[methyl 4-(oxiran-2-ylmethoxy)but-2-enoate]-co-[2-
({allyloxy}methyl)oxirane]-co-[2-({3-Methylbut-2-en-1-yl-oxy}methyl)oxirane]-co-[2-({2-
Methallyloxy}methyl)oxirane]-co-[(E)-3-methyl-4-(oxiran-2-ylmethoxy)but-2-en-1-yl 
acetate]-co-[(E)-4-(oxiran-2-ylmethoxy)but-2-en-1-yl acetate]-co-[2-({allyl 
oxy}methyl)oxirane] 
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PPGE-co-PMAGE-graft-MA-graft-AA 
Formula: C4H9O(C8H12O4)x(C8H14O2)y(C10H16O4)z(C7H12O2)a(C10H16O4)b(C9H14O4)c 
To a solution of PPGE-co-PMAGE-graft-MA (52 mg, 0.19 mmol, 1.0 equiv, w.r.t. PMAGE) 
in 1.1 mL of CH2Cl2 was added allyl acetate 2.3 (130 mg, 0.76 mmol, 4.0 equiv), Hoveyda-
Grubbs’ second-generation catalyst (6 mg, 0.01 mmol, 0.05 equiv) and the mixture was 
stirred at reflux for 18 h. The reaction mixture was quenched with dimethyl sulfoxide (0.1 
mL, 1.4 mmol) and stirred for 5 min. The reaction mixture directly purified by size exclusion 
chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PPGE-co-PMAGE-graft-MA-graft-
AA as a brown oil (51 mg, 90%). 
IR (K, cm-1): 3365, 2881, 1720, 1666, 1255, 1066, 921. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.19 (s, 9H, CH3). Section x, 6.92 (d, J = 15.8 
Hz, 1H, H6), 6.06 (d, J = 15.8 Hz, 1H, H7), 4.18-4.11 (m, 2H, H5), 3.77–3.36 (m, 8H, H2-4 & 
9). Section y, 5.23–5.21 (m, 1H, H6’) 4.04–3.95 (m, 2H, H5’), 3.77–3.36 (m, 5H, H2’-4’), 1.74 
(s, 3H, H8’ or H9’), 1.66 (s, 3H, H8’ or H9’). Section z, 5.88–5.71 (m, 1H, H6’’), 4.04–3.95 (m, 
2H, H5’’), 3.77–3.36 (m, 5H, H2’’-4’’). Section a, 4.93 (s, 1H, H7a’’’), 4.85 (s, 1H, H7b’’’), 3.86 (s, 
2H, H5’’’), 3.77–3.36 (m, 5H, H2’’’-4’’’), 1.70 (s, 3H, H8’’’). Section b, 5.56 (t, J = 7.1 Hz, 1H, 
H27), 4.61 (d, J = 6.7 Hz, 2H, H29), 4.18-4.11 (m, 2H, H25), 3.77–3.36 (m, 5H, H22-24), 2.09-
1.99 (m, 3H, H28), 1.70 (s, 3H, H31). Section c, 5.88–5.71 (m, 2H, H46 & H47), 4.54 (d, J = 
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4.5 Hz, 2H, H48), 4.18-4.11 (m, 2H, H45), 3.77–3.36 (m, 5H, H42-44), 2.09-1.99 (m, 3H, H50). 
Overall Ratio (x;y;z:a:[b+c]) = 24:3:3:44:26 (Average Mw per unit = 163.06 g.mol-1). 
13C NMR (126 MHz, CDCl3) J ppm:  Initiator, not observed. Section x, 166.6 (C8), 144.8 
(C6), 120.6 (C7), 78.9* (C3), 78.8* (C3), 78.7* (C3), 76.1, 72.2, 71.0, 70.2, 69.9, 69.4, 66.9 
(C2 & C4 & C5), 51.5 (C9). Section y, 137.2 (C7’), 121.2 (C6’), 78.9* (C3’), 78.8* (C3’), 78.7* 
(C3’), 76.1, 72.2, 71.0, 70.2, 69.9, 69.4, 66.9 (C2’ & C4’ & C5’), 25.8 (C8’ or C9’), 14.0 (C8’ or 
C9’).Section z, 126.2 (C6’ or C6’’), 78.9* (C3’’), 78.8* (C3’’), 78.6* (C3’’), 76.1, 72.2, 71.0, 70.2, 
69.9, 69.4, 66.9 (C2’’ & C4’’ & C5’’). Section a, 142.2 (H6’’’), 111.9 (H7’’’), 78.9* (C3’’’), 78.8* 
(C3’’’), 78.6* (C3’’’), 76.1, 72.2, 71.0, 70.2, 69.9, 69.4, 66.9 (C2’’’ & C4’’’ & C5’’’), 19.4 (H8’’’).  
Section b, 170.9 (C30 or C49), 170.6 (C30), 142.2 (C26), 120.6 (C27), 78.9* (C23), 78.8* (C23), 
78.6* (C23), 76.1, 72.2, 71.0, 70.2, 69.9, 69.4, 66.9 (C22 & C24 & C25), 60.3 (C29), 20.9 (C31), 
19.4 (C28). Section c, 170.9 (C30 or C49), 170.6 (C49), 131.1 (C46), 126.2 (C47), 78.9* (C43), 
78.8* (C43), 78.6* (C43), 76.1, 72.2, 71.0, 70.2, 69.9, 69.4, 66.9 (C42 & C44 & C45), 64.3 (C48), 
20.9 (C50). 
GPC: Mn = 22453, Mw = 38213,  = 1.70. 
 
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Polyether:-tert-Butyl-7-hydroxy-poly[butyl 3-((3-(oxiran-2-
ylmethoxy)propyl)thio)propanoate] 

PAGE-graft-BMP 
Formula: C4H9O(C13H24O4S)x 
To a solution of PAGE (50 mg, 0.44 mmol, 1.0 equiv) in 1.0 mL of toluene was added butyl 
3-mercaptopropionate (350 µL, 2.2 mmol, 5.0 equiv) and AIBN (36 mg, 0.22 mmol, 0.5 
equiv). The reaction mixture was degassed via three freeze-pump-thaw cycles and heated 
at 80 °C for 18 h. The reaction mixture was quenched with methanol (1.0 mL, 24 mmol) and 
stirred for 5 min. The reaction mixture was directly purified by size exclusion 
chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PAGE-graft-BMP as a clear oil (118 
mg, 97%).  
IR (K, cm-1): 2992, 1740, 1121, 1083, 955 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.19 (s, 9H, CH3). Section x, 4.09 (t, J = 6.7 
Hz, 2H, H10), 3.66–3.32 (m, 7H, H1-4), 2.76 (t, J = 7.4 Hz, 2H, H8), 2.61-2.56 (m, 4H, H6&7), 
1.87–1.78 (m, 2H, H5), 1.65–1.56 (m, 2H, H11), 1.44–1.32 (m, 2H, H12), 0.93 (t, J = 7.4 Hz, 
3H, H13). 
13C NMR (126 MHz, CDCl3) J ppm: Section x, 171.9 (C9), 78.6* (C2), 77.2* (C2), 71.0, 70.9, 
70.0 (C1 & C3 & C4), 64.5 (C10), 39.6 (C8), 35.2 (C6 or C7), 34.9 (C6 or C7), 30.6 (C11), 29.6 
(C5), 19.1 (C12), 13.7 (C13). 
GPC: Mn = 15377, Mw = 17683,  = 1.15 
 
 
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Polyether:-tert-Butyl-7-hydroxy-poly[butyl 3-((3-(oxiran-2-
ylmethoxy)propyl)thio)propanoate] 

PMAGE-graft-BMP 
Formula: C4H9O(C14H26O4S)x 
To a solution of PMAGE (56 mg, 0.44 mmol, 1.0 equiv) in 1.0 mL of toluene was added 
butyl 3-mercaptopropionate (350 µL, 2.2 mmol, 5.0 equiv) and AIBN (36 mg, 0.22 mmol, 
0.5 equiv). The reaction mixture was degassed via three freeze-pump-thaw cycles and 
heated at 80 °C for 18 h. The reaction mixture was quenched with methanol (1.0 mL, 24 
mmol) and stirred for 5 min. The reaction mixture was directly purified by size exclusion 
chromatography, LH-20 (1:1 MeOH/CH2Cl2) furnishing PMAGE-graft-BMP as a clear oil 
(120 mg, 95%).  
IR (K, cm-1): 3010, 1745, 1196, 1110, 920. 
1H NMR (500 MHz, CDCl3) J ppm:  Initiator, 1.19 (s, 9H, CH3). Section x, 4.10 (t, J = 6.7 
Hz, 2H, H10), 3.71–3.23 (m, 7H, H1-4), 2.76 (t, J = 7.4 Hz, 2H, H8), 2.64-2.57 (m, 4H, H6&7), 
2.42–2.38 (m, 1H, H5), 1.69–1.58 (m, 2H, H11), 1.44–1.34 (m, 2H, H12), 1.01 (d, J = 7.0 Hz, 
3H, H14), 0.94 (t, J = 7.4 Hz, 3H, H13). 
13C NMR (126 MHz, CDCl3) J ppm: Section x, 171.9 (C9), 78.6 (C2), 71.3, 70.1, 69.8 (C1 & 
C3 & C4), 64.9 (C10), 36.3 (C8), 35.1 (C6 or C7), 34.9 (C6 or C7), 34.0 (C5), 30.6 (C11), 19.1 
(C12), 16.8 (C14), 13.7 (C13). 
GPC: Mn = 23560, Mw = 26622,  = 1.13 

 
 
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Polyether:-tert-Butyl-7-hydroxy-poly[2-({proan-3-ol}methyl)oxirane] 

PMAGE-OH 
Formula: C4H9O(C7H14O3)x 
To a solution of PMAGE (100 mg, 0.78 mmol, 1.0 equiv) in 3.0 mL of THF was added 
BH3.DMS (65 mg, 0.86 mmol, 1.1 equiv) dropwise at 0 °C and the mixture was stirred for 2 
h. To the reaction mixture was added aqueous 3 N aqueous NaOH (1.13 mL, 3.38 mmmol, 
4.5 equiv) and aqueous 30% w/w H2O2 (240 µL, 2.34 mmol, 3.0 equiv), and the reaction 
mixture was left to stir at RT for 1 h. THF was removed under vacuum and the crude mixture 
purified using size exclusion chromatography, LH-20 (MeOH) furnishing PMAGE-OH as a 
clear oil (76 mg, 67%).  
IR (K, cm-1): 3330, 3022, 2906, 2865, 1090. 
1H NMR (400 MHz, Methanol-d4) J ppm:  Initiator, 1.16 (s, 9H, CH3). Section x, 3.93–3.04 
(m, 9H, H2-5&7), 2.04–1.64 (m, 1H, H6), 0.95-0.90 (m, 3H, H8).  
13C NMR (101 MHz, Methanol-d4) J ppm: Initiator, not observed. Section x, 78.7* (C3), 
78.1* (C3), 73.8, 70.9, 69.9, 69.7, 64.3 (C2 & C4 & C5 & C7), 36.1 (C6), 13.2 (C8). 
 
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Polyether:-tert-Butyl-7-hydroxy-poly[oxiran-2-ylmethanol]-co-[2-({2-Methallyl 
oxy}methyl)oxirane] 


PG-co-PMAGE 
Formula: C4H9O(C3H6O2)x(C7H12O2)y 
To a solution of PAGE-co-MAGE (1:1) (200 mg, 0.82 mmol, 1.0 equiv) in 1.2 mL of MeOH 
was added 1,3-dimethylbarbituric acid (258 mg, 1.65 mmol, 2.00 equiv) and Pd(PPh3)4 (48 
mg, 0.04 mmol, 0.05 equiv) and the mixture was stirred for at RT for 18 h. The crude mixture 
was purified using size exclusion chromatography, LH-20 (MeOH/CH2Cl2 2:1) furnishing 
PG-co-PMAGE as a yellow oil (160 mg, 97%).  
IR (K, cm-1): 3350, 2910, 2890, 1660, 1081, 866. 
1H NMR (400 MHz, CDCl3) J ppm:  Initiator, 1.19 (s, 9H, CH3). Section a, 3.72–3.42 (m, 
5H, H2-4), 2.15 (br s, 1H, OH). Section b, 4.95 (s, 1H, H7’a), 4.89 (s, 1H, H7’b), 3.89 (s, 2H, 
H5’), 3.82–3.35 (m, 5H, H2’-4’), 1.72 (s, 3H, H8’). 
13C NMR (101 MHz, CDCl3) J ppm: Initiator, not observed. Section a, 79.8* (C3), 78.8* 
(C3), 70.2, 69.9 (C2 & C4), Section b, 141.9 (H6’), 112.3 (H7’), 79.8* (C3’), 78.8* (C3’), 75.3 
(C5’), 70.2, 69.9 (C2 & C4), 19.4 (H8’). 
GPC: Mn = 8260, Mw = 10420,  = 1.26 
 
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Polyether:-tert-Butyl-7-hydroxy-poly[2-hydroxy-3-methyl-4-(oxiran-2-ylmethoxy)butyl 
acetate]-co-[2-({propan-3-ol}methyl)oxirane] 

PMAGE-graft-AA-graft-OH 
Formula: C4H9O(C10H18O5)x(C7H14O3)y 
To a solution of PMAGE-graft-AA (30 mg, 0.20 mmol, 1.0 equiv) in 2.0 mL of THF was 
added BH3.DMS (20 µL, 0.22 mmol, 1.1 equiv) dropwise at 0 °C and the mixture was stirred 
for 2 h. To the reaction mixture was added 3 N aqueous NaOH (0.30 mL, 0.90 mmmol, 4.5 
equiv) and aqueous 30% w/w H2O2 (0.1 mL, 0.60 mmol, 3.0 equiv), and the reaction mixture 
was left to stir at RT for 2 h. THF was removed under vacuum and crude mixture purified 
using size exclusion chromatography, LH-20 (MeOH) furnishing PMAGE-graft-AA-graft-OH 
as a clear oil (34 mg, 85%).  
IR (K, cm-1): 3260, 2906, 2877, 2865, 1736, 1091. 
1H NMR (400 MHz, Methanol-d4) J ppm:  Initiator, 1.16 (s, 9H, CH3). Section x, 4.20-4.14 
(m, 1H, H7), 3.98-3.91 (m, 2H, H9), 3.88–3.14 (m, 7H, H2-5), 2.01–1.85 (m, 1H, H6), 1.22 (s, 
3H, H11), 1.00-0.94 (m, 3H, H8). Section y, 3.88–3.14 (m, 9H, H2’-5’ and H7’), 2.01–1.85 (m, 
1H, H6’), 1.00-0.94 (m, 3H, H8’). Overall Ratio (x:y) = 30:70 (Average Mw per unit = 167.60 
g.mol-1). 
13C NMR (101 MHz, Methanol-d4) J ppm: Initiator, not observed. Section x, 175.3 (H10), 
78.9* (C3), 78.8* (C3), 73.8, 70.9, 71.0, 69.9, 64.3 (C2 & C4 & C5 & C9), 57.8 (C7), 36.1 (C6), 
20.1 (C11), 12.9 (C8). Section y, 78.9* (C3’), 78.8* (C3’), 73.8, 70.9, 71.0, 69.9, 64.3 (C2’ & 
C4’ & C5’ & C9’), 36.1 (C6’), 13.2 (C8’). 
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Polyether:-tert-Butyl-7-hydroxy-poly[2-methyl-3-(oxiran-2-ylmethoxy)propane-1,2-diol] 

PMAGE-graft-(OH)2 
Formula: C4H9O(C7H14O4)x 
To a solution of PMAGE (56 mg, 0.44 mmol, 1.0 equiv) in 8.0 mL of water:t-BuOH (1:1 v/v) 
was added AD-mix-9 (940 mg) at 0 °C and the mixture was stirred for 2 h. To the reaction 
mixture was added methanesulfonamide (42 mg, 0.44 mmmol, 1.0 equiv) and the reaction 
mixture was left to stir at RT for 0.5 h. Solvent was removed under vacuum and crude 
mixture purified using size exclusion chromatography, LH-20 (MeOH) furnishing PMAGE-
graft-(OH)2 as a clear oil (50 mg, 70%).  
IR (K, cm-1): 3300, 2912, 2877, 2865, 1005. 
1H NMR (400 MHz, Methanol-d4) J ppm:  Initiator, not observable Section x, 3.87 – 3.25 
(m, 10H, H2-4 and H5 and H7 and OH), 1.18 (s, 3H, H8). 
13C NMR (101 MHz, Methanol-d4) J ppm: Initiator, not observed. Section x, 78.7* (C3), 
78.6* (C3), 75.7 (C2 or C4 or C5 or C7), 72.2 (C6), 71.3, 69.8, 69.5 (C2 & C4 & C5 & C7), 20.7 
(C8). 
 
 
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Polyether:-tert-Butyl-7-hydroxy-poly[2,3-dihydroxy-3-methyl-4-(oxiran-2-ylmethoxy)butyl 
acetate]-co-[2-methyl-3-(oxiran-2-ylmethoxy)propane-1,2-diol] 

PMAGE-graft-AA-graft-(OH)2 
Formula: C4H9O(C10H18O6)x(C7H14O4)y 
To a solution of PMAGE-graft-AA (50 mg, 0.33 mmol, 1.0 equiv) in 6.0 mL of water:t-BuOH 
(1:1 v/v) was added AD-mix-9 (705 mg) at 0 °C and the mixture was stirred for 2 h. To the 
reaction mixture was added methanesulfonamide (32 mg, 0.44 mmmol, 1.0 equiv) and the 
reaction mixture was left to stir at RT for 0.5 h. Solvent was removed under vacuum and 
crude mixture purified using size exclusion chromatography, LH-20 (MeOH) furnishing 
PMAGE-graft-AA-graft-(OH)2 as a clear oil (42 mg, 70%).  
IR (K, cm-1): 3300, 2904, 2877, 2899, 1782, 1013. 
1H NMR (400 MHz, Methanol-d4) J ppm:  Initiator, not observable Section x, 3.74 – 3.17 
(m, 12H, H2-4 & H5 & H7 & H9 & 2OH), 1.32 (s, 3H, H11), 1.09 (s, 3H, H8). Section y, 3.74 – 
3.17 (m, 10H, H2’-4’ and H5’-7’), 1.05 (s, 3H, H8). Overall Ratio (x;y) = 30:70 (Average Mw 
per unit = 182.20 g.mol-1). 
13C NMR (101 MHz, Methanol-d4) J ppm: Initiator, not observed. Section x, 78.7* (C3), 
78.6* (C3), 75.7 (C2’ or C4’ or C5’ or C9’), 72.2 (C6), 71.3, 69.8, 69.6, 66.5 (C2’ & C4’ & C5’& 
C9’), 20.9 (C11), 20.7 (C8). Section y, 78.7* (C3’), 78.6* (C3’), 75.7 (C2’ & C4’ & C5’& C7’), 72.2 
(C6’), 69.8, 69.6, 66.5 (C2’ & C4’ & C5’& C7’), 20.7 (C8’). 
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